Search by Journal

  • HOME 
  •  >  Search by Journal
  •  >  Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences

Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences

Volume , Issue suppl.1 / 2022
English Article   Japanese Article
  • Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.
Japanese Article YPL. Clinical pharmacy of Society 5.0 to weave by fusion of the intellect
山本康次郎1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 92-92, 2022.
Japanese Article 23-01-S01-1. Efforts about the securing of reliability of MID-NET
大田有佳里1), 岸塲真理1), 關野一石1), 宇山佳明1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 93-93, 2022.
Japanese Article 23-01-S01-2. It is > through an activity about the < master standardization about the standardization containing the COVID-19-related drug in the medical institution
高田敦史1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 94-94, 2022.
Japanese Article 23-01-S01-3. The need of the correspondence data standardization, cooperation to the new coronavirus infection in the drugstore
豊見敦1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 95-96, 2022.
Japanese Article 23-01-S01-4. Data reliability on conducting epidemiologic studies
幾田慧子1), 中川俊作1), 寺田智祐1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 97-97, 2022.
Japanese Article SL1. Role of a digital medical future image and the in that prospective pharmacist
市川太祐1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 98-98, 2022.
Japanese Article EL1. It is ... mainly on scientific collection, evaluation of the drug information, utilization - pharmacokinetics
大谷壽一1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 99-99, 2022.
Japanese Article EL2. Proteomics analysis and data health care based on big data
和賀巌1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 100-100, 2022.
English Article 23-02-S02-1. Oncology pharmacist in Japan - Practice, Research, and Future Perspectives
土屋雅美1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 101-102, 2022.
English Article 23-02-S02-2. Comparison of Japanese and US Pharmacy Education Systems and Daily Pharmacy Practice
Mio Ezura1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 103-104, 2022.
English Article 23-02-S02-3. Specialty training in oncology and daily practice of clinical pharmacists in the United States
Jeffrey C. Bryan1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 105-106, 2022.
Japanese Article 23-02-S03-1. [How to edition] One step of the clinical studies beginning: Of "the kind" of the study find; and a way of raising
岡田直人1), 合田光寛1,2), 石澤啓介1,2,3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 107-107, 2022.
Japanese Article 23-02-S03-2. [How to edition] We understand ... regulation and an ethic definitely before beginning clinical studies
金光祥臣1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 108-108, 2022.
Japanese Article 23-02-S03-3. [How to edition] A type and precaution of the real world data which can inflect for a study
小原拓1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 109-109, 2022.
Japanese Article 23-02-S03-4. [practice edition] From the experience of the clinical studies using the electronic medical chart in ... own institution that general hospital pharmacist can do it
漣航平1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 110-111, 2022.
Japanese Article 23-02-S03-5. [practice edition] The thing that we need when a clinical pharmacist conducts a study using JADER
松尾純1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 112-112, 2022.
Japanese Article 23-02-S03-6. [practice edition] Make use of the experience of the clinical studies using the database of single institution - home and abroad
八木達也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 113-113, 2022.
Japanese Article 23-02-S04-1. DX which we saw from small and medium size hospital pharmacist
荒川隆之1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 114-114, 2022.
Japanese Article 23-02-S04-2. Has an electronic medical chart not become "the computerization of the paper?"
楢林敦1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 115-115, 2022.
Japanese Article 23-02-S04-3. Medical DX in the drugstore
豊見敦1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 116-116, 2022.
Japanese Article 23-02-S04-4. ... which thinks about medical quality, security, management in a viewpoint of approach - hospital pharmacist to visualization of the information necessary for the House of DX woes of the times administration
関利一1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 117-117, 2022.
Japanese Article 23-02-S04-5. DX which we saw from the settings of the pharmacy education
倉田香織1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 118-118, 2022.
Japanese Article 23-03-S05-1. From a viewpoint of improvement in role - infection measures addition 1 of the pharmacist sought by infection control, the infection practice support of the corona evil
塩田有史1), 三鴨廣繁2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 119-119, 2022.
Japanese Article 23-03-S05-2. ... which makes use of the knowledge that we obtained in the infection preventive measures against new development - corona evils addition of the activity of the municipal hospital pharmacist sought by the improvement in infection measures addition
片山歳也1), 鈴木朋克2), 小島さおり3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 120-121, 2022.
Japanese Article 23-03-S05-3. Next-generation antimicrobial proper use by the pharmacy service under health insurance drugstore pharmacist
瀧藤重道1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 122-122, 2022.
Japanese Article 23-03-S05-4. Expectation to infection control, a pharmacist in the infection practice support who fixed the eyes on the improvement in infection measures addition
三鴨廣繁1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 123-123, 2022.
Japanese Article 23-03-S06-1. The task share that an HIV specialist expects from a pharmacist
柳澤邦雄1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 124-124, 2022.
Japanese Article 23-03-S06-2. Task shifting to the pharmacist at the start of treatment
樋口裕哉1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 125-125, 2022.
Japanese Article 23-03-S06-3. Pharmacist task shifting in treatment assessment
平野淳1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 126-126, 2022.
Japanese Article 23-03-S06-4. Task shifting to pharmacists in long-term care
戸矢崎信也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 127-127, 2022.
Japanese Article 23-03-S07-1. About the latest antiemesis therapy evidence (about prophylactic measures, measures of prominence-related retching)
前田章光1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 128-128, 2022.
Japanese Article 23-03-S07-2. Evidence of the antiemesis therapy which a pharmacist makes
飯原大稔1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 129-130, 2022.
Japanese Article 23-03-S07-3. About the condition of a patient, a drug causing retching, vomiting (the clinical reasoning)
桂川健司1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 131-131, 2022.
Japanese Article 23-03-S07-4. About the image views that we want to control by retching, vomiting
田近正洋1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 132-132, 2022.
Japanese Article 23-03-S07-5. We think about appropriate retching, vomiting measures from a real intervention case!
橋詰淳哉1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 133-133, 2022.
Japanese Article 23-06-S08-1. We challenge a multicenter study
林稔展1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 134-134, 2022.
Japanese Article 23-06-S08-2. For the enforcement of the multicenter study across the type of job
武智研志1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 135-135, 2022.
Japanese Article 23-06-S08-3. Perform the each study for patients with difference - heart failure with a single institution study and the multicenter study; and -
川田敬1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 136-136, 2022.
Japanese Article 23-06-S08-4. The multicenter phase II study that a pharmacist conducts
飯原大稔1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 137-138, 2022.
Japanese Article 23-06-S08-5. It is ... from the situation of thing - enforcement medical institution which we worked on to conduct a multicenter study smoothly
玉木慎也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 139-140, 2022.
Japanese Article 23-06-S09-1. Cooperation of hospital pharmacist and the opening of an office pharmacist at disaster in Gunma
矢島秀明1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 141-141, 2022.
Japanese Article 23-06-S09-2. The pharmaceutical information management at disaster and systems construction for disaster pharmaceutical affairs
江川孝1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 142-142, 2022.
Japanese Article 23-06-S09-3. How do win information to become the key to pharmaceutical products supply at disaster; role - of the - Japan Red Cross pharmacist society
小林映子1,2), 細谷龍一郎3), 細谷治1), 森英樹4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 143-144, 2022.
Japanese Article 23-06-S09-4. Possibility ... of information sharing system - drug support at disaster
市川学1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 145-145, 2022.
Japanese Article 23-06-S09-5. The support system of importance and the Japanese Society of Hospital Pharmacists of the information management at disaster
高山和郎1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 146-146, 2022.
Japanese Article 23-06-S10-1. Efforts of next-generation upbringing to support sustainable career path
土屋雅美1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 147-147, 2022.
Japanese Article 23-06-S10-2. In the days when does not show a point, it is ... from the person whom we met, mind not to waver, position of resilience ... best hospital pharmacist
藤堂真紀1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 148-148, 2022.
Japanese Article 23-06-S10-3. Career path as the pharmacoepidemiology researcher
原梓1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-150, 2022.
Japanese Article 23-06-S10-4. A medical way of working sustainable throughout the trade: The secret is work life balance
大西友美子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-152, 2022.
Japanese Article 23-06-S10-5. Why does pharmacy management go well when we support career path? ... ... which sounding out complies with now in individual True North of the pharmacist
大里洋一1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 153-153, 2022.
English Article 23-07-IS01-1. Patient-centered Pharmaceutical Care
Chun-Yu Wang1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 154-154, 2022.
English Article 23-07-IS01-2. Mechanisms of SPP1 / αvβ3 axis mediated enzalutamide resistance in castration-resistant prostate cancer and therapeutic strategy
Xiaocong Pang1,2), Xiaojiao Sun3), Yanlun Gu1,2), Xu He1,2), Zhenming Liu3), Song Song3), Jie Xia4), Jixin Zhang5), Yimin Cui1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-156, 2022.
English Article 23-07-IS01-3. Humanitarian Assistance to Ukrainian Refugees in the Republic of Moldova
Takashi Egawa1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 157-158, 2022.
English Article 23-07-IS01-4. Selection of immediately disintegrating drugs and improvement of dispensing and administration
HeeJin Jeong1), MinHee Kum1), SeoYoung Son1), KyungMi Jung1), SooYeon Lee1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 159-160, 2022.
English Article 23-07-IS01-5. Effectiveness of the improved prescription review system for outpatients receiving chemotherapy
MiSeon Han1), SunA Lee1), YoungHee Lee1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 161-162, 2022.
English Article 23-07-IS02-1. Drug development for Niemann-Pick disease Type C : a mechanistic approach to optimize drug-cholesterol interaction
Yusei Yamada1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2022.
English Article 23-07-IS02-2. Nationwide survey of pharmacies for trends in antimicrobial use and AMR-reduction measures
Hirokazu Horikoshi1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 164-164, 2022.
English Article 23-07-IS02-3. Identifying Early Predictive Markers for Immune-Related Adverse Events in Nivolumab-Treated Patients
Shinya Takada1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 165-165, 2022.
English Article 23-07-IS02-4. Association between statin use and daptomycin-related musculoskeletal adverse events
Masayuki Chuma1), Aki Nakamoto2), Takashi Bando2), Takahiro Niimura3), Yutaka Kondo4), Hirofumi Hamano5), Naoto Okada2), Mizuho Asada6), Yoshito Zamami5), Kenshi Takechi7), Mitsuhiro Goda8), Koji Miyata8), Kenta Yagi3), Toshihiko Yoshioka2), Yuki Izawa-Ishizawa9), Hiroaki Yanagawa3), Keisuke Ishizawa8), Yoshikazu Tasaki1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-167, 2022.
English Article 23-07-IS02-5. Clinical application education for integration of drug information and basic pharmacology
Masahiro Ueda1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-169, 2022.
Japanese Article 23-08-S11-1. Task shift task shares from a pharmacist to the person except the pharmacist
岸本真1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 170-170, 2022.
Japanese Article 23-08-S11-2. Of task shift/share of the self-injection practical skill instruction for patients with diabetes in the Nishijin Hospital, actually
三宅健文1), 池田未久里1), 植村有加1), 安田早織1), 辻芙美1), 矢野美保2), 牛嶋麻紀1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 171-172, 2022.
Japanese Article 23-08-S11-3. Task shift task share by pharmaceutical management PBPM in wards, and the like
篠永浩1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2022.
Japanese Article 23-08-S11-4. Task shift task share about the pharmaceutical management, and the like in the perioperative period
舟越亮寛1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2022.
Japanese Article 23-08-S11-5. Promotion and team approach in medical care of task shift/share
眞野成康1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2022.
Japanese Article 23-08-S12-1. Purpose explanation and the authorized situation and instructions of 2021
河原昌美1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2022.
Japanese Article 23-08-S12-2. It is the pharmaceutical intervention for the relapsed patient after the renal pelvis cancer technique which irAE by the Pembrolizumab was suspected in
高橋愛未1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-178, 2022.
Japanese Article 23-08-S12-3. The heart failure case that resulted in disturbance of consciousness by hyperammonemia due to colon cancer - 5-FU
松尾圭祐1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-180, 2022.
Japanese Article 23-08-S12-4. The stomach cancer case that examined vomiting during cancer medical therapy and a cause of the oedema lower limb, and was given pharmaceutical intervention
米山大志1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 181-181, 2022.
Japanese Article 23-08-S12-5. The case that was able to accomplish allogeneic stem cell transplant in correspondence with fever and TLS at the acute lymphoid leukemia - bridging therapy
渡邉貴子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2022.
Japanese Article 23-08-S12-6. About the role that the pharmacist specialized in a cancer takes
池田龍二1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2022.
Japanese Article 23-08-S13-1. Try evaluation by organ system! - Tips for circulation management drugs -
西田祥啓1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2022.
Japanese Article 23-08-S13-2. According to the organ system: Nerve analogous drug (PADIS)
山本麻里子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2022.
Japanese Article 23-08-S13-3. It is kidney edition a challenge for the evaluation according to the organ system in sepsis
今中翔一1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2022.
Japanese Article 23-08-S13-4. According to the organ system: Infection analogous drug
枦秀樹1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2022.
Japanese Article 23-10-S14-1. Reinforcement of life training and person fortune upbringing of the pharmacist whom Kyoto pharmacist society works on
三浦誠1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2022.
Japanese Article 23-10-S14-2. Efforts in the study session for nurses of the nutrition therapy abecedarian who can make use tomorrow, and arrested the characteristic of the adults learner
金子真由美1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2022.
Japanese Article 23-10-S14-3. Invention and effect of the multi-type of job nourishment domain study session for young people under 40 years old
矢倉尚幸1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-191, 2022.
Japanese Article 23-10-S14-4. Self-study and educational practice in pursuit of the essence of the turnover pharmacists from hospital pharmacist to a drugstore pharmacist
藤田あゆみ1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-193, 2022.
Japanese Article 23-10-S14-5. The practical study method that they will make use of knowledge and experience in patients, and worth doing, the growth can realize
長谷川裕矢1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-195, 2022.
Japanese Article 23-10-S15-1. From the position of one - clinical practice pharmacist with suspected aciclovir encephalopathy in the elderly men who do not have renal failure in a history -
中嶋宏太1,2,3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-197, 2022.
Japanese Article 23-10-S15-2. From the position of one - clinical pharmacist of the Parkinson's disease which an effect of levodopa decreased by a banana -
保戸塚里美1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2022.
Japanese Article 23-10-S15-3. From the position of the clinical pharmacist who did graduation in vancomycin and one acute nephropathic - fundamental researches in patients with tazobactam/piperacillin combination cancer -
中谷香織1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2022.
Japanese Article 23-10-S15-4. From the position of the teacher of environmental made - college of pharmacy to support case report -
安武夫1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2022.
Japanese Article 23-10-S15-5. From the position of a teacher, the clinical on-site manager of point - college of pharmacy of the case report for abecedarians -
内倉健1), 百賢二1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2022.
Japanese Article 23-10-S16-1. How to write clinical results in the pharmacist system specialized in clinical pharmacy
花輪剛久1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-203, 2022.
Japanese Article 23-10-S16-2. How to write case report in the pharmacist system specialized in a cancer
三宅知宏1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2022.
Japanese Article 23-10-S16-3. How to write case report in the pharmacist system specialized in medical therapy
小川敦1), 関根祐子2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-206, 2022.
Japanese Article 23-10-S16-4. How to write case report in the pharmacist system specialized in local pharmacy care
出石啓治1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2022.
Japanese Article 23-11-S17-1. The way of the metabolism dietetics education in the pharmacy school
千葉正博1), 唐沢浩二1), 岡本まとか1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2022.
Japanese Article 23-11-S17-2. Future - that - rehabilitation nourishment reconsidering the nourishment management by the pharmacist, a rehabilitation drug result
東敬一朗1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2022.
Japanese Article 23-11-S17-3. A pharmacist "being able to do it by medical care in remote area in the dietetics"
門脇寛篤1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2022.
Japanese Article 23-11-S17-4. A role and challenge of the pharmacist maximizing convalescent nourishment support
松本彩加1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2022.
Japanese Article 23-11-S17-5. Relation pharmacist in local one body type NST
近藤宏樹1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2022.
Japanese Article 23-11-S17-6. Role of the drugstore as the healthy station
小黒佳代子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2022.
Japanese Article 23-11-S18-1. Than a study of the algorithm making to be hard to take medicine, and to support associated with report - deglutition functional decline of the medication situation investigation in the old man insurance institution, the intraoral Residual medicine investigation -
肥田典子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-215, 2022.
Japanese Article 23-11-S18-2. Problems of the tablet crush
鈴木慶介1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2022.
Japanese Article 23-11-S18-3. Incompatibility in the crush and simple suspension method
石田志朗1), 倉田なおみ2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2022.
Japanese Article 23-11-S18-4. We add a role and the eating deglutition function recovery system of the pharmacist in the dysphagia measures team
関谷秀樹1), 石井杏奈1), 山崎香代1), 鷲澤尚宏1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2022.
Japanese Article 23-11-S18-5. How to drink medicine guide - to lead from eating dysphagia - diet situation
倉田なおみ1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-220, 2022.
Japanese Article 23-11-S19-1. We cope with ... evaluation that you should do if we examine disturbance of consciousness
森安恵実1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2022.
Japanese Article 23-11-S19-2. Approach for patients with disturbance of consciousness of the intensive care domain
吉廣尚大1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2022.
Japanese Article 23-11-S19-3. Approach for patients with disturbance of consciousness of the cancer domain
東加奈子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2022.
Japanese Article 23-11-S19-4. Approach for patients with disturbance of consciousness of the psychiatry domain
加藤隆寛1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2022.
Japanese Article 23-12-S20-1. Renal disease study prospective from "renal failure practice guidelines at the revised edition cancer medical therapy"
松原雄1), 柳田素子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2022.
Japanese Article 23-12-S20-2. The point that you should seize in the clinical studies enforcement of kidney and the cardiovascular disease
原梓1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2022.
Japanese Article 23-12-S20-3. The drug-related nephropathic basics and clinical studies
中川俊作1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2022.
Japanese Article 23-12-S20-4. Drug-related nephropathic clinical studies utilizing the database
國津侑貴1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-229, 2022.
Japanese Article 23-12-S21-1. Backstage ... of ... upbringing to learn through the cooperation with inside the hospital, the area together
池末裕明1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2022.
Japanese Article 23-12-S21-2. Efforts for promotion of clinical studies about the cancer relaxation medical care in connection with medical facilities and upbringing of the coworker
松村千佳子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2022.
Japanese Article 23-12-S21-3. Carrier support and personnel training through the member of society postgraduate education of the pharmacist staff
内藤隆文1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2022.
Japanese Article 23-12-S21-4. Study type pharmacist upbringing strategy - Osaka University Pharm. in all study type 6-year pharmacy education systems D course ...
前田真一郎1,2), 奥田真弘1,2), 藤尾慈1,3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-234, 2022.
Japanese Article 23-12-S21-5. Point of review, the article examination to be useful for article making
田崎嘉一1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2022.
Japanese Article 23-12-S22-1. Hyperkalemic management of patients with kidney disease chronic for the preservation period
吉田紗理1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2022.
Japanese Article 23-12-S22-2. Hyperkalemic ... ... which steps, and knows the depth of patients on dialysis
吉田拓弥1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2022.
Japanese Article 23-12-S22-3. Hyperkalemic management of renal-transplant recipients
安田知弘1), 恒川龍二1), 木全司1), 長谷川雄基2), 田中慧2), 余西洋明2), 西沢慶太郎2), 二村健太2), 岡田学2), 平光高久2), 後藤憲彦2), 鳴海俊治2), 渡井至彦2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2022.
Japanese Article 23-12-S22-4. Management of the hyperkalemia at the health insurance pharmacy
菅原鉄矢1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2022.
Japanese Article 23-13-S23-1. The condition of a patient and treatment of respiratory illness with the airflow obstruction
福岡和也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2022.
Japanese Article 23-13-S23-2. The onset risk of infection mechanism of COVID-19 and the asthmatic patients: A point and reproduction of the pulmonary tissue judging from the viewpoint of importance and the laboratory study of the appropriate inhalation therapy
山本直樹1,2,3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-242, 2022.
Japanese Article 23-13-S23-3. Point judging from the pharmacist viewpoint of the acute phase hospital
朝倉佳代子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2022.
Japanese Article 23-13-S23-4. Point judging from the pharmacist viewpoint in the regional alliances by the corona evil
尾上雅英1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2022.
Japanese Article 23-13-S23-5. A change of the inhalational instruction in the corona evil that we saw from a drugstore pharmacist and future problem
服部静香1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2022.
Japanese Article 23-13-S24-1. Heart rehabilitation of the old heart failure
安達仁1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2022.
Japanese Article 23-13-S24-2. Physical therapy for the hospitalization-related ability drop prevention of patients with old heart failure and local heart rehabilitation
齊藤正和1), 作山晃裕1), 森沢知之1), 高橋哲也1), 藤原俊之1,2), 代田浩之1,3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2022.
Japanese Article 23-13-S24-3. Point when we use ... chronic cardiac insufficiency therapeutic drug to reconsider for the ... heart failure pandemic era for elderly people
中川隼一1), 島崎博士1), 平島徹1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2022.
Japanese Article 23-13-S24-4. It is ... from the viewpoint of prevention, treatment and palliative care - circulatory organ charge pharmacist of the heart failure in patients with cancer
田中雅幸1,2), 藤井良平2), 諏訪惠信3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-250, 2022.
Japanese Article 23-13-S25-1. Health support drugstore, the regional alliances drugstore which supports an area
廣田憲威1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2022.
Japanese Article 23-13-S25-2. Cooperation between local drugstores supporting treatment at home
白石丈也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2022.
Japanese Article 23-13-S25-3. Support treatment at home; living-in-; supporting; examine; the role of the pharmacist
餅原弘樹1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2022.
Japanese Article 23-13-S25-4. Look back on the home care support of the pharmacist under the pandemic
齊藤直裕1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2022.
Japanese Article 23-13-S25-5. It is cooperation ... between ... medical care cooperation and drugstores from "a thing" in the treatment at home to "humans"
串田一樹1), 廣原正宜1), 宮崎生子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2022.
Japanese Article PL. Efforts and problem of the Japanese cure association for the post-corona
山本康次郎1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2022.
Japanese Article EL3. The Japanese alphabet of the electronic prescription judging from information system
土井俊祐1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2022.
Japanese Article 24-01-SP-1. Approach of Ministry of Health, Labour and Welfare in the data health reform
田中彰子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2022.
Japanese Article 24-01-SP-2. Structure and the information use and application which can confirm medical information in the whole country
岡田美保子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2022.
Japanese Article 24-01-SP-3. A problem and the prospects of standardization in the computerization of the prescription information and the data use and application
大江和彦1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2022.
Japanese Article 24-01-SP-4. Structure and PHR which can utilize own health medical care information
中島直樹1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-262, 2022.
Japanese Article SL2. Machine learning, standardization, the quantum computing that Society 5.0 of the pharmaceutical study reform began
鳥飼幸太1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2022.
Japanese Article 24-02-S26-1. We understand pharmacokinetic analysis software: From a principle to pit fall
佐古兼一1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2022.
Japanese Article 24-02-S26-2. A further move of the population analysis: Population pharmacokinetics meta analysis
石原慎之1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-266, 2022.
Japanese Article 24-02-S26-3. We understand essence of the free form drug concentration: What do you mean? Why is it important?
横山雄太1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-268, 2022.
Japanese Article 24-02-S26-4. TDM in consideration of the interaction between drug - endogenous material: Distribution to lipoprotein
土岐浩介1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-270, 2022.
Japanese Article 24-02-S26-5. Way of thinking of the pharmacokinetic assessment on the basis of pharmacokinetics, physiology, pharmacology
山本武人1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2022.
Japanese Article 24-02-S27-1. Challenges from clinical duties to the new study domain utilizing the IT technique to unfold
牛尾聡一郎1), 木村郁哉1), 川端崇義1), 三浦太郎1), 濱野裕章1), 鍛治園誠1), 西原茂樹1), 村川公央1), 座間味義人1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2022.
Japanese Article 24-02-S27-2. You utilize data science, and can you solve a clinical question? It is ... with the database study by ... clinical pharmacist
八木達也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2022.
Japanese Article 24-02-S27-3. We learned for evidence construction for pharmaceutical products proper use in ... graduate school and clinical settings
小出博義1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-275, 2022.
Japanese Article 24-02-S27-4. Study ... about thing - cancer-related duties X cancer drug resistance mechanism that we obtained it by conducting fundamental researches in the position of the clinical pharmacist
高橋理充1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2022.
Japanese Article 24-02-S28-1. Challenge to the basics, the intractable disease conquest that assumed a clinical fusion study a breakthrough
城野博史1,2), 齋藤秀之1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2022.
Japanese Article 24-02-S28-2. Development of the basics, clinical fusion type study being aware of the strength of the pharmacy
大山要1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2022.
Japanese Article 24-02-S28-3. Basic clinical fusion type study by the data science that assumed medical big data a base
座間味義人1), 牛尾聡一郎1), 濱野裕章1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2022.
Japanese Article 24-02-S28-4. Expression of circadian rhythm and drug transportation transporter control of the RNA editing enzyme in human proximal tubules cells
小柳悟1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2022.
Japanese Article 24-02-S28-5. The basics, clinical studies aiming at the treatment optimization of patients with infection
松元一明1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2022.
Japanese Article 24-03-S29-1. Administrative efforts about the pediatric pharmaceutical products development
文靖子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2022.
Japanese Article 24-03-S29-2. Proper use promotion of pharmaceutical products in the childhood medical therapy judging from a viewpoint of the academia
石川洋一1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2022.
Japanese Article 24-03-S29-3. Proper use of pharmaceutical products in the childhood medical therapy judging from the viewpoint of the pharmacist who worked for a pediatric special hospital
齊藤順平1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2022.
Japanese Article 24-03-S29-4. We think about pharmaceutical products proper use of the childhood medical therapy in the general hospital from the position of the drug section manager
平下智之1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2022.
Japanese Article 24-03-S29-5. Proper use of pharmaceutical products in the childhood medical therapy judging from the viewpoint of the pediatrician
河田興1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-287, 2022.
Japanese Article 24-03-S30-1. We think about the TDM of the 5-FU system anticancer agent based on evidence
白岩健1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-289, 2022.
Japanese Article 24-03-S30-2. TDM of busulfan that creation of the evidence is expected
山崎伸吾1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2022.
Japanese Article 24-03-S30-3. Choice of the quantitative analysis technology to extend TDM duties
森川剛1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2022.
Japanese Article 24-03-S30-4. Importance of the inflammatory response on performing TDM
榎屋友幸1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2022.
Japanese Article 24-03-S30-5. TDM approach by Model-informed precision dosing
尾田一貴1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2022.
Japanese Article 24-03-S31-1. The multi-type of job cooperation education in university and connection to business training
津田真弘1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2022.
Japanese Article 24-03-S31-2. With the multi-type of job cooperation education in the pharmacy business training in the circulatory organ domain
段林正明1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2022.
Japanese Article 24-03-S31-3. Emergency intensive care, Interprofessional Education in the disaster healthcare setting
檜山洋子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2022.
Japanese Article 24-03-S31-4. We make use of the infection related to multi-type of job round in a clinic and show a pharmacy student, a medical student the back of the professional
今井徹1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-298, 2022.
Japanese Article 24-03-S31-5. Pharmacy business training aiming at upbringing of the pharmacist who could collaborate in a cancer chemotherapy team
上ノ段友里1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2022.
Japanese Article 24-03-S31-6. When a pharmacist changes, medical care changes: Towards the future to be able to shine
矢野育子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-301, 2022.
Japanese Article 24-06-S32-1. Efforts to the construction of the blood drug levels assay utilizing the LC/MS/MS and the therapeutic drug monitoring of the psychiatry domain
前川正充1,2), 佐藤紀宏1), 鈴鹿雅人1), 佐藤祐司1), 菊地正史1,2), 眞野成康1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-303, 2022.
Japanese Article 24-06-S32-2. Challenge to the administration of psychotropic drug optimization utilizing a genetic information and blood drug concentration
猿渡淳二1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2022.
Japanese Article 24-06-S32-3. The onset prediction marker of the interstitial lung disease with the anticancer medicine
山本和宏1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2022.
Japanese Article 24-06-S32-4. Real world data drive type human pharmacology study aiming at optimization of the medical therapy
合田光寛1,2), 神田将哉1,2), 吉岡俊彦1,2), 新村貴博3), 櫻田巧2), 小川敦2), 相澤風花2), 八木健太3), 石澤有紀4), 座間味義人1,5), 石澤啓介1,2,3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2022.
Japanese Article 24-06-S32-5. Development to the personalized medicine that assumed pharmacokinetic information under the special condition of a patient a base
田中遼大1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2022.
Japanese Article 24-06-S33-1. We will think about CKD and treatment of the heart failure who had anemia
木下照常1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-309, 2022.
Japanese Article 24-06-S33-2. We will think about treatment of acute myeloid leukemia in the elderly people who had multiple diseases
阿部史誉1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-311, 2022.
Japanese Article 24-06-S34-1. Insurance of the infertility treatment receives becoming it and a start of the fecundity preservation therapy study promotion business
前沢忠志1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2022.
Japanese Article 24-06-S34-2. Infertility treatment, assisted reproductive technology and medical therapy: We think about the relation of the pharmacist
日置三紀1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2022.
Japanese Article 24-06-S34-3. Practice of the relation of the pharmacist in the cancer reproductive medicine and the pharmaceutical evaluation
佐々木実緒1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-315, 2022.
Japanese Article 24-06-S34-4. Pharmaceutical products risk to patients with the reproductive capability
米村雅人1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2022.
Japanese Article 24-07-S35-1. Revised point of the GCP affecting a clinical experimental medicine
黒田智1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2022.
Japanese Article 24-07-S35-2. Response of the sponsor accompanied with the GCP revision
渡部ゆき子1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2022.
Japanese Article 24-07-S35-3. A fact of the management of the use of trial medicine and future problem
老本名津子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2022.
Japanese Article 24-07-S35-4. Expectation to a decentralization clinical study
岩崎優1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-321, 2022.
Japanese Article 24-07-S35-5. The role of the drug section in the decentralization clinical study and future problem
近藤直樹1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2022.
Japanese Article 24-07-S36-1. Medical therapy depending on the condition of a patient of the pain
中川貴之1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2022.
Japanese Article 24-07-S36-2. Polypharmacy in the medical therapy of the pain and the correspondence
萬谷摩美子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2022.
Japanese Article 24-07-S36-3. Use of inappropriateness of the medicine relieving a pain
成瀬暢也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-326, 2022.
Japanese Article 24-07-S36-4. The prescription start that fixed its eyes on the end in the medical therapy of the pain
山口重樹1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2022.
Japanese Article 24-07-S37-1. underdose in the cardiovascular disease judging from the viewpoint of the physician
佐藤宏行1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2022.
Japanese Article 24-07-S37-2. The heart rate control in patients with heart failure and problem of Clinical Inertia
高井靖1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2022.
Japanese Article 24-07-S37-3. Only dose adequacy of underdose - DOAC in the anticoagulation is not mission; is ...
芦川直也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2022.
Japanese Article 24-07-S37-4. ... which thinks about continuation, the start at the underdose - decreased renal function of the renin-angiotensin system inhibitor
大橋泰裕1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2022.
Japanese Article 24-08-S38-1. The women whom prominence-related retching with cyclophosphamide developed in in large quantities in 50s
小室雅人1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2022.
Japanese Article 24-08-S38-2. The women whom ptosis and weakness of lower extremities developed in during colon cancer treatment in 70s
橋口宏司1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2022.
Japanese Article 24-08-S38-3. The women who appealed for intense lassitude in colon cancer treatment in 60s
土屋雅美1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2022.
Japanese Article 24-08-S38-4. Men with suspected creatine kinase rise by drug interactions in 70s
藤田行代志1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2022.
Japanese Article 24-08-S38-5. It is ... from the position of expectation - primary physician to a pharmacist playing an active part in the cancer domain
岸田直樹1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2022.
Japanese Article 24-08-S39-1. Study development, acquaintances linking the point to the point and next generation upbringing to carry the next generation
河添仁1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2022.
Japanese Article 24-08-S39-2. Learning gained from the experience of multi-center joint research and expanding connections with people
那須いずみ1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2022.
Japanese Article 24-08-S39-3. To you to be the pharmacist who had study mind and clinical mind
小林一男1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2022.
Japanese Article 24-08-S39-4. Fundamental researches to solve a clinical problem in the cancer chemotherapy
川尻雄大1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2022.
Japanese Article 24-08-S39-5. Training ... of medical human resources promoting the study of the reverse translational research - clinical problem solving type to work in pharmacy
今井哲司1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2022.
Japanese Article 24-08-S40-1. The perioperative care team pharmacist whom Japanese Society of Anesthesiologists expects
松本美志也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2022.
Japanese Article 24-08-S40-2. Perioperative care outpatient department, the distance until pharmacist placement
鈴木史絵1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2022.
Japanese Article 24-08-S40-3. Struggle to become the member of the operating room
天野杏南1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2022.
Japanese Article 24-08-S40-4. We make the evidence of the pharmaceutical intervention with operating room duties
猪狩賢蔵1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2022.
Japanese Article 24-08-S40-5. Aim as an operating room pharmacist
柴田みづほ1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-347, 2022.
Japanese Article 24-08-S40-6. Know-how of the pharmacist intervention in the postoperative pain management team
長谷川哲也1), 疋田真理1), 坂本真紀1), 松本高広1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-349, 2022.
Japanese Article 24-10-S41-1. Promotion of duties efficiency and the task shift by the robot utilization to formulations, preparation duties in the Mie Univ. Hospital
向原里佳1), 岩本卓也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-351, 2022.
Japanese Article 24-10-S41-2. It is ... for safety and the efficiency of construction - compounding of medicines duties of new drug duties by the harmony with a robot and the person
高瀬友貴1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-353, 2022.
Japanese Article 24-10-S41-3. Challenge ... to development - formulations mistake zero of the robot drugstore, waiting time zero
渡部正之1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2022.
Japanese Article 24-10-S41-4. Efforts of the DX promotion that intended the construction of advanced drug duties in the university hospital pharmacy
座間味義人1), 牛尾聡一郎1), 濱野裕章1), 鍛治園誠1), 西原茂樹1), 村川公央1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2022.
Japanese Article 24-10-S42-1. Relation to patients with sleep loss that complicated the psychiatric care - depression disorder and extrapyramidal symptoms to patients with cancer by the pharmacist
高瀬久光1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-357, 2022.
Japanese Article 24-10-S42-2. Role of delirium and the pharmacist in patients with cancer
菅原英輝1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2022.
Japanese Article 24-10-S42-3. Intervention to metastases to brain-induced epilepsy
赤嶺由美子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2022.
Japanese Article 24-10-S42-4. Intervention to patients with mental disorder of the cancer onset
坪内清貴1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2022.
Japanese Article 24-10-S42-5. The point of contact with psychooncology and the kidney
門脇大介1), 橋本麻衣1), 猿渡淳二2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2022.
Japanese Article 24-10-S43-1. Personalized medicine and pathophysiology simulation model utilization as the treatment strategy examination base
中田智久1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-363, 2022.
Japanese Article 24-10-S43-2. Pharmacokinetic interaction with the Chinese medicine
猿渡淳二1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2022.
Japanese Article 24-10-S43-3. How do have an evaluation, clinical application of drug interaction; from the ... clinical studies, clinical pharmacist's experience -
八木達也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2022.
Japanese Article 24-10-S43-4. Pharmacoepidemiology study - using fact-finding - medical care big data of the drug interactions based on the clinical viewpoint
濃沼政美1), 百賢二2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2022.
Japanese Article 24-11-S44-1. Why is a symposium of the career path necessary now?
川上和宜1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2022.
Japanese Article 24-11-S44-2. How are you thinking about the future and the anxiety as the pharmacist?
江頭早紀1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2022.
Japanese Article 24-11-S44-3. The middle age thinks of what, and do you try a clinical study hard?
高橋克之1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2022.
Japanese Article 24-11-S44-4. Experience real - institution transfer of the career path in the general hospital; and -
田頭尚士1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2022.
Japanese Article 24-11-S44-5. Career path to talk about from experience of the chief pharmacist of the institution specialized in three cancers
山口正和1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2022.
Japanese Article 24-11-S45-1. A summary and the preparations situation of the next revision pharmacy education model core curriculum
本間浩1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2022.
Japanese Article 24-11-S45-2. A role of "the clinical pharmacy." "Clinical pharmacy", it is the intermediary to a bedside teaching
小佐野博史1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2022.
Japanese Article 24-11-S45-3. The future prospects of a policy and the bedside teaching of the new "clinical pharmacy" education
鈴木匡1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2022.
Japanese Article 24-11-S45-4. "The hygiene pharmacy, public sanitation pharmacy" in the revision model core curriculum about "a pharmacy study"
平田收正1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2022.
Japanese Article 24-11-S45-5. We think about the medical person professionalism education in the pharmacy education
鈴木小夜1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2022.
Japanese Article 24-11-S46-1. How should you think about BCP of the drug section?
高山和郎1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-378, 2022.
Japanese Article 24-11-S46-2. Of BCP in the small and medium size hospital, actually
岸本真1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2022.
Japanese Article 24-11-S46-3. Of BCP in the basic hospital, actually
横山泰昭1), 舟越亮寛1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2022.
Japanese Article 24-11-S46-4. About efforts as the trade group for "the trust recovery of the generic drug"
田中俊幸1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2022.
Japanese Article 24-12-S47-1. Not only, for a medical person, we read an article, but also why is experience to write by oneself necessary?
片岡裕貴1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-383, 2022.
Japanese Article 24-12-S47-2. We learned by the first step - letter writing to systematic review writing and participation in open call for participants study
蔵田靖子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2022.
Japanese Article 24-12-S47-3. Invention and wall on practicing systematic review & meta-analysis
小武和正1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2022.
Japanese Article 24-12-S47-4. We consider the validity of the study to enroll in the process of the systematic review that we experienced in an intensive care domain: Between Diversity and heterogeneity
吉廣尚大1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2022.
Japanese Article 24-12-S47-5. Systematic review & meta-analysis of the cancer domain aiming at pharmaceutical products proper use
森尾佳代子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2022.
Japanese Article 24-12-S48-1. Cooperation of patients and the multi-type of job and the pharmacy supporting community medical care
吉山友二1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2022.
Japanese Article 24-12-S48-2. From the position of role - primary physician of the pharmacist in regional alliances, the team approach in medical care -
木村琢磨1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2022.
Japanese Article 24-12-S48-3. Exploring the ideal form of pharmacies that support community medical care: Initiatives at a small pharmacy in a local city, "Jyujin Pharmacy"
野田敏宏1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2022.
Japanese Article 24-12-S48-4. Patients follow-up in the community medical care and reporting to a physician
山本雄一郎1,2,3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2022.
Japanese Article 24-12-S48-5. A biological clock and chronotherapy
大戸茂弘1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2022.
Japanese Article 24-12-S48-6. Team approach in medical care education and attempt of the community medical care pharmacy education
山下美妃1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2022.
Japanese Article 24-12-S49-1. Problems from the analysis of the tracing report to the prescription adequacy in the psychiatry domain seeing
土井信幸1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2022.
Japanese Article 24-12-S49-2. The information of patients with mental disorder is insufficient, and how does a hurdle of the prescription intervention break the current situation of high ... health insurance pharmacy?
中田裕介1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-396, 2022.
Japanese Article 24-12-S49-3. Adequacy of the psychotropic drug prescription: Cooperation ... with the drugstore family for drug global assessment adjustment management ... medical office, a drugstore
加藤剛1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2022.
Japanese Article 24-12-S49-4. Interactive relation as polypharmacy measures in the psychiatry medical therapy
須田修輔1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2022.
Japanese Article 24-12-S49-5. Polypharmacy measures to catch in a multidirectional viewpoint: Polypharmacy measures in the education
野田幸裕1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-400, 2022.
Japanese Article 24-13-S50-1. Operation and inflection of the tracing report in the cancer special hospital
松井礼子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2022.
Japanese Article 24-13-S50-2. Construction ... such as area PBPM, TR, and the like which assumed the ICT of - area core hospital made with a base of the community medical care cooperation for the future a base
関利一1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2022.
Japanese Article 24-13-S50-3. Because a pharmacist of the community pharmacy supports patients with cancer, we think about effective support and cooperation
長久保久仁子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2022.
Japanese Article 24-13-S50-4. Patients with cancer support by cooperation construction and the telephone follow-up in the specialized medical institution cooperation drugstore
村田勇人1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-405, 2022.
Japanese Article 24-13-S50-5. Expectation for the way and hospital pharmacist and the health insurance pharmacy pharmacist of the information sharing that we saw from patients
山口育子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-407, 2022.
Japanese Article 24-13-S51-1. The basics and development of a nuclide, the drug for the Nuclear medicine treatment
久下裕司1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2022.
Japanese Article 24-13-S51-2. Relation of the in-hospital introduction and pharmacist of the radioactive medicines for the Nuclear medicine treatment
加納大輔1,2,3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-410, 2022.
Japanese Article 24-13-S51-3. About the association between fact and image of the Nuclear medicine treatment
石守崇好1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2022.
Japanese Article 24-13-S51-4. About an activity of the Japanese Society of Nuclear Medicine
間賀田泰寛1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2022.
Japanese Article 24-13-S52-1. Collaboration with the physician at the ICI administration in the district hospital
矢野琢也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2022.
Japanese Article 24-13-S52-2. It is the turn of the drugstore pharmacist! Long-term side effect management of ICI treated patients
下川友香理1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2022.
Japanese Article 24-13-S52-3. It is ... for application to adverse event evaluation - common practice of the patients using the immune checkpoint inhibitor by ePRO
東加奈子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2022.
Japanese Article 24-13-S52-4. From a health-related quality of life measurement tool in the medicine medicine cooperation than an expectation development example of the irAE early detection information sharing for the irAE management
清水久範1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2022.
Japanese Article 24-13-S52-5. Need and problems ... of the study across the fence of the irAE management - health insurance pharmacy pharmacist
辻将成1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2022.
Japanese Article Receiving a prize -1. (winning the Japanese cure prize from an academic society lecture) the application to creation and the clinical pharmacy study of the nerve mental disorder model on the basis of heredity and an environmental agent
山田清文1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2022.
Japanese Article Receiving a prize -2. (winning the prize for encouragement lecture) a clinical evaluation of the pharmaceutical intervention about antimicrobial proper use support and antifungal agent proper use support
植田貴史1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2022.
Japanese Article Receiving a prize -3. (winning the prize for encouragement lecture) basic - clinical studies about the medical therapy optimization of Special population mainly on the impaired renal function
近藤悠希1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2022.
Japanese Article Receiving a prize -4. (winning the prize for encouragement lecture) development of the individualization medical therapy in the psychiatry domain
赤嶺由美子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2022.
Japanese Article Receiving a prize -5. (winning the prize for encouragement lecture) an effect of the antimicrobial medicine and a clinical epidemiology study on safety
中川俊作1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2022.
Japanese Article PA-1. The examination of the optimal administration method in elderly people of the daptomycin and factor analysis about the side effect expression
佐村優1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2022.
Japanese Article PA-2. Effect of the COMT Val158Met genetic polymorphism giving it to an internal change of 3-OMD which is L-dopa under the entacapone combination and the metabolite
山本譲1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2022.
Japanese Article PA-3. Comparison between the placenta, the brain barrier of MDR1 for the tissue drug distribution and the BCRP contribution
藤田有美1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-426, 2022.
Japanese Article PA-4. Search of the new protective for the cisplatin-induced renal failure using In Silico and the In Vivo approach
若井恵里1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2022.
Japanese Article PA-5. Inspection of the effect of the cyclooxygenase inhibitor which paid its attention to a side effect and the resistance of the anticancer agent
岡本敬介1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2022.
Japanese Article PA-6. Development of the new therapy of patients with cardiopulmonary arrest utilizing medical big data
新村貴博1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2022.
Japanese Article PA-7. The search of the active body of the small bowels organic anionic transportation polypeptide (OATP) inhibitory action by the juice and examination of the inhibitory activity
森田時生1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2022.
Japanese Article PA-8. Pharmacokinetic/pharmacodynamic analysis of vancomycin in the special group: Examination in extremely-low-birth-weight infants and patients with Enterococcus faecium bacteremia
笹野央1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2022.
Japanese Article PA-9. Adipose gastrointestinal absorption kinetic analysis derived from a diet through cholesterol transporter NPC1L1
梨本俊亮1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2022.
Japanese Article PA-10. Expression of CYP1 gene analysis with an expression profile of cytochrome P450 in MOG-G-CCM cells derived from a human astrocytoma and polycyclic aromatic hydrocarbon and the antiepileptic drug
小澤秀介1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2022.
Japanese Article 25-02-S53-1. Expectation and problem of the AI utilization to pharmaceutical products security
佐藤弘康1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2022.
Japanese Article 25-02-S53-2. There is a task shift share with information system and humans supporting duties of the hospital pharmacist and thinks
中尾元紀1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2022.
Japanese Article 25-02-S53-3. Medical DX and literacy education
池田和之1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2022.
Japanese Article 25-02-S53-4. Use and application of the large-scale clinical data to raise medical safety
畑武生1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2022.
Japanese Article 25-02-S53-5. Digitization and medical security
町谷安紀1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-439, 2022.
Japanese Article 25-02-S54-1. The drugstore where an area is supported in a support, the area
寺島健二1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-441, 2022.
Japanese Article 25-02-S54-2. About risk management to be useful for regional alliances demanded from a pharmacist now
野村浩夫1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2022.
Japanese Article 25-02-S54-3. ... that a visitor tells important thing - hint because a drugstore stays in history
酒井孝征1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2022.
Japanese Article 25-02-S54-4. Thought (proposal from the position of the university teacher educating a next-generation pharmacist) of the drugstore pharmacist who succeeded it from father
鈴木匡1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-445, 2022.
Japanese Article 25-03-S55-1. A drug discovery study to practice in the viewpoint of clinical reactions of drugs: The translational research which targeted an anticancer agent adverse event
相澤風花1), 岡林亜美2), 森山大嗣2), 薗田悠平1), 高橋志門1), 新村貴博3), 合田光寛1,2), 座間味義人4), 吉岡俊彦1), 八木健太3), 石澤有紀5), 石澤啓介1,2,3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2022.
Japanese Article 25-03-S55-2. An Ikuyaku study to practice in the viewpoint of clinical reactions of drugs: Clinical Pharmacometrics
青山隆彦1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2022.
Japanese Article 25-03-S55-3. The individualization medical therapy that assumed human pharmacology a base
平井利典1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-449, 2022.
Japanese Article 25-03-S55-4. Inflection of the evidence aiming at optimization of the medical therapy
上田昌宏1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-451, 2022.
Japanese Article 25-03-S56-1. Pharmacist specialized in prospective first aid
添田博1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2022.
Japanese Article 25-03-S56-2. We think about a role to demand from a pharmacist specialized in first aid from case report, the study examination of the pharmacist system specialized in first aid
服部雄司1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2022.
Japanese Article 25-03-S56-3. Role to expect of a pharmacist specialized in first aid from the situation of the physician
織田順1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2022.
Japanese Article 25-03-S56-4. Activity as the emergency authorized pharmacist at the small and medium size hospital
齋藤靖弘1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-456, 2022.
Japanese Article 25-03-S56-5. Activity as the emergency authorized pharmacist at the large-scale hospital
岡崎裕太朗1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2022.
Japanese Article 25-03-S56-6. Process of clinical pharmacy study in the emergency intensive care domain
尾田一貴1), 齋藤秀之1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2022.
Japanese Article 25-04-S57-1. Five-Year Plan to Overcome Stroke and Cardiovascular Disease and the Basic Act on Cardiovascular Disease Countermeasures - Birth of the Japan Stroke Medical Care Workers Union for Multidisciplinary Collaboration with Stroke -
橋本洋一郎1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2022.
Japanese Article 25-04-S57-2. Relation ... of ... acute phase hospital pharmacist who supports the medical treatment of patients with stroke, and ties it
甲斐光1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2022.
Japanese Article 25-04-S57-3. Relation of the pharmacist to patients with stroke in the convalescent rehabilitation ward
多胡和樹1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2022.
Japanese Article 25-04-S57-4. Of the pharmaceutical management, instruction for patients with stroke, actually
青木裕明1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-463, 2022.
Japanese Article 25-04-S58-1. Bridges from discharge support to at-home duties
米田勝晃1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2022.
Japanese Article 25-04-S58-2. The patients support for anyone? Efforts to together happy "patients support" "regional alliances"
長谷川まゆみ1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-466, 2022.
Japanese Article 25-04-S58-3. Efforts of the medicine medicine cooperation to hospitalization and release support in our hospital
安保文恵1), 工藤航也1), 青山聡1), 高橋幸1), 田口勲1), 戸舘輝人1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2022.
Japanese Article 25-04-S58-4. Practice ... of the postgraduate training curriculum which adopted ... health insurance pharmacy training to think about upbringing of the pharmacist who took regional alliances
薩摩由香里1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 468-468, 2022.
Japanese Article 25-04-S58-5. The drugstore pharmacist training and effect to promote hospitalization and release support on hospital pharmacist
萱野勇一郎1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 469-469, 2022.
Japanese Article 25-05-S59-1. A clinical pharmacist doing it to be found in medical service fees
佐藤邦義1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 470-470, 2022.
Japanese Article 25-05-S59-2. Diabetic nephropathy extension prevention business in the health insurance pharmacy
森貴幸1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2022.
Japanese Article 25-05-S59-3. Efforts - for inspection - polypharmacy cancellation of the medical service fees revision item by the intervention of the hospital pharmacist
堀井剛史1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2022.
Japanese Article 25-05-S59-4. Challenge to the evidence creation by pharmacist-led specific clinical studies
毛利順一1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2022.
Japanese Article 25-05-S60-1. Appropriate use and formulary of medicines
紀平哲也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2022.
Japanese Article 25-05-S60-2. Construction of a standard formulary as a drug information resource and its usefulness
上田彩1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2022.
Japanese Article 25-05-S60-3. Introduction and operation of formulary at Toda Chuo Medical Care Group and aiming for collaboration with Asaka district
安藤正純1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-477, 2022.
Japanese Article 25-05-S60-4. Positioning and issues of regional formularies in community pharmacies
畑中典子1,2,3,4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 478-478, 2022.
Japanese Article 25-05-S60-5. The position and challenges of formularies from the perspective of physicians
菅原重生1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 479-479, 2022.
Japanese Article 25-06-S61-1. COVID-19 acute phase, treatment with Chinese medicine evidence
高山真1), 有田龍太郎1), 並木隆雄2), 小田口浩3), 三谷和男4), 矢久保修嗣5), 久永明人6,7), 貝沼茂三郎8), 伊藤隆7)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 480-481, 2022.
English Article 25-06-S61-2. The Development and Application of NRICM101 and NRICM102 in the Treatment of COVID-19
蘇奕彰1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 482-483, 2022.
Japanese Article 25-06-S61-3. Influenza protective efficacy of the Hochuekkito by the biophylaxis activity
高梨馨太1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-484, 2022.
Japanese Article 25-06-S61-4. Problem rearranging for Chinese medicine to be used for infection treatment
渡辺賢治1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 485-485, 2022.
Japanese Article 25-06-S62-1. Suitable part as a pharmacist and the part of diabetes medical treatment instruction person filler
林太祐1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 486-487, 2022.
Japanese Article 25-06-S62-2. Practice ... of role - CKD team approach in medical care of the pharmacist as the kidney disease medical treatment instruction person
飯田浩子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 488-488, 2022.
Japanese Article 25-06-S62-3. What should role - when, anyone of the pharmacist in the circulatory organ domain hold? ...
大橋泰裕1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 489-490, 2022.
Japanese Article 25-06-S62-4. While seek integration and the leadership of ... heterogeneity that was necessary for me, and the evolution called the heart failure medical treatment instruction person struggles; ...
土岐真路1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 491-492, 2022.
Japanese Article 25-07-S63-1. We think about the second carrier of the hospital pharmacist
赤瀬朋秀1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 493-494, 2022.
Japanese Article 25-07-S63-2. Relationship - Japan and Britain comparative study - of "a display opportunity of the specialized ability" and "the job satisfaction" of the drugstore pharmacist
三島重顕1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 495-496, 2022.
Japanese Article 25-07-S63-3. Comparison between analysis and job satisfaction change between the types of job by the change of job of the "potentiality, actual existence" that hospital pharmacist reaches quitting a job factor
濃沼政美1), 小串興平2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 497-497, 2022.
Japanese Article 25-07-S63-4. The second carrier making use of the hospital pharmacist's experience intellect
高地恵市1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 498-498, 2022.
Japanese Article 25-07-S63-5. It is ... from the viewpoint of work motivation - human resource administration of the hospital pharmacist
神崎浩孝1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 499-500, 2022.
Japanese Article 25-07-S64-1. Why and one step ... to the solution to How - clinical question
山崎美保1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 501-501, 2022.
Japanese Article 25-07-S64-2. To solve eating, dysphagia of elderly people and problems of the medicine
森直樹1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 502-502, 2022.
Japanese Article 25-07-S64-3. Information sharing tool "medication notebook for messages" that we aimed at the safe internal use anticancer medicine medical therapy
森光保武1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 503-503, 2022.
Japanese Article 25-07-S64-4. About technique to practice preventive measures against incident accident recurrences using the incident management system effectively
冨岡謙二1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 504-504, 2022.
Japanese Article 25-08-S65-1. Result and problem of NAP 2016
大曲貴夫1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 505-505, 2022.
Japanese Article 25-08-S65-2. AMR measures to work on for mind of the activity oneself and others mutual prosperity of the non-full-time union official in the small institution out of one of NAP2016
千葉博暁1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 506-506, 2022.
Japanese Article 25-08-S65-3. Activity of the full-time union official in the university hospital after NAP2016
河口義隆1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 507-507, 2022.
Japanese Article 25-08-S65-4. How should you be associated with the activity in the pharmacy school after NAP2016 as a pharmacist for NAP2023?
村木優一1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 508-508, 2022.
Japanese Article 25-08-S66-1. Basic knowledge and point to keep in mind of the childhood medical therapy
山田孝明1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 509-509, 2022.
Japanese Article 25-08-S66-2. Relation ... communication of vaccine and the pharmacist and medical safe ...
鈴木高弘1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 510-511, 2022.
Japanese Article 25-08-S66-3. Health maintenance increase of means of transportation that a pharmacist undergoes
菊池千草1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 512-512, 2022.
Japanese Article 25-08-S66-4. The biostatistical basics in the medical system study
稲葉洋介1), 仕子優樹1), 高嶋郁海2), 小澤義人1), 鈴木貴明3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 513-513, 2022.
Japanese Article 25-10-S67-1. The duties that a pharmacist performs to use a drug to the situation of the patients individual safely
姜元美1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 514-515, 2022.
Japanese Article 25-10-S67-2. Self-care of the rescue medicine to work on by the multi-type of job
曽根敦子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 516-516, 2022.
Japanese Article 25-10-S67-3. Community medical care, efforts and task to cooperation which are found by a drugstore pharmacist
前地香奈子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 517-518, 2022.
Japanese Article 25-10-S67-4. About the duty of the pharmacist engaged in relaxation medical care to be required by clinical practice
塩川満1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 519-520, 2022.
Japanese Article 25-10-S68-1. Practice - of antimicrobial proper use - de-escalation for the drug resistant bacterium
櫻井紀宏1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 521-521, 2022.
Japanese Article 25-10-S68-2. Antimicrobial proper use support to utilize a system, and to practice
菅原義紀1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 522-523, 2022.
Japanese Article 25-10-S68-3. Analysis ... of Serious ADR using use and application - adverse drug reaction database of medical big data in the antimicrobial proper use
山田智之1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 524-524, 2022.
Japanese Article 25-10-S68-4. Evidence construction for the antimicrobial proper use by the inflection of the big data and machine learning
今井俊吾1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 525-525, 2022.
Japanese Article 25-10-S68-5. Infection control, infection practice support at the health insurance pharmacy
瀧藤重道1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 526-526, 2022.
Japanese Article 25-11-S69-1. The handling of an excretion course and the excrement of the anticancer medicine
森田一1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 527-527, 2022.
Japanese Article 25-11-S69-2. A fact and problem of the instruction to patient in anticancer medicine exposure measures
黒田直子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 528-528, 2022.
Japanese Article 25-11-S69-3. Washing method of the clothing of the patients who received cancer medical therapy
谷川大夢1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 529-529, 2022.
Japanese Article 25-11-S69-4. Attitude survey of usefulness and the pharmacist of the brochure about the prevention of anticancer medicine exposure in the patients home
徳留章1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 530-531, 2022.
Japanese Article 25-11-S69-5. Exposure to simple suspension method measures in the transluminal administration of oral anticancer medicine
青木学一1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 532-533, 2022.
Japanese Article 25-11-S70-1. How should we run the DI room? It is ... with ... ward drug duties and the DI duties of Society5.0
若林進1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 534-534, 2022.
Japanese Article 25-11-S70-2. How do you manage the miscellaneous information of the DI room?
荒義昭1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 535-535, 2022.
Japanese Article 25-11-S70-3. You share it, and how do you utilize the information such as a side effect report, potentially serious medical errors, the incident, and the like?
川名真理子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 536-536, 2022.
Japanese Article 25-11-S70-4. How do you devise the information sharing with the ward exclusive duty pharmacist?
中田英夫1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 537-537, 2022.
Japanese Article 25-11-S70-5. How do you devise the DI duties of the small and medium size hospital?
大庭理寛1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 538-538, 2022.
Japanese Article 25-12-S71-1. Topic of the migraine headache therapeutic agent (antibody preparation, triptan drugs)
小西久美1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 539-540, 2022.
Japanese Article 25-12-S71-2. Topic of the hypercholesterolemic therapeutic agent (antibody preparation, statin system)
岩佐千尋1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 541-541, 2022.
Japanese Article 25-12-S71-3. About the effect on fetuses of the ADHD therapeutic drug
山崎香織1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 542-542, 2022.
Japanese Article 25-12-S71-4. The latest topic of the multiple sclerosis therapeutic agent
畠山史朗1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 543-543, 2022.
Japanese Article 25-13-S72-1. Importance - of problem - multi-type of job cooperation of the mental health which an HIV infected person holds
矢倉裕輝1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 544-544, 2022.
Japanese Article 25-13-S72-2. Is the combination rate of the agent for the psychiatry high in the person with positive HIV-positive person and mental disorder - HIV? -
平野淳1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 545-545, 2022.
Japanese Article 25-13-S72-3. About the drug dependence case in the health insurance pharmacy and the psychiatry concomitant drug in the HIV domain
石原千春1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 546-547, 2022.
Japanese Article 25-13-S72-4. How should the pharmacist face each other for drug dependence?
松井美由紀1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 548-549, 2022.
Japanese Article 25-13-S72-5. High-speed antiradiation missile reduction approach for the drug addiction
松本俊彦1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 550-551, 2022.
Japanese Article 25-13-S73-1. Expect it of the condition of a patient and treatment, a pharmacist of alcoholism
松本俊彦1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 552-553, 2022.
Japanese Article 25-13-S73-2. We think about a cancer and relations of the alcohol
岸本真1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 554-554, 2022.
Japanese Article 25-13-S73-3. About diabetes and alcohol
堀川俊二1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 555-555, 2022.
Japanese Article 25-13-S73-4. Cardiovascular disease and alcohol
高井靖1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 556-556, 2022.
Japanese Article S74-1. Importance and point to keep in mind of heart failure medical therapy (GDMT) in conformity with guidelines
奥村貴裕1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 557-558, 2022.
Japanese Article S74-2. Master the key drugs for heart failure treatment - β-blockers and mineralocorticoid receptor antagonists -
鈴木正論1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 559-559, 2022.
Japanese Article S74-3. How is the pharmacist associated with drug "ARNI needing invention in" introduction and up titration?
芦川直也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 560-560, 2022.
Japanese Article S74-4. Should use the SGLT2 inhibitor Q&A - SGLT2 inhibitor for all cases; or ...
木下照常1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 561-561, 2022.
Japanese Article S75-1. Including the relation to the second emergency patient in the emergency visit, the cooperation with the hospitalization ward
宮田祐一1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 562-562, 2022.
Japanese Article S75-2. Importance of the medicine medicine cooperation in the emergency visit and the problem
齊藤将之1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 563-563, 2022.
Japanese Article S75-3. It is construction and evaluation ... of the emergency visit dispatch system through ... poisoning hot line for future emergency visit pharmacist duties
宮崎雄紀1), 松原ちはる1), 横山征史1), 網野一真1), 矢嶋直子1), 小口正義1), 跡部治1), 西澤優子2), 野首元成3), 登内盛治1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 564-565, 2022.
Japanese Article S75-4. Disaster occurrence, possibility of the majority disabled then a pharmacist.
檜山洋子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 566-566, 2022.
Japanese Article S75-5. Hurry to a stroke hot line, an emergency visit; is relation to the thrombolytic therapy by ... pharmacist and effect ...
細谷龍一郎1,2), 一條真彦3), 島智子1), 石川衣里子1), 北島健士1), 柴崎功1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 567-568, 2022.
Japanese Article S76-1. Practical confirmation ... pseudoaldosteronism ... of the side effect
佐古守人1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 569-569, 2022.
Japanese Article S76-2. ... which thinks about confirmation ... drug-related long QT syndrome that the side effect is practical
梶原洋文1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 570-570, 2022.
Japanese Article S76-3. Of practical confirmation ... drug eruption of the side effect examine; person, way of thinking ...
松田光弘1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 571-571, 2022.
Japanese Article 23-04-O01-1. Effect on formulations incident that formulations robot and formulations support system introduction give and prescription intervention
中西美怜1), 八木達也1), 石田卓矢1), 山本知広1), 三浦文美1), 大澤志保1), 相曽由起子1), 藤田葵1), 山口れな1), 伊藤悠1), 曾布川実里1), 袴田美典1), 丸山早織1), 三浦基靖1), 川上純一1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 572-572, 2022.
Japanese Article 23-04-O01-2. The current situation of the representation input order system of doubt inquiry investigation and the pharmacist of the hospitalization prescription in our hospital
橋本知樹1), 眞継賢一1), 濱口良彦1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 573-573, 2022.
Japanese Article 23-04-O01-3. Efforts of the duties efficiency of the confirmation of bringing medicine before hospitalization by the medical treatment management introduction based on the protocol outpatient department
嶺豊春1), 中川博雄1), 橋詰淳哉2), 兒玉幸修1), 大山要1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 574-574, 2022.
Japanese Article 23-04-O01-4. An approach and problem for the improvement in adherence by the telephone follow-up
安藤美彩1), 岩切智美2), 奥村学3), 池田龍二2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 575-575, 2022.
Japanese Article YIA1-1. Bile acid - drug interactions study in OATP4C1 aiming at the administration plan optimization of the renal excretion type drug at liver damage
山内碧1), 佐藤紀宏2), 大竹彩奈2), 公文代將希2), 佐藤裕2), 菊地正史2), 山口浩明3,4), 阿部高明5,6), 前川正充1,2), 眞野成康1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 576-576, 2022.
Japanese Article YIA1-2. Protective efficacy of the proton pump inhibitor for the capecitabine-induced hand-and-foot syndrome in patients with breast cancer
竹村美穂1), 池村健治2), 吉波哲大3), 豊住勇治1), 新谷拓也2), 上田幹子1), 島津研三3), 奥田真弘2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 577-577, 2022.
Japanese Article YIA1-3. Analysis of the risk factor about the haemorrhage symptom in the apixaban internal use patients
松田清那1), 上島智1), 平大樹1,2,3), 田淵陽平2), 小澤友哉4), 伊藤英樹4,5), 中川義久4), 堀江稔4), 寺田智祐2,3), 桂敏也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 578-578, 2022.
Japanese Article YIA1-4. Interaction study of ritonavir based on comprehensive evaluation of CYP inhibitory activity: Possibility of interaction between DOAC and COVID-19 treatment drug paxlovid
爲本雄太1), 保月静香1), 佐藤洋美1), 樋坂章博1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 579-579, 2022.
Japanese Article YIA1-5. Protection of the coenzyme Q10 emulsion for the tissue disorder by the ischemic reperfusion
池田真由美1), 横山さや香1), 八巻義朗1), 佐藤夕紀2), 柏木仁2), 今井俊吾2), 武隈洋3), 菅原満2,3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 580-580, 2022.
Japanese Article YIA2-1. Timing (the fourth report) of the K-value measurement for low K blood symptom discovery with the Shakuyakukanzoto
嶋田沙織1), 伊藤雅1), 本間真人1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 581-581, 2022.
Japanese Article YIA2-2. The search of the concomitant drug influencing the lamotrigine dermatopathy risk using medical big data and inspection by the multicenter practice information
坂東寛1), 合田光寛1,2), 新田侑生3), 中馬真幸3), 小川敦1), 櫻田巧1), 桐野靖1), 石澤啓介1,2,4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 582-582, 2022.
Japanese Article YIA2-3. Possibility of the reduction effect with a risk factor and renin-angiotensin axis antihypertensive medications of the onset of proteinuria with the neovascularisation inhibitor in patients with nephrocyte cancer
松本彩子1,2), 山岡健太1), 池末裕明1), 平畠正樹1), 橋田亨1), 山崎俊成2), 川喜田睦司2), 室井延之1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 583-583, 2022.
Japanese Article YIA2-4. The characteristic of elderly people with the atrial fibrillation and the examination that the change of the oral anticoagulant drug or the cancellation is it-related directly
石郷友之1), 相神智宏1), 片野唆敏2), 矢野俊之3), 小山雅之3,4), 神津英至3), 大堀克彦3,5), 中野敬太1), 藤居賢1), 戸田貴大6), 福土将秀1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 584-584, 2022.
Japanese Article YIA2-5. Risk factor analysis of the rise in serum KL-6 value after the Everolimus start after the heart transplant
鈴木悠平1), 折山豊仁1), 山本武人1,2), 高田龍平1), 波多野将3), 網谷英介3), 辻正樹3), 武城千恵3), 小室一成3), 小野稔4), 鈴木洋史1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 585-585, 2022.
Japanese Article YIA3-1. Examination of the acute renal failure incidence by antiMRSA medicine and tazobactam/piperacillin combination
山下佑麻1), 川口博資2,3), 櫻井紀宏3), 中村安孝1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 586-586, 2022.
Japanese Article YIA3-2. Evaluation of the optimal administration method based on PK/PD using the free form CMZ concentrations of the haemodialysis patients for ESBL-producing Enterobacteriacae bacteria
並木孝哉1,2), 横山雄太1,3), 枦秀樹2), 地引綾3), 河添仁1,3), 松元一明4), 鈴木小夜1,3), 中村智徳1,3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 587-587, 2022.
Japanese Article YIA3-3. We look at the onset of renal failure anticipatory rear of an AUC level by the vancomycin one point drawing blood and the trough level and examine a mark
大坪愛実1), 丹羽隆1), 安江萌夏1), 原田紗希1), 山田悠人1), 山田未知1), 松岡芹佳1), 山本泰士1), 鈴木昭夫1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 588-588, 2022.
Japanese Article YIA3-4. About the effect that febrile neutropenia gives to an internal change of the arbekacin in children
都築仁美1), 中馬真幸1), 寺川央一1), 寒藤雅俊1), 岩山訓典1,3), 山本譲1), 久保靖憲1), 神山直也1,2), 眞鍋貴行1,2), 田崎嘉一1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 589-589, 2022.
Japanese Article YIA3-5. Pharmacokinetic analysis of rem decibuilding in the COVID-19 patients and main metabolite (GS-441524)
室井宏仁1), 入江慶1,2), 中川淳3), 田村亮1), 江藤正明4), 池末裕明1), 橋田亨1,2), 富井啓介3), 室井延之1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 590-590, 2022.
Japanese Article YIA4-1. Blood level analysis of active metabolite GS-441524 of the rem decibuilding in sustained hemofiltration patients on dialysis
西川有沙美1), 糸原光太郎1), 伊藤功朗2), 米澤淳1), 佐藤裕紀1), 松村勝之1), 濱田哲2), 田辺直也2), 甲斐慎一3), 松原雄4), 井本英志6), 平井豊博2), 柳田素子4), 大鶴繁5), 寺田智祐1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 591-591, 2022.
Japanese Article YIA4-2. About the acid-proof degradation of lansoprazole OD tablets by the simultaneous suspension of the citrate-containing preparation
中川祐紀子1), 鈴木拓也1), 居林優輝1), 加藤美咲2), 嶋田努1), 崔吉道1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 592-592, 2022.
Japanese Article YIA4-3. Search of the risk factor of the antifungal agent-induced liver damage by the cooperation of a spontaneous report database and electronic medical chart data
朝居祐貴1), 山本高範1), 佐藤賛治1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 593-593, 2022.
Japanese Article YIA4-4. Expression investigation of the hypomagnesemia with the treatment with head and neck cancer cetuximab and effect examination of the Mg prophylaxis
松金良祐1), 一色理沙2), 末次王卓1), 廣田豪1), 辻敏和1), 金谷朗子1), 江頭伸昭1,2), 家入一郎1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 594-594, 2022.
Japanese Article YIA4-5. Examination of the factor affecting the antibody acquisition ability with the new corona vaccine in the patients with the immunodeficiency risk
岡田直人1), 中村信元2), 清水太郎3), 安藤英紀3), 相澤風花1), 新村貴博4), 八木健太4), 合田光寛1,5), 石田竜弘3), 石澤啓介1,4,5)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 595-596, 2022.
Japanese Article YIA5-1. Search for unknown target molecules related to renal tubular toxicity of cancer molecular targeting drug vemurafenib
真川明将1), 堀田祐志1), 家田直弥2), 前田康博3), 片岡智哉4), 中川秀彦2), 日比陽子4), 木村和哲1,4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 597-597, 2022.
Japanese Article YIA5-2. The new beclomethasone dipropionate-containing enteric microsphere preparation development that pointed to the selective delivery to large intestine
内田淳1,2), 林勇寿1), 山田幸平1), 佐藤秀行1), 河田圭司2), 尾上誠良1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 598-598, 2022.
Japanese Article YIA5-3. Construction of the cyclopedic and quantitative predictive law of the dialysis extraction coefficient of the drug which we incorporated a dialysis enforcement condition in
荻上尚樹1), 宮田優希1), 山本武人1,2), 鈴木洋史1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 599-599, 2022.
Japanese Article YIA5-4. Medicine mechanic cooperation study for the objective detective law development of the antihistamine-induced in paired performance at driving using eyes measurement
相良篤信1,2), 安喜勇人2), 吉村広輝2), 清水孝恒1), 佐野元彦1), 湯本哲郎1,2), 細江智夫1), 田中健次2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 600-600, 2022.
Japanese Article YIA5-5. Usefulness of the continuation prescription support protocol by the pharmacist-led ward team cooperation
杉本智哉1), 杉野晃希1), 小原里奈1), 山室栄一1), 小園利加2), 木村元宏3), 遠山幸男1), 久田達也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 601-601, 2022.
Japanese Article 23-05-O02-1. One case that supported using the clinical reasoning for the diarrhea that developed during Cabozantinib remedy
木村大地1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 602-602, 2022.
Japanese Article 23-05-O02-2. From study on distance - clinical on-site investigation between optimal patients - pharmacists at medication counseling -
牛膓沙織1), 鈴木菜生2), 仲山千佳3), 宮城雪菜2,4), 宮地佑佳2), 大嶋耐之2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 603-603, 2022.
Japanese Article 23-05-O02-3. Effect on cancer medical therapy in the ambulatory practice that new coronavirus infection (COVID-19) outbreak gives and medication counseling
小柳津瞳1,13), 山口智江2,13), 前田章光3,13), 大島有美子4,13), 中井剛5,12,13), 原田哲彦6,13), 藤村浩司7,13), 小西郁代5,13), 坂野博紀6,13), 杉本智哉7,13), 佐々木俊則8,13), 佐藤由美子9,13), 堀田和男10,13), 川合甲祐11,13), 久田達也7,13), 宮崎雅之5,13)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 604-604, 2022.
Japanese Article 23-05-O02-4. Problem based on the intervention content analysis of the pharmacist outpatient department for the oral anticancer medicine initial prescription
郷真貴子1), 山田志緒里1), 西村充礼1), 村瀬寛美1), 松山卓矢1), 木村美智男1), 吉村知哲1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 605-605, 2022.
Japanese Article 23-05-O02-5. Intervention effect of the pharmacist specialized in a cancer in the trial regimen application
辻千明1,2), 田中祐子1,2), 嶋田努1), 長瀬克彦2), 崔吉道1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 606-606, 2022.
Japanese Article 23-05-O03-1. About the cooperation of the system and the ICI proper use team of the use of pharmaceutical products for irAE out of the adaptation
黒田純子1), 伊與田友和1), 大江敬太郎1), 渡邉美保1), 佐々木栄作2), 金沢賢也3), 鈴木弘行4), 佐治重衡2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 607-607, 2022.
Japanese Article 23-05-O03-2. Examination of an investigation and the evaluation of the supportive care for chemotherapy-induced peripheral neuropathy in our hospital
林雄一郎1), 奥田遥香2), 西本美淑3), 石部洋一4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 608-608, 2022.
Japanese Article 23-05-O03-3. A case of administration of lutetium (177Lu) oxodotreotide to a patient with decreased renal function
鈴木秀隆1), 加納大輔1), 望月伸夫1), 大橋周平2), 森田敬裕3), 今岡大4), 池田公史4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 609-609, 2022.
Japanese Article 23-05-O03-4. Fact-finding of recurrent Ewing sarcoma regimen in AYA generation patients
川元愛実1), 馬見新佳那子1), 細野亜古2,4), 馬場楓1), 内藤陽一2,3,5), 中島裕理2,3), 楠原正太2), 船坂知華子2), 仲尾岳大2,3), 近藤千紘2), 原野謙一2,3), 松原伸晃2), 川崎敏克1), 向原徹2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 610-610, 2022.
Japanese Article 23-05-O03-5. Questionary survey about the recognition about the immune checkpoint inhibitor for drugstore pharmacists and the immune-mediated adverse event
井上将貴1), 五十嵐隆志1), 三浦智史2), 川崎敏克1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 611-611, 2022.
Japanese Article 23-05-O04-1. The effect that inspection before injection prescription issuance by the exclusive duty pharmacist of the intensive care unit gives to adequacy of the medical therapy
上林里絵1), 池村健治2), 若井恵里3), 岡本明大1), 佐々木典子1), 杉本浩子1), 平井利典1), 加藤秀雄1), 向原里佳1), 石倉健4), 今井寛4), 岩本卓也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 612-612, 2022.
Japanese Article 23-05-O04-2. Drug economic study in psoriasis treatment with the antibody preparation based on Drug Survival of Real-World
税所篤行1), 山口道也2), 樫部公一3), 石田博3), 平野靖3), 岡智之4), 田村美穂1), 高砂美和子1), 内田豊1), 幸田恭治1), 北原隆志1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 613-613, 2022.
Japanese Article 23-05-O04-3. PT-INR change factor analysis after the biliary tract obstruction in the warfarin remedy patients
中澤孝文1,2), 山崎伸吾1), 内田雅士1,2), 鈴木貴明1,2), 中村貴子1), 大塚将之3), 石井伊都子1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 614-614, 2022.
Japanese Article 23-05-O04-4. Relations with the hypomagnesemia onset by the long-term use of the proton pump inhibitor in elderly patients
米田夏奈葉1), 中村暢彦1), 肥後孝2), 楠本正明1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 615-615, 2022.
Japanese Article 23-05-O04-5. Relations with the diarrhea that is Afatinib blood level and a side effect in the non-small cell lung cancer
横田隼人1), 佐藤一洋2), 坂本祥2), 奥田佑道2), 浅野真理子2), 竹田正秀2), 中山勝敏2), 三浦昌朋1,3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 616-616, 2022.
Japanese Article 23-05-O05-1. Examination of the effect of ABCB1 and the ABCG2 genetic polymorphism on internal change of the Abemaciclib metabolite
前田章光1), 入江慶2), 安藤仁3), 橋本直弥1), 福島昭二2), 盛重純一3), 衣斐寛倫4), 加藤正孝5), 内田幸作1), 岩田広治6), 澤木正孝6)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 617-617, 2022.
Japanese Article 23-05-O05-2. The current situation and the problem that are contraindicated to the combination of the CYP3A inhibitor in the pharmaceutical products package insert
大野能之1), 永井尚美2), 樋坂章博3), 高田龍平1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 618-618, 2022.
Japanese Article 23-05-O05-3. Change factor analysis of the OATP1B1 activity that assumed the plasma Coproporphyrin-I concentrations in cyclosporine treated patients an index
渡邉拓真1), 田中遼大1), 鈴木陽介2), 小野寛之1), 根上純2), 吉島千智2), 小田絢子2), 龍田涼佑1), 大野恵子2), 伊東弘樹1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 619-619, 2022.
Japanese Article 23-05-O05-4. Stereoselective interaction of effect and amiodarone of CYP3A5 giving it to the internal change of the tolvaptan optical isomer in patients with heart failure
阿久津駿太1), 見野靖晃1), 内藤隆文1), 星川昂平1), 早乙女雅夫2), 前川裕一郎2), 川上純一1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 620-620, 2022.
Japanese Article 23-05-O05-5. The exploring of the substitute excipient as a substitute for the milk sugar: Usefulness evaluation of the starch infinitesimal grain
吉川知宏1), 岡本広世1), 竹内健太1), 平田敦士1), 長井紀章2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 621-621, 2022.
Japanese Article 23-05-O06-1. Characteristic of patients with second response expression with the COVID-19 vaccination in patients during cancer medical treatment
宇野彩香1), 森脇俊和2), 渡邊雅明1), 長崎茜1), 関健吾1), 中嶋夏海1), 大平愼1), 山本祥之2), 小林真理子2), 本間真人1), 人見重美3), 関根郁夫4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 622-622, 2022.
Japanese Article 23-05-O06-2. The development of the flowchart identifying patients needing high-dose vancomycin administration for treatment concentrations area arrival and inspection of the prediction precision
田中雄大1), 山口諒1), 可児紘子1), 山本武人1,2), 鈴木洋史1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 623-623, 2022.
Japanese Article 23-05-O06-3. The pharmacodynamics at the antipsychotics combination based on the receptor occupation theory and pharmacokinetic interaction analysis
赤下学1), 中谷絵理子1), 菊池英慧1), 黄倉崇1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 624-624, 2022.
Japanese Article 23-05-O06-4. Inspection about the possibility that it becomes a factor that feeling lonely affects the multiple drug remedy of elderly people
多田貴彦1,2), 相川学美1), 高添倫子1), 矢吹洸二1), 後藤結実子1), 小野美歌1), 岡田はるみ1), 寺島茜1), 鈴木達彦2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 625-625, 2022.
Japanese Article 23-05-O06-5. About a dose and the effectiveness of the enoxaparin depending on the renal function in patients who received Total Knee Arthroplasty and safety
平町隆明1), 飯島悠希1), 北郷真史1), 石原慎之1), 玉木宏樹1), 矢野貴久1), 直良浩司1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 626-626, 2022.
Japanese Article 23-05-O07-1. Effect of the copper transporter genetic polymorphism giving it to a treatment result after the chemoradiotherapy before operation on patients with cancer of the esophagus
藤田一馬1), 本山悟2,3), 佐藤雄亮2), 脇田晃行2), 南谷佳弘2), 三浦昌朋1,4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 627-627, 2022.
Japanese Article 23-05-O07-2. Examination about the association of AUC and the onset that estimated from a Carboplatin fruit dose had administration plan of by the body-surface area method of the DeVIC therapy of serious platelet count decrease
梅原健吾1), 高田慎也1), 山佳織2), 山岸佳代1), 藤本勝也3), 小林道也4), 佐藤秀紀2), 美濃興三1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 628-628, 2022.
Japanese Article 23-05-O07-3. Plasma endothelin -1 predicts the severe proteinuria onset with the bevacizumab administration: Observational, prospective study
二瓶哲1), 池田樹生1), 青木朋彦1), 寺長根大輝1), 村里風太1), 佐藤文彦1), 佐々木章2), 旭浩一3), 工藤賢三1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 629-629, 2022.
Japanese Article 23-05-O07-4. Multidirectional evaluation about the second cancer risk of the malignant lymphoma therapeutic drug using the large-scale practice information database
土手賢史1,2), 豕瀬諒2), 後藤良太2), 小林由佳1), 村木優一2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 630-630, 2022.
Japanese Article 23-05-O07-5. Search of the actual situation and the risk factor of the lassitude in patients with cancer under treatment in a foreign chemotherapy room
根來寛1), 藤原拓也2), 山下慎司1), 国分秀也3), 佐野元彦4), 矢野良一5)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 631-631, 2022.
Japanese Article 23-09-O08-1. Promotion of the inhalational instruction information sharing by a general inhalational check sheet in Hiroshima and the template introduction
真志田絵美子1), 櫻下弘志1), 高橋麻里1), 柴田ゆうか1), 岩本博志2), 松尾裕彰1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 632-632, 2022.
Japanese Article 23-09-O08-2. Illness inflection ... of one - drug change prescription that we examined it, and HbA1c improved by cooperation, medicine medicine cooperation remarkably
亀山聡美1), 酒向聡子1), 今西正人1), 桑原千春2), 三輪佳余子3), 横山道江3), 川路明人4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 633-633, 2022.
Japanese Article 23-09-O08-3. Questionary survey to expand practice and a workshop of the medicine medicine cooperation for health insurance pharmacies
長山佳之1), 新島大輔1), 矢田部恵1), 工藤彰1), 工藤浩史1), 谷健太郎1), 石嶋麗1), 今村有那1), 大塚健太郎1), 小川千晶1), 谷地豊1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 634-634, 2022.
Japanese Article 23-09-O08-4. Operation of the new tracing report specialized in promotion - cancer chemotherapy of the medicine medicine cooperation that use and application had of ICT and evaluation -
森沢惇平1), 門田亜紀1), 野村政孝1), 岡本茉奈実1), 川田敬1,2), 石田智滉1), 藤田博子1), 田村尚久1,2), 赤垣恵太1), 依岡千恵子1), 川添哲嗣2,3), 常風興平1), 宮村充彦1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 635-635, 2022.
Japanese Article 23-09-O08-5. Construction - of the information sharing system utilizing promotion - Web system of the medicine medicine cooperation that use and application had of ICT
上杉粋世1), 上野直哉1), 松本義将1), 東野純一2), 宅間大祐2), 稲本悠3), 森沢惇平4), 野村政孝4), 門田亜紀4), 常風興平4), 西森康夫5), 宮村充彦4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 636-636, 2022.
Japanese Article 23-09-O09-1. Weight fluctuation of patients with epilepsy before and after the new coronavirus outbreak
杉山尭紀1,2), 山本吉章2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 637-637, 2022.
Japanese Article 23-09-O09-2. Investigation of the use actual situation of the heating-type cigarette for the smokers with rheumatoid arthritis and other chronic diseases and the use reason
伊佐地央明1), 山田清文1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 638-638, 2022.
Japanese Article 23-09-O09-3. Examination of the characteristic of the patient of the low-dose edoxaban administration pertinence case in the old atrial fibrillation case and the scale
彦坂夏菜1), 川根誉代1), 岡祐介1), 土井崇1), 佐合裕子1), 芦川直也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 639-639, 2022.
Japanese Article 23-09-O09-5. Attitude survey of the staff for the polypharmacy in the national cancer research center center Hospital
樫原芽依1), 東郁子1), 渡部大介1), 齋藤義正1), 石川光信1), 赤木徹1), 橋本浩伸1), 古川哲也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 640-640, 2022.
Japanese Article 23-09-O10-1. Investigation of the occurrence of adverse events in patients taking venetoclax in combination with azole antifungal drugs
新井瞬1), 有野徹1), 楠見彰宏1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 641-641, 2022.
Japanese Article 23-09-O10-2. Incidence of adverse events caused by administration of trastuzumab deruxtecan to HER2-positive breast cancer
桑村恒夫1), 三上忠司1), 山口美樹2), 中川義浩1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 642-642, 2022.
Japanese Article 23-09-O10-4. Example that was able to detect renal failure by the nivolumab from adrenal cortical steroid doses and a change of the serum creatinine
和田康弘1), 吉田健也2), 中西亨2), 堀内雅人3), 高田充弘3), 久志本浩子3), 井上智子4), 伴晶子1), 小林義和1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 643-643, 2022.
Japanese Article 23-09-O10-5. Examination about the effect that neutropenia in the trifluridine Tipiracil hydrochloride + bevacizumab therapy gives to effect of treatment
大畑紘一1), 藤井宏典1), 松岡芹佳1), 左高史織1), 渡辺大地1), 廣瀬智恵美1), 小林亮1,2), 飯原大稔1), 木山茂3), 牧山明資3), 松橋延壽3), 高橋孝夫3), 吉田和弘3), 鈴木昭夫1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 644-644, 2022.
Japanese Article 23-09-O11-1. Evaluation of the prophylactic antiemesis effect at aprepitant supplementation in the Carboplatin + etoposide therapy
門萌子1), 坂本達彦1), 齋藤佳敬1), 内山数貴1), 菅野亮太1), 谷口理1), 武隈洋1), 品川尚文2), 清水康3), 秋田弘俊3), 菅原満1,4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 645-645, 2022.
Japanese Article 23-09-O11-2. Examination about patients service property and loperamide optimum doses in the diarrhea symptom management derived from Abemaciclib
橋本直弥1), 村田史子1), 伊藤裕子1), 内田幸作1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 646-646, 2022.
Japanese Article 23-09-O11-3. Inspection of the protective efficacy of magnesium oxide for the hypomagnesemia with the antiEGFR antibody medicine for patients with colon cancer
高木淳平1), 奈良克彦1), 荻上尚樹1), 山本武人1,2), 鈴木洋史1), 高田龍平1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 647-647, 2022.
Japanese Article 23-09-O11-4. Usefulness (the case report which was able to relieve the adverse event of eyes) of the telephone follow-up for the S-1 remedy patients
徳升晃大1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 648-648, 2022.
Japanese Article 23-09-O11-5. 1 case that was regarded as an immune-mediated adverse event by the Atezolizumab which the diarrhea that developed after the irinotecan administration used for previous treatment
杉山弘樹1), 中田淳也1), 更谷和真1), 柴田洋2), 原田晴司1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 649-649, 2022.
Japanese Article 23-09-O12-1. Preliminary study for proper use of nirmatrelvir/ritonavir
冨田猛1), 木村丈司1), 山本和宏1), 野崎晃1), 田村直暉1), 藤田浩平1), 飯田真之1), 大村友博1), 矢野育子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 650-650, 2022.
Japanese Article 23-09-O12-2. Examination of the effect of the medical therapy for the hiccups that we included the background factor which was easy to accept hiccups during COVID-19 treatment and a steroid rotation in
佐古有紀1), 吉川明良1), 山内健1), 伊藤徳明2), 実綿慶2), 北原良洋2), 沖本真史2), 渡辺美和1), 高蓋寿朗2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 651-651, 2022.
Japanese Article 23-09-O12-3. Study on the effectiveness of sotrovimab for Japanese people aged 75 years and older
陳内博之1), 相賀真由1), 奥山友香里1), 沖田直美1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 652-652, 2022.
Japanese Article 23-09-O12-4. The effect that COVID-19 vaccination gives to the immune-mediated adverse event of the immune checkpoint inhibitor
関健吾1), 森脇俊和2), 渡邊雅明1), 宇野彩香1), 長崎茜1), 中嶋夏海1), 大平愼1), 山本祥之2), 小林真理子2), 本間真人1), 人見重美3), 関根郁夫4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 653-653, 2022.
Japanese Article 23-09-O12-5. Safety of sotrovimab and remdesivir combination therapy in hemodialysis patients with mild to moderate COVID-19 in the 6th wave
浦田元樹1), 岩川真也1), 森住誠1), 大野良晃2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 654-654, 2022.
Japanese Article 23-09-O13-1. The relation to the new corona vaccine group inoculation by the pharmacist and economical evaluation
長谷川豊1), 村上佳愛1), 谷垣求1), 中谷健一1), 山内一史1), 金子昌平1), 山田暁代1), 伊藤優子1), 松岡智美1), 谷口嘉宏1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 655-655, 2022.
Japanese Article 23-09-O13-2. Examination about the sterilization with the ozone gas of the gown for the prevention of infection in the closure space
小竹武1), 坂下友恵1), 岡本優子1,2), 西光優衣1), 橋本貴子1,3), 日比野泰志1,3), 井上知美1), 石渡俊二1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 656-656, 2022.
Japanese Article 23-09-O13-3. Examination about the effect of the new coronavirus vaccine on vital prognosis of patients on dialysis with new coronavirus infection (COVID-19)
田中義輝1), 岡田由加1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 657-657, 2022.
Japanese Article 23-09-O13-4. Report of the use situation and Pseudomonas aeruginosa of the medicine carbapenem-based after AST start-sensitive rate for 4 years
小林謙一1,3), 丸山智幸1,3), 品田識博1,3), 西堀武明2,3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 658-658, 2022.
Japanese Article 23-09-O13-5. Effects of intravenous lascufloxacin infusion on test values
上田真也1), 植松若那1), 蜂巣寿哉1), 薄雅人2), 松田平和1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 659-659, 2022.
Japanese Article 24-04-O14-1. Pharmaceutical intervention of the ward pharmacist in the neurosurgical ward
青山慎1), 伊藤聡一郎1), 谷口俊洋1), 山田哲也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 660-660, 2022.
Japanese Article 24-04-O14-3. One case that the evaluation based on the pharmaceutical viewpoint contributed to a definitive diagnosis of the heart failure
村上翔梧1), 野村剛久1), 佐古守人1), 黒沢秀夫1), 西牟田昇吾1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 661-661, 2022.
Japanese Article 24-04-O14-4. Evaluation of the effect to patients with heart failure by the system change of the multi-type of job team intervention
小山勝真1,2,3,4), 藤村達大2), 藤田美穂2), 前原達哉3), 村橋千里4), 堀尾桂子5), 幸田恭治1), 北原隆志1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 662-662, 2022.
Japanese Article 24-04-O15-1. Questionary survey about the reporting of the medicine using the video for nursing mothers
堀田菫1), 石野清亮1), 夏目章巴1), 杉山奈々美1), 坂田友美1), 桑名諒美1), 瀧口里美1), 矢部勝茂1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 663-663, 2022.
Japanese Article 24-04-O15-2. Theoretical consideration about the safety at mother's milk shift and nursing of the Bilastine
大久保正1,2), 田中真理子2), 大久保七枝3), 大久保節子4), 大久保美穂5)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 664-664, 2022.
Japanese Article 24-04-O15-3. Effect inspection of the active at-home support reporting to the multi-type of job by the drugstore pharmacist
吉永千裕1), 横井杏菜1), 水野正子2), 浅井治行3), 山田葉子3), 三宅宏季4), 石川友康5), 供田将志6), 菊池千草7), 堀英生8), 鈴木匡8)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 665-665, 2022.
Japanese Article 24-04-O15-4. A case study of home visits in which drugs were reduced during the terminal stage of cancer and approaches were taken according to changes in condition
鈴木邦彦1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 666-666, 2022.
Japanese Article 24-04-O16-1. One case that a severe immune-mediated adverse event (immune-related adverse event: irAE) by the Atezolizumab developed
林田颯志1,2), 森善洋1), 佐道紳一1), 岩村直矢1), 山島美緒2), 樋口則英1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 667-667, 2022.
Japanese Article 24-04-O16-2. Evaluation of the usefulness of the multiple prophylaxis of the anticholinergic drug for the irinotecan-induced Colin symptom
渡辺拓也1), 齋藤佳敬1), 武隈洋1), 清水康2), 秋田弘俊2), 小松嘉人3), 菅原満1,4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 668-668, 2022.
Japanese Article 24-04-O16-3. 1 case that resulted in hyperammonemia by the Cabozantinib
山本崇弘1), 齋尾真希1), 秦英司1), 藤吉正哉1), 松木由佳子2), 永原天和2), 島田美樹1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 669-669, 2022.
Japanese Article 24-04-O16-4. The effect that peripheral neuropathy of primary treatment oxaliplatin in patients with gastric cancer gives the effectiveness of the second treatment taxane system anticancer agent and safety
左高史織1), 藤井宏典1), 飯原大稔1), 林秀樹2), 味澤香苗2), 奥村直樹3), 牧山明資3), 吉田和弘3), 鈴木昭夫1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 670-670, 2022.
Japanese Article 24-04-O16-5. Example that steroid succeeded as the prevention of the hand-and-foot syndrome with standard quantity cytarabine
谷口結基1), 田中美帆1), 太田達也1), 田中章郎1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 671-671, 2022.
Japanese Article 24-04-O17-1. Examination of the predictor effective for a long term of tramadol for the cancer pain
高武嘉道1), 藤本愛理1), 中原萌子1), 鶴山萌子1), 三好孝法1), 山口泰弘1), 深澤真実1), 川俣洋生1), 花田聖典1), 橋本雅司1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 672-672, 2022.
Japanese Article 24-04-O17-2. The construction of the multi-type of job collaboration opioid parenteral injection preparation system supporting the at-home shift in the new establishment hospital and investigation about the operational situation
上葛義浩1), 小池良且1), 秋川佳美1), 稲垣美緒1,2), 中山貴美也1), 太田秀基1,2), 山田成樹1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 673-673, 2022.
Japanese Article 24-04-O17-4. We look at the rear about dermatopathy frequencies of morphine sustained hypodermic injection and the hydromorphone sustained hypodermic injection and weigh a mark
増田真也1,2), 田中怜2,3), 佐藤哲観4), 賀茂佳子2), 森本重輝2), 鴨志田武2), 石川寛2), 佐藤哲2), 天田斉子2), 近藤美奈5), 高橋健二6), 高橋千恵子6), 篠道弘2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 674-674, 2022.
Japanese Article 24-04-O17-5. Look at examination ... multicenter rear about the effect reinforcement of the warfarin by the combination of the fentanyl; mark observational study ...
槙原克也1), 土生康司2), 後藤愛実3), 吉野新太郎4), 三沖大介4), 石原泰子5), 山田正実6), 江島智彦7), 三松史野8), 力武良行2), 宮田興子2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 675-675, 2022.
Japanese Article 24-04-O18-1. Examination of the childhood thyroid block - iodine preparation in the iodine 131-radioimmunotherapy treatment
大江敬太郎1), 古内容子1,2), 大堀裕太2), 織内昇3), 志賀哲3), 菅原茂耕3), 佐野秀樹4), 稲野彰洋2), 黒田純子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 676-676, 2022.
Japanese Article 24-04-O18-2. Anticancer medicine exposure investigation in the scale hospital out of the district
百瀬公博1), 有賀智美2), 伏見幸浩1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 677-677, 2022.
Japanese Article 24-04-O18-3. About the usefulness of the sodium selenite oral cavity collapse tablets in the low selenium blood symptom
桶本幸1,2), 荒川宗徳1), 関本裕美2), 山下大輔2), 小原直紘2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 678-678, 2022.
Japanese Article 24-04-O18-4. The making of the preventive measures against occupational exposure manual about internal use Hazardous Drug formulations and attitude survey of the pharmacist
齋藤裕子1), 平川寛之1), 太田潤一1), 岡田浩司1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 679-679, 2022.
Japanese Article 24-04-O19-1. Examination of the presence of the change of the FN incidence before and after the COVID-19 outbreak in patients during the febrile neutropenia (FN) high risk regimen enforcement
島貫裕実子1), 下村昭彦2), 小室雅人1), 河村雪乃2), 谷山智子2), 寺門浩之1), 清水千佳子2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 680-680, 2022.
Japanese Article 24-04-O19-2. Examination of the factor associated with the overall survival of patients who received gemcitabine + paclitaxel (albumin suspension type) therapy for progress, recurrent pancreatic cancer
伊藤大輔1), 竹中翔也1), 守屋昭宏1), 浅野裕紀1), 岩井美奈1), 宇佐美英績1), 吉村知哲1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 681-681, 2022.
Japanese Article 24-04-O19-3. Analysis of the onset of proteinuria risk factor of the Lenvatinib in patients with hepatocellular carcinoma
高橋周平1), 守田和憲1), 北岡朋子1), 徳永晃己1), 柴田啓智1), 田上治美1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 682-682, 2022.
Japanese Article 24-04-O19-4. Establishment of the technique of the multiple use of the anticancer medicine lyophilized products and the fact-finding
片原帆奈美1), 鈴木秀隆1), 佐野慶行1), 中田千博1), 加納大輔1), 望月伸夫1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 683-683, 2022.
Japanese Article 24-04-O19-5. Examination about the inflection of the liver volume of the anticancer agent-related cirrhosis atrophy speed in the differentiation
宇野美雪1), 稲井邦博2,3), 西島昭彦3), 法木左近4), 内木宏延2), 後藤伸之1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 684-684, 2022.
Japanese Article 24-05-O20-1. Prescription fact-finding of olanzapine to patients with diabetes using the receipt database
山下慎介1,2), 今井俊吾3,4), 百賢二5,6), 柏木仁3), 佐藤夕紀3), 菅原満3,7), 武隈洋2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 685-685, 2022.
Japanese Article 24-05-O20-2. Shift ... of introduction and the in-house production system of preparations and results - prescription check system IRIS accompanied with the electronic medical chart replacement and MDB
山中理1), 山村篤史2), 早川太朗2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 686-686, 2022.
Japanese Article 24-05-O20-3. Fact-finding of the pituitary gland side effect of immune checkpoint inhibitor using the Japanese adverse drug reaction database
浅野裕紀1), 宇佐美英績1), 木村美智男1), 吉村知哲1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 687-687, 2022.
Japanese Article 24-05-O20-5. Analysis - of the drug-induced aggressiveness with evaluation - antiepileptic drug of safety of medicine using Spontaneous Reporting System and the effectiveness
中村優李1), 川田敬1,2), 石田智滉1), 常風興平1), 野村政孝1), 丸岡由奈1), 岡本茉奈実1), 岡崎萌水1), 山口真夏1), 吉岡三郎1), 宮村充彦1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 688-688, 2022.
Japanese Article 24-05-O21-1. Usefulness evaluation of the all cases check by the pharmacist for the registration of the drug allergy information
坂本拓也1), 渡邊卓巳1), 小澤明日香1), 白石貴寿1), 荒井宏人1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 689-689, 2022.
Japanese Article 24-05-O21-2. Efforts ... to push forward with strategic - drug desk work of the duties efficiency for the task shift promotion
篠田健一1), 川原由紀子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 690-690, 2022.
Japanese Article 24-05-O21-3. Examining feedback methods from incident and pre-avoid reports
辻井佳代1), 鳥井祥子1), 庄司瑞野1), 瀬名波暢子1), 谷大輔1), 小林政彦1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 691-691, 2022.
Japanese Article 24-05-O21-4. Expansion of efficiency and the ward drug duties of compounding of medicines duties by the mechanization
入江利行1), 町田聖治1), 富田敏章1), 清水誉志1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 692-692, 2022.
Japanese Article 24-05-O21-5. 2 cases that became the opportunity to reconsider the significance that an in-hospital pharmacist conducted prescription modified confirmation of the outside Parliament prescription
大津由美子1), 岩西雄大1), 望月千枝1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 693-693, 2022.
Japanese Article 24-05-O22-1. Inspection of the drug costs reduction effect with the biofollowing article in University of Toyama Hospital
高木昭佳1), 加藤敦1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 694-694, 2022.
Japanese Article 24-05-O22-2. Report on the introduction of formulary at Kyoto Daiichi Red Cross Hospital
大林巧志1,2), 増田章秀1,2), 冨島公介1,2), 小森桂子1), 舩越真理1), 土谷有美1), 濱崎佐知子2), 白石淳2), 三神一哉2), 福田亙2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 695-695, 2022.
Japanese Article 24-05-O22-3. Fact-finding about the ethical drug which reached the sale cancellation in this country
橋本貴子1,3), 石坂敏彦2), 安井友佳子2), 藤井一美1), 小竹武3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 696-696, 2022.
Japanese Article 24-05-O22-4. Prescription adequacy effect of the use of DOAC patients by the formula reoperational start of the oral anticoagulant drug
吉田享平1), 森川剛1), 小池恵理1), 花岡容子1), 清野義一1), 久保田健1), 岡澤香津子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 697-697, 2022.
Japanese Article 24-05-O22-5. Consideration of the impact of ARB hospital formulary on outpatient prescriptions
志村明日香1), 川邊一寛1), 畠山成寛1), 川邉桂1), 小池博文1), 佐橋幸子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 698-698, 2022.
Japanese Article 24-05-O23-1. It is ... based on efforts - regional alliances under the supply instability of pharmaceutical products
小山晃生1), 赤木和由1), 木村泰巳1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 699-699, 2022.
Japanese Article 24-05-O23-2. Examination of the task share of pharmacy and pharmaceutical products SPD for the in-hospital pharmaceutical products steady supply
岩田円夏1), 関屋裕史1), 緒方豊2), 福永洋子3), 森木豊栄3), 長友隆雄1), 岩切智美1), 池田龍二1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 700-700, 2022.
Japanese Article 24-05-O23-3. Efforts of our center for the supply restrictions of pharmaceutical products
花房喜子1), 鈴木ゆきえ1), 阿部聡美1), 渡邉幸枝1), 草野元1), 梶山夕美子2), 鈴木通子3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 701-701, 2022.
Japanese Article 24-05-O23-4. About effect and the correspondence that the supply anxiety problem of pharmaceutical products gave to adoption medicine
花田聖典1), 高武嘉道1), 永野真久1), 大橋邦央1), 橋本雅司1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 702-702, 2022.
Japanese Article 24-05-O23-5. Appropriate management - of efforts - large amount pharmaceutical products of the pharmacy for the hospital management
白石久1), 門田亜紀1), 西村さとみ1), 丸岡由奈1), 森沢惇平1), 岡崎雅史1), 野村政孝1), 川田敬1), 常風興平1), 宮村充彦1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 703-703, 2022.
Japanese Article 24-05-O24-1. Search of the risk factor about the periphery catheterization of vein-related bloodstream infection onset
遠山泰崇1), 福島祐子1), 赤星一恵1), 末延裕海1), 新宮裕美1), 小野友香理1), 野村一馬1), 村上里穂1), 後藤友里絵1), 矢野由起1), 瀬口りか1), 矢野可南子1), 平山沙和1), 井上真1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 704-704, 2022.
Japanese Article 24-05-O24-2. Intervention report to infection treatment using the infection surveillance in patients on dialysis
大塚登志喜1), 大井捺美1), 高橋正明1), 長沢法子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 705-705, 2022.
Japanese Article 24-05-O24-3. Efforts of our hospital for the proper use of TAZ/PIPC
立花京香1), 後藤健志1), 鎌田理紗子1), 斎藤祥子1), 竹尾恵理子1), 酒井欣嗣2), 伊藤功治1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 706-706, 2022.
Japanese Article 24-05-O24-4. Evaluation of the antimicrobial proper use by the cataract surgery clinical path change
平野有紀1), 吉野走1), 岩村直矢1), 佐道紳一1), 澤井豊光2), 小野大地3), 樋口則英1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 707-707, 2022.
Japanese Article 24-05-O24-5. One case of the Salmonella bacteremia that improvement was found in by the intervention of the antimicrobial proper use support team
足立参希1), 小武和正2), 中野祐樹3), 重留一貴4), 飛田高志5)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 708-708, 2022.
Japanese Article 24-05-O25-1. Effect of AST exclusive duty for the antimicrobial proper use in the local third first aid-designated municipal hospital and the joint intervention of the ward exclusive duty pharmacist
熊谷康平1), 宮本祐吾2), 上村和昭3), 川崎貞男4), 木原理絵1), 續木康夫1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 709-709, 2022.
Japanese Article 24-05-O25-2. Efforts to continuous monitoring of the use of antimicrobial that an antimicrobial proper use support team cooperated with pharmacy
矢賀和子1), 河口義隆1,2), 幸田恭治1), 北原隆志1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 710-710, 2022.
Japanese Article 24-05-O25-3. Study of the cutoff value of the early clinical response in AUC and the MRSA infection that we calculated from one point of drawing blood of vancomycin and the early impaired renal function
植田貴史1,2), 中嶋一彦1,2), 竹末芳生2,3), 一木薫1), 石川かおり1), 高橋佳子4), 石原美佳4), 木村健4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 711-711, 2022.
Japanese Article 24-05-O25-4. Examination about the association between effectiveness and MIC of the VCM treatment for the MRCNS bacteremia
三好真琴1), 櫻井紀宏2), 掛屋弘2,3), 中村安孝1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 712-712, 2022.
Japanese Article 24-05-O25-5. Intervention to extracorporeal membrane oxygenation and the vancomycin TDM for the neonates who underwent sustained hemofiltration dialysis
内藤沙紀1), 内田淳1), 輿石泰良1), 須長祐人2), 吉沢雅史2), 河野洋介2), 長谷部洋平2), 戸田孝子2), 橘田文彦1), 犬飼岳史2), 河田圭司1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 713-713, 2022.
Japanese Article 24-09-O26-1. Interest degree investigation in the drugstore duties of the pharmacy student
竹増理恵1), 長井克仁2), 富樫由美1), 松岡有利子1), 福野修平2), 浦嶋庸子2), 小西廣己2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 714-714, 2022.
Japanese Article 24-09-O26-2. The specialist job cooperation education that we conducted using WEB meeting system during hospital training
薄井健介1,2), 大内竜介1,2), 渡邊卓嗣1,2), 成澤健3), 大塚眞理子3), 岡田浩司1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 715-715, 2022.
Japanese Article 24-09-O26-3. Efforts - of our hospital in the construction (the third report) - pharmacist version clinical ladder making of the hospital pharmacist staff education system
小山郁美1), 稲野寛1), 婦川貴博1), 山本悠樹1), 坂倉智子1), 近藤留美子2), 厚田幸一郎2), 尾鳥勝也1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 716-716, 2022.
Japanese Article 24-09-O26-4. Effect to confidence of construction and the medication counseling of the hearing loss e-learning system
俵口奈穂美1), 窪田敏夫1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 717-717, 2022.
Japanese Article 24-09-O27-1. Experimental evaluation of the ad usum externum preparation choice in the use of the makeup
亀井貴志1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 718-718, 2022.
Japanese Article 24-09-O27-2. Properties of matter change to a rice cake form by the mixture of the ointment for the dexamethasone oral cavity and the commercial oral moisturizer
久土徹也1), 山田直香1), 岡田莉奈1), 松本ゆいこ1), 宮本康敬1), 内藤慶子2), 配島桂子2), 川口千香1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 719-719, 2022.
Japanese Article 24-09-O27-3. The effectiveness and safety of the post-operative pain management that added administration to a colon cancer surgery case at the acetaminophen IV infusion liquid appointed hour
堀田栄治1), 高橋裕治1), 佐野正毅1), 斎藤健一郎2), 高嶋吉浩2), 宗本義則2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 720-720, 2022.
Japanese Article 24-09-O27-4. Efforts for the polypharmacy in the multi-type of job collaboration team
山崎新平1), 矢川結香1), 秋吉尚雄1), 藤村弥生1), 山戸真子1), 吉岡幹人2), 野口直子3), 吉国健司1), 小倉秀美1), 山口健也4), 折口秀樹5)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 721-721, 2022.
Japanese Article 24-09-O27-5. Identification of the food and drink drug interaction ingredient through the OATPs inhibition with the citrus fruits bellows
荒井智貴1), 秋好健志1,2), 森田時生1), 片岡寛樹1), 矢島広大1), 植草義徳1), 羽田紀康3), 今岡鮎子1), 大谷壽一1,2,4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 722-722, 2022.
Japanese Article 24-09-O28-1. Analysis - using associated - Fib4-index with a liver function improvement effect by the Pemafibrate and impaired glucose tolerance
西垣賢1), 田村圭将2), 米田勝晃3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 723-723, 2022.
Japanese Article 24-09-O28-2. Weight loss effect according to the degree of corpulence in the GLP-1 receptor agonist
渡部正太1), 重成大介1), 尾崎良輔1), 奥村美佑1), 北田衛1), 大村侑平1), 太田明秀1), 岡野翔1), 中田浩雅1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 724-724, 2022.
Japanese Article 24-09-O28-3. The examination of the intervention effect of the ophthalmology consultation encouragement by the drugstore pharmacist on patients with diabetes: Cluster randomized controlled trial (protocol)
小川愛1), 鈴木達彦2), 須藤寛3), 岡林慎二4), 山本洋介4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 725-725, 2022.
Japanese Article 24-09-O28-4. Evaluation of the costs reduction to need for treatment, and the like of Adverse Drug Event by proper use of the medicine for the mental nerve in the psychiatry inpatient
久保賢晃1), 舘知也1,2), 青山京介1), 古山愛紗1), 渡邉繭子2), 青山智2), 野口義紘1), 田中和秀2), 安田昌宏2), 柴田明彦3), 水井貴詞2), 寺町ひとみ1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 726-726, 2022.
Japanese Article 24-09-O28-5. One patient whom longtime phenobarbital powder, benzodiazepine addiction by taking etizolam tablets developed in
佐藤裕之1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 727-727, 2022.
Japanese Article 24-09-O29-1. Evaluation (the second report) of the ward pharmacist duties in the Okayama University Hospital altitude critical care center using the customer satisfaction analysis
大川恭昌1), 真鍋洋平1), 小沼利光1), 山田あかね1), 川西秀明1), 勝部理早1), 井上智美2), 村川公央1), 中尾篤典3), 座間味義人1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 728-728, 2022.
Japanese Article 24-09-O29-2. The current situation investigation about the pharmaceutical intervention by the pharmacist who is resident in an emergency visit
中西裕明1), 大山翔1), 熊野瑛巴1), 藤田将輝1), 澤田真嗣1), 野口裕介1), 小森玉緒1), 岡橋孝侍1), 友金幹視1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 729-729, 2022.
Japanese Article 24-09-O29-3. Examination of the method to promote improvement in sense of crisis and the behavior modification for the disaster in the drug section
山尾真貴子1), 青木勇樹1), 柏原道志1), 矢部勝茂1), 梶原千里2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 730-730, 2022.
Japanese Article 24-09-O29-4. Activity report - as medical support - pharmacist in the hospitalization wait station of the COVID-19-positive person
坂口結斗1), 長濱藍1), 駒井勇太1), 府川祥子1), 白木萌1), 有銘千賀子1), 市原麻友子1), 石木仁美1), 和泉勝一1), 松下貴英1), 安里衣真1), 下村周嗣1), 玉城亜寿香1), 久田潤平1), 喜多洋嗣1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 731-731, 2022.
Japanese Article 24-09-O29-5. Contribution of the pharmacist for the electronic medical chart construction for the disaster
仲里泰太郎1,2), 小林政彦2), 中出雅治1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 732-732, 2022.
Japanese Article 24-09-O30-1. The effect that a dose of the ST medical mixture gives to the serum creatinine level of renal-transplant recipients
辻本高志1), 鵜野竜馬1), 東亮佑1), 高橋諒多1), 川本由加里1), 高本大路2), 高田祐輔2), 佐々木元2), 田邉起2), 後藤仁和1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 733-733, 2022.
Japanese Article 24-09-O30-2. Investigation on TSH level reduction in patients taking roxadustat
西田麻以1), 長尾由佳1), 古谷祥子1), 菅直恵1), 山田菜月1), 藥師径子1), 赤木晋介1), 徳田衡紀1), 高柳和伸1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 734-734, 2022.
Japanese Article 24-09-O30-3. Literature survey on the mechanism of nocebo effect and cholecystokinin
加藤未来1), 間宮桐子1), 井澤美苗1), 石川春樹1), 望月眞弓1), 青森達1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 735-735, 2022.
Japanese Article 24-09-O30-4. Analysis of 6 cases about the association of choler drainage and the PT-INR change in the warfarin remedy patients
根岸瑠美子1), 中澤孝文1,2), 山崎伸吾1), 内田雅士1,2), 鈴木貴明1,2), 中村貴子1), 大塚将之3), 石井伊都子1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 736-736, 2022.
Japanese Article 24-09-O31-1. Search of the vomiting expression factor in linezolid treated patients
堤竹蔵1,2), 今井俊吾3,4), 柏木仁3), 佐藤夕紀3), 菅原満2,3,5), 武隈洋2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 737-737, 2022.
Japanese Article 24-09-O31-2. One case in which anamorelin was discontinued due to persistent hyperglycemia
田嶋大輝1), 高木昭佳1), 加藤敦1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 738-738, 2022.
Japanese Article 24-09-O31-3. One transluminal case that zirconium cyclo sodium silicate hydrate remained in in stomach after administration
後藤伴美1), 山村亮太1), 柴田智隆2), 上野希望1), 龍田涼佑1), 田中遼大1), 坂本照夫2), 伊東弘樹1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 739-739, 2022.
Japanese Article 24-09-O31-4. Search of the factor having an influence on the length of stay in elderly patients operated on for osteoarthritis
三宅優子1), 小瀬英司1), 山元孝俊1), 光永義治1), 安野伸浩1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 740-740, 2022.
Japanese Article 24-09-O31-5. The examination of the safe surveillance method for the cholinergic crisis in the use of distigmine patients: Descriptive epidemiology study in the third emergency acute medical institution
森愛絵1), 西村健二1), 石田亮2), 亀井健人1), 赤木晋介1), 徳田衡紀1), 高柳和伸1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 741-741, 2022.
English Article IO-01. Clinical utility of infliximab TDM in rheumatoid arthritis management
Sho Masui1,2), Atsushi Yonezawa1,2), Kazuto Nakae1,2), Miyuki Nakamura1,2), Motomu Hashimoto3), Akira Onishi3), Hideo Onizawa3), Takayuki Fujii3,4), Kosaku Murakami5), Koichi Murata3,4), Masao Tanaka3), Kotoko Yokoyama6), Noriko Iwamoto6), Takashi Shimada6), Kotaro Itohara1), Shunsaku Nakagawa1), Satoshi Imai1), Takayuki Nakagawa1), Makoto Hayakari1), Shuichi Matsuda4), Akio Morinobu3,7), Kazuo Matsubara1), Tomohiro Terada1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 742-743, 2022.
English Article IO-02. Pharmacokinetics and exposure-response analyses of upadacitinib in patients with moderate to severe ulcerative colitis - Analyses of induction and maintenance clinical trials
Mohamed-Eslam F. Mohamed1), Ana Victoria Ponce-Bobadilla2), Sven Stodtmann2), Doerthe Eckert2), Wen Zhou1), Wei Liu1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 744-745, 2022.
English Article IO-03. Effects of long-term multiple immunosuppressants on everolimus pharmacokinetics in patients after renal transplantation
Tomoyuki Sakaue1), Kazuhiro Yamamoto1), Takahito Endo2), Takeshi Ishimura2), Masato Fujisawa2), Tomohiro Omura1), Ikuko Yano1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 746-747, 2022.
English Article IO-04. Monte Carlo simulation to determine optimal ceftazidime dosing in patients receiving continuous hemodiafiltration
Yugo Chisaki1), Manami Mitsuyama1), Miyu Yasukawa1), Yoshitaka Yano1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 748-749, 2022.
English Article IO-05. Lansoprazole exacerbates linezolid-induced thrombocytopenia : potential drug interaction via human organic anion transporter 3
Danni Wang1), Kenji Ikemura1,2), Masahiro Okuda1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 750-751, 2022.
English Article IO-06. Basic Research for the Practice of Reverse Translational Research in Doxorubicin-induced Cardiomyopathy
Naoki Yoshikawa1), Tomoko Kamei1), Yuichiro Kurone1), Naoto Hirata1), Sadahiko Shimoeda1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 752-753, 2022.
English Article IO-07. Effectiveness and safety of direct oral anticoagulants versus warfarin during chemotherapy for cancer patients aged 75 or older : A nationwide inpatient database study
Chikako Iwai1), Jo Taisuke2,3), Hideo Yasunaga1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 754-755, 2022.
English Article IO-08. Multicenter prospective observational study on hospital pharmacist interventions to reduce inappropriate medications
Shinya Suzuki1,7), Mayako Uchida2,7), Hideki Sugawara4,7), Yukio Suga3,7), Takayuki Nakagawa5,7), Hisamitsu Takase6,7)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 756-757, 2022.
English Article IO-09. A survey on the actual status of web-based hospital-pharmacy collaborative case study meetings during the COVID-19 pandemic
Michiya Akabane1), Yuki Kunitsu1), Masatomo Sudo1), Masaki Sumi1), Koji Uenishi1), Shin-ya Morita1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 758-759, 2022.
Japanese Article P001-23-PM. 2 cases of the haemodialysis patients that examined a preparation change based on the collapse time for the purpose of taking precipitated calcium carbonate-related improvement
鈴木寛1), 小川裕子1), 柏倉康治2), 内田信也2), 影山慎二3), 山内克哉1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 760-760, 2022.
Japanese Article P002-24-AM. Usefulness evaluation to the prescription support of the default use utilizing the ICT
上松祐貴1), 三村享1), 関夏望1), 中澤佑香1), 村井健太郎1), 土屋広行1), 内藤隆文1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 761-761, 2022.
Japanese Article P003-23-PM. Examination of the effect of the injectable antimicrobial, dilution level of antiviral drug and incident preventive measures about the rate of application that paid their attention to an injection prescription
長谷康史1), 荒木良介1), 山田英紀1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 762-762, 2022.
Japanese Article P005-23-PM. The construction of the checking prescription support system depending on renal function and examination about the usefulness
升田万祐子1), 楠川侑吾1), 多留木崇志1), 成瀬圭1), 村田龍宣1), 村岡淳二1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 763-763, 2022.
Japanese Article P006-24-AM. Basic examination about the formulations method of the pediatric dose of a warfarin potassium infinitesimal grain and the granular preparation and the storage method after the medication
秋山滋男1), 中田いちこ2), 宮本悦子3), 齋藤健一4), 政氏藤玄2), 堀祐輔1), 石田志朗5)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 764-764, 2022.
Japanese Article P007-23-PM. Efforts for the effective prescription checking using the drug section system in the injection drug requiring attention every administration
伊東冴栄1), 八木仁史1), 石川夕起1), 村澤康平1), 白石俊介1), 内田裕之1), 満田正樹1), 河井良智1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 765-765, 2022.
Japanese Article P008-24-AM. Investigation about the careful administration case in the treatment with hormone replacement therapy medicine
畑賢太1), 山口和奎1), 得地美帆1), 野木山史恭1), 相馬まゆ子1), 今田愛也2), 藤枝聡子3), 山本浩史4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 766-766, 2022.
Japanese Article P009-23-PM. Type of the comparison (2) - instillator about the transluminal tube (ISO80369-3) passage characteristics of the Chinese medicine extract preparation, comparison - by the difference in tube diameter
毎田千恵子1), 中田いちこ2), 秋山滋男3), 高野克彦1), 船坂龍善4,5), 杉田尚寛6), 宮本悦子5,7)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 767-767, 2022.
Japanese Article P010-24-AM. Precision investigation of the evaluation with the rose by the viewing at the powders inspection
染谷健次1), 八島秀明1,2), 正田遊野1), 阿部正樹1), 荒木拓也1,2), 山本康次郎1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 768-768, 2022.
Japanese Article P011-23-PM. About the communalization of the doubt inquiry contents of hospital pharmacist and the drugstore pharmacist
中川義浩1,2,3), 桑村恒夫1), 野田聖奈子1), 篠崎千尋1), 松本美紅1), 梅崎りさ2), 清原珠美3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 769-769, 2022.
Japanese Article P012-24-AM. The current situation investigation about the steady supply system of a factor and the pharmaceutical company which became the supply restrictions of pharmaceutical products
安原昌宏1), 横山匠太1), 森川記道1), 谷保智美1), 大山展弘1), 内海敦志1), 原田靖子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 770-770, 2022.
Japanese Article P013-23-PM. Pharmaceutical products management by a non-working full time pharmacist and the multi-type of job cooperation in the middle scale hospital operating room
細野真吾1), 磯野礼果1), 亀井幹子2), 白井壽子2), 澁田達史3), 山崎崇1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 771-771, 2022.
Japanese Article P014-24-AM. Fact-finding about the transpiration of the infusion preparation
中邨翔太1), 河内佑樹1), 岸川礼子1), 橋詰淳哉1,2), 龍恵美1), 原澤仁美1), 兒玉幸修1), 大山要1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 772-772, 2022.
Japanese Article P015-23-PM. Preparation of the chewing silverberry agent for the dry mouth including the taste ingredient with the 3D bio printer
田上辰秋1), 木田理沙子1), 小川昂輝1), 尾関哲也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 773-773, 2022.
Japanese Article P016-24-PM. A preparation of the hospital preparation propranolol cream for the purpose of infants hemangioma treatment and evaluation of the pharmaceutics
柏倉康治1), 坪井絵乃1), 田中紫茉子1), 並木徳之1,2), 内田信也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 774-774, 2022.
Japanese Article P017-23-PM. Preparation of the foam preparation for oral mucositis treatment as the hospital preparation
渡辺日菜子1,2), 柏倉康治1), 永井日菜1), 芦原まいか1), 大城真理奈1), 田中紫茉子1), 並木徳之1,2), 内田信也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 775-775, 2022.
Japanese Article P018-24-PM. A study on utility improvement of the hospital preparation: The combination of quick bag and cryopreservation raises convenience of the Mohs ointment
岡本広世1), 吉川知宏1), 竹内健太1), 平田敦士1), 出口粧央里2), 長井紀章2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 776-776, 2022.
Japanese Article P019-23-PM. Study on Zetia (R) tablet 10mg one dose package
平山優希1), 長山晃1), 森下和美1), 川上典子1), 近藤昌子1), 金顯凡2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 777-777, 2022.
Japanese Article P020-24-AM. We promote efficiency of a stability evaluation and preparation duties of the note preparation for Omegaven(R)
湖城由佳1), 丹沢彩乃1), 小口敏夫2), 山谷明正1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 778-778, 2022.
Japanese Article P022-24-AM. Efforts of the Clostridioides difficile infection with ward pharmacist screening
岩鼻優1), 佐々木康弘1), 橘淳1), 天野美里1), 益子里美1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 779-779, 2022.
Japanese Article P023-23-PM. Smooth introduction of the simple suspension method that adopted a nurse questionnaire
安富暉浩1), 犬飼千智1), 安田成男1), 辻井佳代1), 小林政彦1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 780-780, 2022.
Japanese Article P025-23-PM. One case that phenothiazine derivative combination was considered as the toxic symptom onset, a factor in a lithium concentration therapeutic range, and led to the temporary pacemaker insertion
眞野裕1), 石田茂伸1), 多胡友絵1), 星育子1), 小泉祐一1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 781-781, 2022.
Japanese Article P026-24-AM. Fact-finding of the polypharmacy in our clinic
梅庭大地1,2), 今野江梨1), 藤田大智1), 佐々木理絵1), 天間雅美1), 加藤利佳3), 本郷文教1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 782-782, 2022.
Japanese Article P027-23-PM. Activity result of the urination care team in our hospital
林剛史1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 783-783, 2022.
Japanese Article P028-24-PM. Efforts aiming at medication counseling system reinforcement by the Commander system introduction in the local inclusion care ward in the ward drug duties non-enforcement institution
岸本真1), 徳丸章佳1), 山本梢1), 中野一馬1), 北園幸大1), 田中恭人1), 豊留麻衣1), 池沢若菜1), 森永崇史1), 中村杏果1), 屋敷大輔1), 淵脇ゆかり1), 長ヶ原琢磨1), 荻尾夕起子1), 児玉友和2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 784-784, 2022.
Japanese Article P029-23-PM. 1 case of the pacemaker lead infection that suffered from a choice of the antiMRSA medicine
内村充志1), 曽我弘道1), 前田朱香1), 福島将友1), 町田聖治1), 入江利行1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 785-785, 2022.
Japanese Article P030-24-AM. The osteoporosis therapeutic drug start situation investigation by the FLS (osteoporotic liaison) pass introduction
後藤千尋1), 宮崎早可1), 田中拓可1), 大城里紗1), 安達嘉織1), 佐野隆大2), 福井由美子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 786-786, 2022.
Japanese Article P031-23-PM. Fact-finding of the bringing medicine for the purpose of the cancellation of the polypharmacy
田本光莉1), 矢田山瑞稀1), 島津智行1), 河端真以1), 蝦名勇樹1), 村上智香1), 田中悠季1), 三本松泰孝1), 佐藤弘康1), 田村広志1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 787-787, 2022.
Japanese Article P033-23-PM. Increased pharmacist intervention in discharge guidance - Utilizing pre-avoid reports -
瀬名波暢子1), 門馬佳代子1), 辻井佳代1), 小林政彦1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 788-788, 2022.
Japanese Article P034-24-AM. Investigation of the quantity of pain-killer prescription in front and back where a pharmacist intervenes in in the pain control in the orthopedics ward positively
山口茉由夏1), 保志場康人1), 小山奈津実1), 森脇麻希1), 山口徹郎1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 789-789, 2022.
Japanese Article P035-23-PM. Efforts and evaluation for the drug global assessment adjustment addition in our hospital
伊藤弥紀1), 東恵理1), 永江寛子2), 萩原大樹1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 790-790, 2022.
Japanese Article P036-24-AM. Examination about the effect on serum zinc levels with the zinc acetate dihydrate administration to a premature infant of the hypozincaemia and serum copper concentrations
伊藤俊和1,2), 上ノ山和弥1), 小林和博1), 角本幹夫3), 水本洋4), 桂敏也2), 尾上雅英1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 791-791, 2022.
Japanese Article P037-23-PM. Efforts of the regional alliances in our hospital drug department utilizing the discharge drug control summary
勝岡美菜1), 小寺菜月1), 若林厚史1), 坂本依利1), 高橋彩1), 田畑寛明1), 猿谷淳1), 向一美1), 地野幹子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 792-792, 2022.
Japanese Article P038-24-AM. Effect to the bleeding event prevention by the pharmacist intervention using Data Ware House on use of warfarin inpatient
山岸千恵1), 木下照常1), 杉山和弥1), 森健司1), 滝本典夫1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 793-793, 2022.
Japanese Article P039-23-PM. The observance situation of chronic constipation practice guidelines
小林寛典1), 信澤弘美1), 松元美香1), 大谷道輝1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 794-794, 2022.
Japanese Article P040-24-AM. Current status and issues of pre-avoid reporting at Komaki Municipal Hospital
土本大輔1), 桑原悠里1), 河野美来1), 宮川佐和子1), 林浩之1), 戸田康裕1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 795-795, 2022.
Japanese Article P041-23-PM. Examination about the usefulness of MMAS-4 in the medication Adobe alane evaluation
石井照樹1), 大嶋成奈優1), 沖廣絵里子1), 高橋公子1), 石原瑛太郎1), 篠永浩1), 加地努1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 796-796, 2022.
Japanese Article P042-24-AM. Relation of the pharmacist in the neonatal intensive care unit
門倉史枝1), 岡田瑞希1), 松谷春花1), 河原香織1), 藤原康浩1), 合田泰志1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 797-797, 2022.
Japanese Article P043-23-PM. Observational study about the usefulness of the SURPASS (SURgical PAtient Safety System) introduction in the perioperative antithrombotic drug management
堀内保顕1), 加藤里奈1), 加藤秀雄1), 向原里佳1), 世古口典子1), 佐々木典子2), 水谷栄梨1), 大井正貴3), 坂井田寛4), 兼児敏浩2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 798-798, 2022.
Japanese Article P044-24-AM. Efforts and evaluation of the pharmacist to the perioperative delirium measures in the digestive organ surgery domain
宮原強1), 野中美佳1), 草葉一友1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 799-799, 2022.
Japanese Article P045-23-PM. Contribution degree investigation in the pharmacist participation in planning of the heart rehabilitation conference
千葉貴志1), 池田絢絵1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 800-800, 2022.
Japanese Article P046-24-AM. Examination about the tube obstruction risk in the transluminal medication for extremely-low-birth-weight infants
田中悠介1), 金田亜季子1), 石川雄也1), 八島秀明1), 阿部正樹1), 荒木拓也1,2), 山本康次郎1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 801-801, 2022.
Japanese Article P047-23-PM. Medical treatment adequacy mainly on the antimicrobial medicine to patients who received extracorporeal circulation device by the cooperation of a pharmacist and the clinical engineer in the intensive care domain
小林洋平1), 中川貴弘1), 河津敏明1), 荒川昌洋2), 烏野隆博1,3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 802-802, 2022.
Japanese Article P048-24-AM. One case that the hypermagnesemia with advanced magnesium oxide tablets was regarded as a cause of disturbance of consciousness rapidly
藏本裕信1), 樽屋志保1), 権藤直人1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 803-803, 2022.
Japanese Article P049-23-PM. Fact-finding about the use level of injection drug unification in the intensive care unit
立石裕樹1,10), 今井徹2,10), 川邊一寛3,10), 玉造竜郎4,10), 安藝敬生5,10), 今中翔一6,10), 奥川寛7,10), 中馬真幸8,10), 前田幹広9,10)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 804-804, 2022.
Japanese Article P050-24-AM. Efforts to duties construction aiming at the perioperative drug control addition acquisition
日江井和英1), 宮部芳之1), 土本暁斗1), 安田翔1), 中村英嗣1), 大塚祐紀子1), 佐藤和也1), 松由幸司1), 塚原民夫1), 甲斐三由紀2), 山崎潤二3), 梶川真樹4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 805-805, 2022.
Japanese Article P051-23-PM. Introduction and evaluation of the calculation tool for the purpose of the intravenous feeding flow rate adequacy in the emergency care
長澤欣弘1), 中村槙一郎1), 瀧内瑛輔1), 尾形美絵1), 近藤和宏1), 羽生智宏1), 新関みどり1), 田村和彦1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 806-806, 2022.
Japanese Article P052-24-AM. Effect and a risk factor to acute renal failure of the vancomycin + piperacillin/tazobactam combination therapy for the seriously ill patients: Single institution rearward observational study
濱名哲大1), 大橋明歩1), 片山侑紀1), 梅村穣2), 藤見聡2), 藤田敬子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 807-807, 2022.
Japanese Article P053-23-PM. Examination of the efforts method for the acquisition of the drug global assessment adjustment addition by the intensive care unit permanent residence pharmacist
大塚晋也1), 林隼輔1), 蔭山博之1), 長谷川英雄1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 808-808, 2022.
Japanese Article P055-23-PM. The preoperative statin internal use in the statin drugs common use patients affects the blood pressure at the induction of anaesthesia
土本希1,2), 宮本朋佳1), 木村初1), 小泉祐一1), 森正信2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 809-809, 2022.
Japanese Article P056-24-AM. In the seriously ill COVID-19 patients, look at the rear that evaluated the effectiveness that bowel control by the naldemedine gives; a mark observational study
片山侑紀1), 濱名哲大1), 大橋明歩1), 川田真大2), 梅村穣2), 藤見聡2), 藤田敬子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 810-810, 2022.
Japanese Article P057-23-PM. Examination of the usefulness by a pharmacist conducting an alteplase preparation preparation in the critical care center
小林悠1), 内山耕作1), 種村繁人1), 渡邊晃平1), 芥子川純里1), 冨田敦和1), 今西忠宏1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 811-811, 2022.
Japanese Article P058-24-AM. Medical safety measures by the incompatibility reporting based on the three-drug incompatibility test that assumed turbidity an index
近藤匡慶1), 源平麻衣1), 深尾彰平1), 田杭直哉1), 菅谷量俊1), 柳田顕郎2), 高瀬久光1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 812-812, 2022.
Japanese Article P059-23-PM. Usefulness evaluation for patients with stroke for the acute phase by the ward pharmacist in the emergency visit
石川衣里子1), 細谷龍一郎1,2), 北島健士1), 柴崎功1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 813-813, 2022.
Japanese Article P060-24-AM. Example that a ward pharmacist provided multidisciplinary treatment for emphysematous pyelonephritis and supported
井出和男1), 石村真琴1), 西垣哲太1), 川邊一寛1), 秋田士雄人1), 加藤英明2), 小池博文1), 佐橋幸子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 814-814, 2022.
Japanese Article P061-23-PM. Investigation about the difference of the medication counseling of the female sex hormone preparation by the Gender of the drugstore pharmacist
矢島杏里1), 長内理大1), 伊野陽子1), 玉木啓文1), 井口和弘1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 815-815, 2022.
Japanese Article P062-24-AM. Introduction of the discontinuation explanation seat before surgery, examination with the photograph as the support before hospitalization
濱崎翔平1), 谷本憲哉1), 谷口潤2), 尾ノ上剛樹1), 山形真一1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 816-816, 2022.
Japanese Article P064-24-AM. About the role of the pharmacist for the high-risk medicine including diabetes, an antithrombotic drug, the anticancer agent in the hospitalization ambulant treatment support
野村浩夫1,2,3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 817-817, 2022.
Japanese Article P065-23-PM. The introduction of the interview by the pharmacist for patients with foreign cancer and the evaluation
平野公美1), 外山未来1), 大和千穂1), 八木貴彦1), 冨田奈々1), 宮本康敬1), 川口千香1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 818-818, 2022.
Japanese Article P066-24-AM. Elucidation and drugstore investigation ... of the potential element of the labor quality of life (Quality of Working Life) of the drugstore pharmacist in the suburbs of secular variation - Kanto
加藤裕太1,2), 関谷剛1), 石井僚3), 平子庸志3), 佐藤宏樹2), 木村廣道1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 819-819, 2022.
Japanese Article P067-23-PM. Fact-finding of the in front of art discontinuation supplement in the pharmacist interview before hospitalization of the perioperative patients
山川裕司1), 柏村友一郎1), 小田泰弘1), 岩切総子1), 島野玲菜1), 若海大智1), 藤井博之1), 伊藤忠明1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 820-820, 2022.
Japanese Article P068-24-AM. Usefulness of the pharmacist intervention in the hospitalization and release support task of the general support center
小寺聖1,2), 渡部実咲1), 田中佳子1), 関谷泰明1), 井上壽江1), 荒井正純2), 平下智之1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 821-821, 2022.
Japanese Article P069-23-PM. Questionary survey to the physician about the evaluation of the pharmacist outpatient department
黒部健太郎1), 宮原強1), 草葉一友1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 822-822, 2022.
Japanese Article P070-24-AM. Usefulness investigation of the pharmacist intervention in the hospitalization support outpatient department of the patients targeted for surgery
早坂美希1), 佐々木順也1), 千葉貴志1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 823-823, 2022.
Japanese Article P071-23-PM. The current situation investigation and problem of the use of prescription notebook situation after the prescription notebook seal introduction and the medication explanation
小野理恵1), 金田亜季子1), 飯塚誠1), 高橋理充1), 長井桃子1), 阿部正樹1), 八島秀明1), 荒木拓也1,2), 山本康次郎1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 824-824, 2022.
Japanese Article P072-24-AM. Usefulness evaluation of the prescription support for the overs and shorts of expendable supplies required for insulin, GLP-1 receptor agonist, SMBG
若原美沙紀1), 中村和行1), 三浦忠将1), 森巧一1), 藤井友和1), 武井貴裕2), 近藤國和3), 水谷直広3), 杉浦洋二1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 825-825, 2022.
Japanese Article P073-23-PM. An effect and evaluation of the insulin instruction to patient by task shift/share
植村有加1), 安田早織1), 辻芙美1), 楠斐未1), 國枝亜矢香1), 矢野美保2), 三宅健文1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 826-826, 2022.
Japanese Article P074-24-AM. Intervention results and evaluation - of the promotion of task shift - team approach in medical care
滝澤康志1), 久保田令枝1), 宮崎邦晃1), 西澤さとみ1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 827-827, 2022.
Japanese Article P075-23-PM. About the periodical change of the prescription order representation input quantity of duties before and after transducing it
小野歩1), 沼田諒1), 折戸融1), 石井勇太1), 片山潤1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 828-828, 2022.
Japanese Article P076-24-AM. Effect of reducing the workload on doctors through task shifting using PBPM and ward drug duties
片桐将志1), 十川友那1), 近藤宏樹1), 中西順子1), 篠永浩1), 原田典和1), 加地努1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 829-829, 2022.
Japanese Article P077-23-PM. Support effect on the basis of a pharmaceutical evaluation on secondary fracture prevention of patients with fragile bone fracture accompanied with the 2022 medical service fees revision
佐藤愛1), 中島美治1), 中村彩1), 内田裕之1), 満田正樹1), 河井良智1), 東川晶郎2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 830-831, 2022.
Japanese Article P078-24-AM. About the introduction examination of the doubt inquiry simplification protocol by the hospitalization prescription based on the actual situation of doubt inquiry in our hospital
中北朝海1), 臼田昌弘1), 大原展1), 木村綾沙1), 木下護1), 神崎愛乃1), 高田莉里1), 白幡千慧1), 藤田英里子1), 内田裕子1), 大森俊和1), 樋口愛子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 832-832, 2022.
Japanese Article P079-23-PM. Examination about the overtime prescription reduction effect by the prescription support of the pharmacist
菅直恵1), 西村健二1), 石田亮2), 亀井健人1), 赤木晋介1), 徳田衡紀1), 高柳和伸1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 833-833, 2022.
Japanese Article P080-24-AM. Effect on wound development number by the use of drug for external use using PBPM in the ICU ward
竹腰雄真1), 山本浩二郎1), 前田晃佑1), 山本倫数1), 草薙みか1), 山田直輝1), 中出早代1), 裏野千裕1), 竹村姫穂1), 大里泰章1), 濱田達志1), 岩知道美幸1), 吉澤典成1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 834-834, 2022.
Japanese Article P081-23-PM. Relation of the pharmacist to self-injection instruction of the hydrocortisone preparation for the acute adrenal insufficiency
櫻井雄一郎1,2,3), 桧作和子2), 吉田麻里1), 井上美菜1), 西谷千里3), 有馬純子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 835-835, 2022.
Japanese Article P082-24-AM. Effect of the PBPM enforcement for sleeping drug proper use of the inpatient
石谷理紗1), 長谷川啓1), 細田未紀1), 山根正也1), 千原里美1), 上田宏1), 三好崇文2), 伊東範尚3), 中村好男3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 836-836, 2022.
Japanese Article P083-23-PM. Have the pharmaceutical products by the non-pharmacist using the personal digital assistant; efforts to misprevention
寺田公介1), 佐藤公彦1), 吉野麻結1), 中島寿久1), 石川光信1), 赤木徹1), 橋本浩伸1), 古川哲也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 837-837, 2022.
Japanese Article P084-24-AM. Prescription support ... which understood task shift - condition of a patient by the pharmacist in the interstitial pneumonia, pulmonary fibrosis center
関根悠1), 合津貴志1), 渡邉紘章1), 築地洸大1), 杉野圭史2), 田崎政則1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 838-838, 2022.
Japanese Article P085-23-PM. The preparation of the surgery use drug by the pharmacist is the effect to replace it, and to give at time of the surgery patients
土川拓也1), 小倉花菜1), 濱本裕太1), 古谷一平1), 田中佳子1), 関谷泰明1), 井上壽江1), 平下智之1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 839-839, 2022.
Japanese Article P086-24-AM. Efforts and evaluation for the appropriate correspondence such as anticoagulants, and the like in the perioperative period
石田智之1), 森美保菜1), 末永尚輝1), 八汐祥恵1), 鶴永大貴1), 中村有莉恵1), 堀内智裕1), 赤星真広1), 森岡友美1), 池増鮎美1), 佐多照正1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 840-840, 2022.
Japanese Article P087-23-PM. Evaluation of the pharmacist duties in the hospitalization and release support center using the satisfaction analysis
竹内恵1), 宮原強1), 山田敦子1), 貞嶋栄司2), 田中聡也3), 草葉一友1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 841-841, 2022.
Japanese Article P088-24-AM. Efforts of the pharmacist about the cancellation medicine before stomach, colonoscopic examination in the outpatient
藤井達郎1), 佐々木静香1), 下口谷貴1), 山川拓1), 久保瞳1), 藤井有貴1), 門村将太1), 森本雅子1), 井藤達也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 842-842, 2022.
Japanese Article P089-23-PM. Inspection of the effect of the prescription input support task by the pharmacist in the orthopedics ward
曽根本恵美1), 溝口晶子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 843-843, 2022.
Japanese Article P090-24-AM. Efficiency of the duties with the drug management system which implemented a prescription injection order automatic uptake function
宮崎美香1), 馬場貴子1), 陣上祥子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 844-844, 2022.
Japanese Article P091-23-PM. Construction and problem of the expiration date inspection using the new bar code in the parenteral injection inspection system
下村一徳1), 高橋勝史1), 瀬名波宏昌1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 845-845, 2022.
Japanese Article P092-24-AM. Current situation investigation (2) for the new mobile health-related application development aiming at effective medical treatment and improvement in health science
斉藤将志1), 福井一玄1), 鈴木小夜1), 横山雄太1), 地引綾1), 河添仁1), 中村智徳1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 846-846, 2022.
Japanese Article P093-23-PM. The effect that the prescription of the drug requiring an examination and exhaustive grasp of the examination situation give to ward drug duties
永野真久1), 住吉恵1), 峰山恵理子1), 高武嘉道1), 花田聖典1), 川俣洋生2), 橋本雅司1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 847-847, 2022.
Japanese Article P094-24-AM. An onset of congenital heart defect vascular disorder risk accompanied with the cross-placental transfer: Analysis using the large-scale database
岡田章1,2), 若林里依1), 世良庄司1,2), 永井尚美1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 848-848, 2022.
Japanese Article P095-23-PM. The prescription situation investigation of capecitabine and the drug for external use in Japan using the NDB opening database
中村俊貴1), 坂本岳志1), 境美智順1), 木村雅彦1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 849-849, 2022.
Japanese Article P096-24-AM. Effect of the reporting that use and application had of in-hospital big data (DWH) which gave it to proper use of the eldecalcitol
伊東久貴1), 三村享1), 村井健太郎1), 竹澤崇1), 坂上進1), 堀口香織1), 土屋広行1), 内藤隆文1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 850-850, 2022.
Japanese Article P097-23-PM. Construction of the positioning database of the medicine for prescription suggestion based on evidence
高嶋理子1), 柴田里枝子1), 石川真代2), 大野逸子1), 杉平直子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 851-851, 2022.
Japanese Article P098-24-AM. Relative examination with the urination independence at prescription pattern of the lower urinary tract symptom (LUTS) therapeutic drug vertical section-like for the stage using the stroke regional alliances pass and convalescent discharge
隅屋暦1), 正源寺美穂2), 平子紘平3), 小川依4), 池永康規5), 玉井郁巳6), 増田晃伯7), 橋本昌子8), 藤田有美1,9), 嶋田努1,9), 崔吉道1,9)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 852-852, 2022.
Japanese Article P099-23-PM. Graded approach for formula repenetration
森良江1), 前万紀子1), 堀勇太2), 磯部佳歩1), 中浴伸二3), 森本茂文1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 853-853, 2022.
Japanese Article P100-24-AM. Search of the low carnitine blood symptom onset risk factor with the pivoxil group using adverse drug reaction database (JADER)-containing antimicrobial
佐々木稜太1), 服部真也1), 高田慎吾1), 山田武宏1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 854-854, 2022.
Japanese Article P101-23-PM. Efforts of the continuous medication counseling utilizing the telephone follow-up by the health insurance pharmacy pharmacist
長沼敬子1), 上田博史1), 染谷光洋1), 中田祐一1), 谷口亮央1), 中島史雄1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 855-855, 2022.
Japanese Article P102-24-AM. Questionary survey about the online medication counseling for pharmacists
植田光紀1), 大野由紀子1), 石川春樹1), 井澤美苗1), 望月眞弓1), 青森達1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 856-856, 2022.
Japanese Article P103-23-PM. Construction of Kurashiki center Hospital adverse drug reaction database (KADER)
古谷祥子1), 長尾由佳1), 田之上理恵1), 藥師径子1), 赤木晋介1), 徳田衡紀1), 高柳和伸1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 857-857, 2022.
Japanese Article P104-24-AM. Comparative study on basic drug information of authorized generics and brand-name drugs
佐々木咲輝1), 政田一樹1), 古俵孝明1), 渡辺享平2), 塚本仁1), 酒井隆全3), 大津史子3), 後藤伸之1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 858-858, 2022.
Japanese Article P105-23-PM. Effects of introducing recommendation function on electronic medical record in formulary operation of G-CSF preparations
山崎瑞季1), 安田浩二1), 木野村元彦1), 櫻井秀司1), 鈴木昭夫1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 859-859, 2022.
Japanese Article P106-24-AM. Strategic research towards in-hospital formulary penetration at Toda Chuo Medical Care Group (TMG) (2nd report)
安藤正純1), 金井紀仁1), 佐藤光2), 宮本拓也3), 澤田雄太4), 奈良部修弘5), 吾妻隼斗6), 永瀬真理子7), 下舘桃子8), 宮崎美子3), 齋藤俊夫9), 濃沼政美10)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 860-860, 2022.
Japanese Article P107-23-PM. Analysis of the effect of the levetiracetam to give a bleeding-related adverse event by oral anticoagulant drug (DOAC) directly using the adverse drug reaction database
濱田雄平1), 奥村啓樹1), 宮崎雅之1), 山田清文1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 861-861, 2022.
Japanese Article P108-24-AM. Efforts to introduce a sleeping pill formulary at Saitama Medical University Hospital - Based on the experience of multidisciplinary collaboration -
水村亮介1,2), 石川章1,2), 伊藤護之1,2), 宇都宮暁1,2), 眞壁秀樹1,2), 佐美三怜佳2), 須賀建太郎2), 黒澤洋志2), 小和瀬由美子2), 喜屋武玲子2), 草野武2), 鈴木景子2), 松岡孝裕2), 松尾幸治2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 862-862, 2022.
Japanese Article P109-23-PM. Investigation of the pharmaceutical products cord published in "the announcement" of cessation of production, sale cancellation of pharmaceutical products sent by the pharmaceutical company
若林進1), 田中秀和2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 863-863, 2022.
Japanese Article P110-24-AM. Pre-rear investigation of Residual medicine patients with diabetes that we coordinated
青木由華1), 坂田洋1), 田中伸明1), 鈴木大吾1), 中村敏史1), 服部芳明1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 864-864, 2022.
Japanese Article P111-23-PM. Analysis about the delirium risk of the antiepileptic drug
久保利樹1), 祖川倫太郎1), 飛田修康1), 橘川奈生1), 角真太郎1), 島ノ江千里1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 865-865, 2022.
Japanese Article P113-23-PM. Investigation of the prescription situation of the antiallergic agent for spring hay fever during pregnancy
前田恵里1), 星野香澄1), 岡田裕子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 866-866, 2022.
Japanese Article P114-24-AM. Extraction of the high-risk drug by the exhaustive analysis of the potential cardiovascular disturbance risk using side effect spontaneous report database (JADER)
井川祐輔1), 江角悟1), 牛尾聡一郎1), 市川裕規1), 濱野裕章1), 鍛治園誠1), 西原茂樹1), 村川公央1), 座間味義人1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 867-867, 2022.
Japanese Article P115-23-PM. Risk factor of the non-fixed form femur fracture based on JADER, profile of the expression time, examination of the drug interaction
鳥海真也1,2), 三森竜司1), 坂本治彦1), 植沢芳広2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 868-868, 2022.
Japanese Article P116-24-AM. In-hospital formulary at a 300-bed public hospital - Aiming to improve patient outcomes -
磯貝一成1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 869-869, 2022.
Japanese Article P117-23-PM. Drug-induced hiccups and relations of the glucocorticoid receptor
細谷龍一郎1,2), 野澤(石井)玲子3), 植沢芳広2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 870-870, 2022.
Japanese Article P118-24-AM. Use investigation of the ropinirole hydrochloride percutaneous absorption type preparation for the Parkinson's disease patients
安高勇気1,2), 藤岡伸助3), 大藪康平2), 坪井義夫3), 神村英利1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 871-871, 2022.
Japanese Article P119-23-PM. Survey on the current status of formulary implementation and the "formulay introduction procedure manual with Japanese Red Cross Society usage guide"
堀大1,10), 野田明宏2,10), 小口正義3), 伊賀正典4,10), 大川浩子5,10), 小林政彦6,10), 村上通康7,10), 森英樹8,10), 谷村学9,10)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 872-872, 2022.
Japanese Article P120-24-AM. Investigation about the proper use of a bone, the calcium metabolism injection drug
鶴山萌子1), 高武嘉道1), 花田聖典1), 川俣洋生2), 橋本雅司1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 873-873, 2022.
Japanese Article P121-23-PM. Inventory survey about the current situation of the proper use of the oral antimicrobial in the pharmacy service under health insurance drugstore and the consciousness
高木栄希1), 川村ひとみ1), 坂本拓也1), 井上優子1), 伊達悠香1), 高橋里沙1), 駒沢穂乃佳1), 鈴木美和1), 白石貴寿1), 荒井宏人1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 874-874, 2022.
Japanese Article P122-24-AM. Survey on anamorelin usage status in our hospital
高田昌季1), 八幡静香1), 野尻雅人1), 清水雅子1), 高瀬美咲枝2), 柴田和彦3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 875-875, 2022.
Japanese Article P123-23-PM. Use fact-finding of the Mashiningan extract for the constipation
小笠原大祐1), 上田賢太郎1), 下石和樹1), 陣上祥子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 876-876, 2022.
Japanese Article P124-24-AM. Investigation about taking sulfamethoxazole trimethoprim (ST) combination drug small size tablets characteristics in children
山口みほ1), 齊藤順平1), 丹沢彩乃1), 歌野智之1), 千葉杏子1), 清水誠一2), 阪本靖介2), 福田晃也2), 笠原群生2), 山谷明正1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 877-877, 2022.
Japanese Article P125-23-PM. The use situation investigation of oxytocin for induced labor, the weak labor in our hospital
徳力麻希1), 池田久雄1), 古久保有希子1), 森岡浩子1), 神原弘和1), 依田恵美3), 橋本奈美子2), 足立充司1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 878-878, 2022.
Japanese Article P126-24-AM. It is an investigation for the proper use for the combination more than two drugs of an antithrombocytic agent, the anticoagulant
前田安里沙1), 山口章江1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 879-879, 2022.
Japanese Article P128-24-AM. The use situation investigation for the purpose of the adequacy of the drug choice in the hyperuricaemia therapeutic drug
岩田裕明1), 山村亮太1), 龍田涼佑1), 田中遼大1), 伊東弘樹1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 880-880, 2022.
Japanese Article P129-23-PM. Examination about the effectiveness of the zoledronic acid injection for the bone density drop that occurred during endocrine therapy after the breast cancer technique
鈴木訓史1), 村多杏美1), 内藤義博1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 881-881, 2022.
Japanese Article P130-24-AM. Use fact-finding of olanzapine in the antiemesis treatment of cancer chemotherapy patients
岡田和也1), 荒井雄樹1), 佐道花菜1), 村田政軌1), 三上知佳1), 木村錦子1), 青井博志1), 治田匡平1), 吉川一吾1), 鈴木渉太2), 池田和之1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 882-882, 2022.
Japanese Article P131-23-PM. Expectation to a drugstore pharmacist judging from inhabitants awareness to locomotive syndrome
冨永宏治1), 森田一俊1), 甲斐麻美子1), 原口恵子2), 白石遙香1), 高木淳一2), 田中泰三2), 江川孝1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 883-883, 2022.
Japanese Article P132-24-AM. Fact-finding about the off-period of the perioperative antithrombocytic agent in the first generation drug dissolution stenting patients
柘植勇大1), 小松敏彰1), 冨澤淳2), 平井美乃里1), 吉瀬絵理1), 尾鳥勝也1,3), 厚田幸一郎4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 884-884, 2022.
Japanese Article P133-23-PM. The prescription situation investigation of the oral antimicrobial in the outpatient department for children
平田貴宏1), 池田久雄1), 平田亜紀1), 足立充司1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 885-885, 2022.
Japanese Article P134-24-AM. Problems of the simple suspension method in the Handa that we knew from questionary survey City solder hospital neurosurgery ward
吉川直利1), 内藤千里2), 板倉由縁1), 横田学1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 886-886, 2022.
Japanese Article P136-24-AM. Usefulness of the medical application in patients with cancer
峯岸智之1), 木本真司1), 河原史明1), 香内綾1), 齋藤浩司1), 成田浩気1), 富山瑠美1), 塩川秀樹1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 887-887, 2022.
Japanese Article P137-23-PM. Survey on continuation of osteoporosis treatment after completion of teriparatide and romosozumab at our hospital
城山晴佳1), 冨田敦和1), 今西忠宏1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 888-888, 2022.
Japanese Article P138-24-AM. Use fact-finding of the carboxymaltose second iron injection for patients with iron-deficiency anemia
神志那萌子1), 濱地広毅1), 横溝綾子1), 前田幹広1), 有木宏宗1), 坂上逸孝1), 田中恒明1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 889-889, 2022.
Japanese Article P139-23-PM. About the use of antimicrobial situation of our hospital for the substrate specific expansion type β - lactamase (ESBL)-producing infection
山本亮子1), 梶本佑輔1), 菊地雄基1), 佐藤英和1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 890-890, 2022.
Japanese Article P140-24-AM. Consciousness, knowledge investigation about the anti-doping in the hospital pharmacist
畠山成寛1), 中川ちひろ1), 井出和男1), 川邉桂1), 小池博文1), 佐橋幸子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 891-891, 2022.
Japanese Article P141-23-PM. Medical expenses reduction effect by the bortezomib generic small capacity standard vial introduction
宇佐美英績1,2), 福岡智宏2), 木村美智男1), 吉村知哲1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 892-892, 2022.
Japanese Article P143-23-PM. Improvement of the economic loss by discontinuation instructions confirmation duties before operation
都築竜太1), 出雲貴文1), 深澤佑樹1), 佐藤渚1), 河本怜史1), 三好文子1), 山田晶子1), 柴田由佳1), 吉田裕紀1), 加藤紗耶香1), 松重奈央1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 893-893, 2022.
Japanese Article P145-23-PM. The effectiveness at disease ornamentation-related antirheumatic drug and methotrexate combination by existing clinical study data and safe analysis
吉井優花1), 大西真由1), 秋田彩佑1), 安部賀央里1), 頭金正博1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 894-894, 2022.
Japanese Article P146-24-AM. Evaluation after the in-hospital formula reintroduction in the small and medium size hospital
浅野志津1), 松本和也1), 廣田あゆ子2), 森英樹2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 895-895, 2022.
Japanese Article P147-23-PM. Association between suvorexant and femur fracture in elderly people
齋藤智之1), 野尻宗子1), 葛西隆敏2), 平塚義宗3), 石島旨章4), 代田浩之2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 896-896, 2022.
Japanese Article P149-23-PM. Investigation about a potentially serious medical errors example of the bringing medicine using the technique of the text mining and the measures
瀧内菜々美1), 久保南菜子1), 神田紘介1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 897-897, 2022.
Japanese Article P150-24-AM. Fact-finding about the source of information who used it at the bringing medicine differentiation of the inpatient in our hospital
秦光平1), 相松伸哉1), 野呂菜緒美1), 南川文哉1), 宮崎寛隆1), 石井ゆに香1), 近藤大介1), 脇由香里1), 渡邉明日香1), 江原亜沙子1), 野田晋司1), 小島さおり1), 松田浩明1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 898-898, 2022.
Japanese Article P151-23-PM. About the efforts of the polypharmacy measures team in the municipal Itami Hospital
細田未紀1), 長谷川啓1), 石谷理紗1), 山根正也1), 千原里美1), 上田宏1), 三好崇文2), 伊東範尚3), 中村好男3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 899-899, 2022.
Japanese Article P152-24-AM. About protection of algae fucoidan for the amyloid beta-induced neurotoxicity in SH-SY5Y cells
永田未希1,2,4), 辻まゆみ2), 小口達敬2,3), 門馬佑太郎2,3), 野原哲人2,3), 大橋英朗2,3), 井藤尚仁2,3), 山本謙2,3), 宇高結子2,3), 佐々木晶子2,3), 木内祐二2,3), 沼澤聡2,3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 900-900, 2022.
Japanese Article P153-23-PM. The construction of the health food search system and fact-finding of the health food intake situation of the pharmacist interview enforcement patients in front of the art
大久保凜香1), 原祐1), 金子真弓1), 坂東香織1), 若松綾華1), 石塚仁保1), 水谷彰史1), 友寄旬1), 山下友輝1), 須藤大雄1), 村中一大1), 中村裕一1), 鈴木千波1), 小原秀治1), 柴波明男1), 樋浦一哉2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 901-901, 2022.
Japanese Article P154-24-AM. Development of the board game enlightening the role of the drugstore pharmacist in the self-medication
小野寺亮1), 富永敦子1,2), 佐藤健太1,2), 石原研治3), 一條宏2), 平澤典保1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 902-902, 2022.
Japanese Article P155-23-PM. Establishment of the fixed-quantity method of nicotine out of saliva and the metabolite
田山剛崇1), 村上拓弥1), 前田志津子1), 杉原数美1), 佐和章弘1), 三宅勝志1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 903-903, 2022.
Japanese Article P156-24-AM. Understanding degree investigation about instruction required, the package insert of the nonprescription drug that we made by a new layout
杉浦愛子1), 小田武秀2), 石川春樹1), 望月眞弓1), 青森達1,3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 904-904, 2022.
Japanese Article P157-23-PM. An osteoporosis prophylaxis project by the cooperation with the drugstore in the hospital and the result
福島さやか1), 箱田裕貴2), 服部亜紀2), 建本百合香2), 工藤裕美2), 黒江良知2), 鎗水可奈1), 西江美智子1), 亀井健人1), 赤木晋介1), 徳田衡紀1), 高柳和伸1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 905-905, 2022.
Japanese Article P158-24-AM. Investigation of the infusion reaction frequencies in changes from a trastuzumab precedence product to Biosimilar
草野泰輝1), 森善洋1), 吉野走1), 林田颯志1), 山根理恵子1), 山口卓朗1), 岩村直也1), 佐道紳一1), 南恵樹2), 樋口則英1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 906-906, 2022.
Japanese Article P159-23-PM. Comparison between etanercept precedence biomedicine and biofollowing article analysis using real world data
川上智也1), 米澤淳1,2), 増井翔1,2), 大西輝3), 鬼澤秀夫3), 藤井貴之3), 村田浩一3), 田中真生3), 森信暁雄3), 横山琴子4), 岩本典子4), 嶋田崇史4), 中川俊作1), 池見泰明1), 寺田智祐1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 907-907, 2022.
Japanese Article P160-24-AM. The effectiveness of the etanercept bio follower product in rheumatoid arthritis treatment and safe evaluation
抱恵子1,2), 雪矢良輔1), 梶田貴司1), 八田和大2), 奥野智之1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 908-908, 2022.
Japanese Article P161-23-PM. About the efforts of the pharmacist for the calculation of the early period of biofollowing article (Biosimilar) introduction addition accompanied with the 2022 medical service fees revision
嶋田紘也1), 大橋啓子1), 木村美貴1), 阿部瑛子1), 池田藍1), 高田あゆみ1), 遠藤修司1), 平岩知子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 909-909, 2022.
Japanese Article P162-24-AM. It is investigated linezolid-induced myelosuppression for the infection after the artificial joint replacement in elderly people 75 years or older
小林俊介1), 安武夫2), 田川誠二1), 小倉敬史1), 北岡晃1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 910-910, 2022.
Japanese Article P163-23-PM. One case with suspected complete atrioventricular block with the vancomycin hydrochloride note
西川祐貴1), 門口直仁1), 宮本千晴1), 森田有香1), 田中聡1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 911-911, 2022.
Japanese Article P164-24-AM. Example that somnolence attributable to palonosetron produced
津久井千之1), 安藤沙耶1), 入岡凌1), 渡部晃裕1), 大塚尚1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 912-912, 2022.
Japanese Article P165-23-PM. An example with suspected side effect of intragastric retention of zirconium cyclo sodium silicate
福島隆宏1), 檜山洋子1), 吉川博1), 佐藤智人1), 大木伸吾2), 松尾裕彰1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 913-913, 2022.
Japanese Article P166-24-AM. The effect that drug interaction with azithromycin gives for an adverse event of tacrolimus
米澤龍1,2), 須永登美子1,3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 914-914, 2022.
Japanese Article P167-23-PM. Evaluation of the adverse event profile of the microscope-related colitis using adverse event spontaneous report database (JADER)
山城海渡1,2), 上田実加2), 尾崎優2), 平田敦士2), 緒方文彦1), 中村武浩1), 川崎直人1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 915-915, 2022.
Japanese Article P168-24-AM. Examination of the factor involved in advisability of the rifabutin introduction in tuberculosis treatment
山崎貴史1), 山科卓也1), 青柳千愛1), 下村真代1), 平木洋一2), 古海和博1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 916-916, 2022.
Japanese Article P169-23-PM. Specialist in citizen of Osaka consecutive side effect Committee 2020 report summary
平方まり子1), 井上千紘2), 坂田勝美3), 清水順子4), 山本京5), 松本ミユキ6)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 917-917, 2022.
Japanese Article P170-24-AM. We look at renal failure frequency of tazobactam/piperacillin and the rear of the risk factor and examine a mark
向山直樹1), 伊藤亮太2), 向山麻衣子1), 成瀬徳彦1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 918-918, 2022.
Japanese Article P171-23-PM. Analysis of the risk factor for the nightmare by the suvorexant
保田和哉1), 池田龍二1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 919-919, 2022.
Japanese Article P172-24-AM. Association between constitution of the patients who took helicobacter pylori sanitization medicine and side effect and IgE high level
尾関佳代子1), 羽田和弘1), 脇屋義文1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 920-920, 2022.
Japanese Article P173-23-PM. Investigation about the bevacizumab cancellation by the rise in protein in urine/creatinine ratio in the Atezolizumab bevacizumab combination therapy
藤田強記1), 井上勝光2), 湊本康則2), 清水裕彰1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 921-921, 2022.
Japanese Article P175-23-PM. Risk factor of favipiravir-induced hepatic dysfunction in the COVID-19 patients
潮平英郎1), 奥村悠2), 金城武士3), Jose Carlos Sandoval Tayag4), 石井岳夫1), 諸見牧子1), 藤田次郎3), 中村克徳1,4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 922-922, 2022.
Japanese Article P176-24-AM. A case in which drug eruption developed after switching to bicalutamide after onset of drug-induced lung injury accompanied by drug eruption due to apalutamide
田中菜央1,2), 北原加奈之3), 楠裕美子1,2), 須永登美子1,4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 923-923, 2022.
Japanese Article P177-23-PM. One patient who had a diagnosis of Stevens-Johnson syndrome approximately four months after completion of treatment by Pembrolizumab
松本ミユキ1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 924-924, 2022.
Japanese Article P178-24-AM. Example that the pancytopenia that it was thought that it was caused by low-dose methotrexate for the rheumatoid arthritis was prolonged by ascites
飯田遥1), 石渡泰芳1), 廣瀬藍子1), 永田将司1), 高橋弘充1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 925-925, 2022.
Japanese Article P179-23-PM. Examination of the therapeutic effect of rebamipide formulation using acetic acid-induced hamster stomatitis model
佐藤光利1), 白石拓也1), 高橋美香1), 長谷部沙耶1), 松本知大1), 河野弥生2), 花輪剛久3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 926-926, 2022.
Japanese Article P180-24-AM. An example of the myelofibrosis that drug-related progressive multifocal leukoencephalopathy by the ruxolitinib was suspected in
宇都宮敦子1), 田中雅幸1,2), 西山徳人1), 中山大輔1), 藤井良平1), 打谷和記1), 村中達也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 927-927, 2022.
Japanese Article P182-24-AM. Effect of the polypharmacy on aggravation of urination, the urine collection symptom in the urology department and search of the risk factor
吉澤俊輔1), 舘知也1,2), 高橋優太1), 青山智2), 野口義紘1), 田中和秀2), 安田昌宏2), 米田尚生3), 水井貴詞2), 寺町ひとみ1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 928-928, 2022.
Japanese Article P183-23-PM. Adverse event evaluation of the Olaparib using patients evaluation type outcome (PRO)
佐々木理絵1), 宮下真美1), 本郷文教1), 中島亜矢子2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 929-929, 2022.
Japanese Article P184-24-AM. Using JADER and electronic medical chart data; is the examination of the bleeding risk by the combination of oral anticoagulant drug and oral antiarrhythmic drug directly
小松唯可1,2), 吉年正宏2), 淺野肇2), 柳江正嗣2), 竹上学2), 横山聡1), 細見光一1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 930-930, 2022.
Japanese Article P185-23-PM. Safety assessment of the change to the Everolimus combination regimen in heart-transplant recipients
塩見真里奈1), 廣部祥子1,2,3), 前田真貴子1,3), 奥田真弘2), 藤尾慈1,4), 前田真一郎1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 931-931, 2022.
Japanese Article P186-24-AM. 1 case of patients with obesity that caused a creatine kinase rise by daptomycin administration
川西秀明1), 上田久美子1), 勝部理早1), 村川公央1), 座間味義人1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 932-932, 2022.
Japanese Article P187-23-PM. Fact-finding (mainly on internal secretion metabolic derangements) of the immune-mediated adverse event with the immune checkpoint inhibitor in our hospital
家田諒1), 早川伸樹1,2), 津川透1,3), 福井愛子1), 亀井浩行1), 桑原宏貴3), 吉野寧維2), 竹中徳子2), 鈴木敦詞2), 山田成樹3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 933-933, 2022.
Japanese Article P188-24-AM. Examination about the background factor accompanied with the onset of neutropenia in the abemaciclib remedy patients
齊藤俊一郎1), 久保淳一1), 眞山遼太1), 佐藤智香1), 大橋史嵩1), 田畑裕和1), 小林龍1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 934-934, 2022.
Japanese Article P189-23-PM. Treatment success of the MOH patients who took a pain-killer more than 40 years
清水瞭1), 石井亮太郎2), 深沢良輔2), 芝田雄登3), 土淵尚也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 935-935, 2022.
Japanese Article P190-24-AM. A case of cytokine storm due to postoperative discontinuation of upadacitinib
澤野有希世1), 柳江正嗣1), 藤原季美子1), 竹上学1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 936-936, 2022.
Japanese Article P191-23-PM. Example that the acute renal failure that took advantage of infection developed in patients during cibenzoline administration, and caused hypoglycemia
伊波樹1,2), 渡邊亜矢子1,2), 佐伯美沙1,2), 伊藤綾花1,2), 永田卓也1,2), 大戸祐治1,2), 田中克巳2,3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 937-937, 2022.
Japanese Article P192-24-AM. Association between liver residual function and side effect expression before the EGFR-TKI start
安部博宣1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 938-938, 2022.
Japanese Article P193-23-PM. Investigation of blood pressure changes and related factors in response to initial dose of sacubitril valsartan in chronic heart failure
田邉優斗1), 大野峻1), 森下怜美1), 鈴木康崇1), 武田元樹1), 菊池健1), 相馬貴史1), 鶴山辰1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 939-939, 2022.
Japanese Article P194-24-AM. Incidence of nausea and vomiting in patients using letermovir
安田早希1), 冨田敦和1), 榎本翔太1), 村瀬実希1), 今西忠宏1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 940-940, 2022.
Japanese Article P195-23-PM. Effect (case report) that the furosemide combination in the case with suspected vestibular nerve damage with gentamicin sulfate gives
秋山眞太郎1), 鈴木正論1,2), 田邉大明3), 舟越亮寛1,4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 941-941, 2022.
Japanese Article P196-24-AM. The case that drug-related syndrome of inapp ADH secretion (SIADH) improved by having switched from duloxetine to mirogabalin
高橋伸幸1,2), 森友紀子4), 岡本まとか1,2), 葛城怜子1,2), 兼元みずき4), 洲之内あずさ4), 二村明徳4), 山口天士1,2), 笠井英世4), 百賢二3), 村上秀友4), 田中広紀1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 942-942, 2022.
Japanese Article P197-23-PM. One case of the extremely-low-birth-weight infants that blood level of vancomycin showed high level by indometacin combination
松澤菜津子1), 小澤秀介1), 成田一理1), 本木絵梨奈1), 内藤隆文1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 943-943, 2022.
Japanese Article P198-24-AM. One case of the acute coronary syndrome (cornice syndrome) accompanied with the allergic reaction with remifentanil
延藤勇1), 豊濱隆1), 庄田裕紀子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 944-944, 2022.
Japanese Article P199-23-PM. The effect that Yokukansan remedy gives to a serum potassium level
守内匡1), 折戸渚紗1), 矢後楓佳1), 守内典子1), 野原今日子1), 松井ひろみ1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 945-945, 2022.
Japanese Article P200-24-AM. An example of colon cancer which was treated with fenofibrate combination for hypertriglyceridemia by the capecitabine, and continued
鈴木優花1), 藤田行代志1), 新井隆広1), 蛭田英里子1), 齊藤妙子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 946-946, 2022.
Japanese Article P201-23-PM. Examination about the side effect expression situation of the ACTH therapy for the West syndrome
原歩未1), 杉井孝綱2), 鈴木英二1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 947-947, 2022.
Japanese Article P202-24-AM. Impact statement of the drug which paid its attention to differentiation, a hormone secretory function of placenta Trophoblast
大山七海1), 古堅彩子2), 澤田理子1), 西村あや子3), 鳴海克哉2), 小林正紀2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 948-948, 2022.
Japanese Article P203-23-PM. Examination about the active change of Xanthine oxidoreductase (XOR) activity and Sirtuin-1
森脇智也1), 田山剛崇1), 前田志津子1), 岡村友理香2), 杉原数美1), 三宅勝志1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 949-949, 2022.
Japanese Article P204-24-AM. Elucidation of the CYP2J2 inhibitory action with the multi-kinase inhibitor
小島綾華1), 加藤美紀1), 村山典恵2), 山崎浩史2), 灘井雅行1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 950-950, 2022.
Japanese Article P205-23-PM. Predictive precision comparison between Scr and VCM concentrations based on CysC in patients with the amyotrophy
山科卓也1), 山崎貴史1), 青柳千愛1), 下村真代1), 古海和博1), 平木洋一2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 951-951, 2022.
Japanese Article P206-24-AM. The impact statement which febrile neutropenia and excessive renal clearance give in blood level of the Teicoplanin and pharmacokinetics
近藤望1), 田中遼大1), 龍田涼佑1), 伊東弘樹1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 952-952, 2022.
Japanese Article P207-23-PM. PK-PD-PGx analysis of vincristine in patients with CHOP therapy enforcement non-Hodgkin's lymphoma
中川潤一1), 高畑武功2), 兵藤塁1), 斎藤絢介3), 陳豫3), 鎌田耕輔2), 立田卓登2), 山下覚2), 細井一広1), 照井一史1), 上野桂代1), 佐藤温3), 新岡丈典1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 953-953, 2022.
Japanese Article P208-24-AM. Effective evaluation of the migraine headache attack onset inhibition of the antiCGRP receptor antibody preparation by population efficacy kinetic analysis - Model-based meta-analysis (MBMA)
中村昂洋1,2), 藤田唯人3), 松永直哉3), 末次王卓1), 廣田豪1), 江頭伸昭1,2), 家入一郎1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 954-954, 2022.
Japanese Article P209-23-PM. The construction of the population pharmacokinetics model of the piperacillin tazobactam combination drug in Japanese children and examination of the administration method
石原慎之1), 大仁田哲修1,2), 猪川和朗2), 西村信弘3), 玉木宏樹1), 矢野貴久1), 森川則文2), 直良浩司1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 955-955, 2022.
Japanese Article P210-24-AM. One case that warfarin was thought to be adsorbed by the remaining in the gastrointestinal tract of the spherical carbonaceous adsorbent
松沼悟1), 高坂聡1), 大場俊輔2), 田口丈士2), 吉元公一1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 956-956, 2022.
Japanese Article P211-23-PM. Gemcitabine administration is the internal change of the CYP2C substrate drug and effect to give to the liver metabolism activity
福野修平1), 笠原恵太2), 高居大樹3), 西本浩子1), 嶋大貴1), 長井克仁1), 小西廣己1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 957-957, 2022.
Japanese Article P212-24-AM. It is safe with tramadol in patients and the effectiveness of the duloxetine combination therapy after the artificial joint replacement
棚町将之1), 森崎崇文1), 星野輝彦1), 杉山留美子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 958-958, 2022.
Japanese Article P213-23-PM. Analysis of the factor affecting the dantrolene-induced hyperkalemia using the adverse event spontaneous report database
椋田千晶1,2), 小川敦1,2), 合田光寛1,3), 吉岡俊彦1,3), 新村貴博1,4), 牛尾聡一郎2), 江角悟2), 岡田直人1), 座間味義人2,3), 石澤啓介1,3,4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 959-959, 2022.
Japanese Article P214-24-AM. Examination about the effect that combination of the CYP2C9 revulsive gives to PT-INR change in the warfarin therapy: Rearward observational study
白石ちひろ1), 平井利典1), 藤田聡2), 土肥薫3), 岩本卓也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 960-960, 2022.
Japanese Article P215-23-PM. One case of the liver-transplant recipients whom blood Everolimus concentrations increased by itraconazole combination remarkably
堀口香織1), 成田一理1), 三田篤義2), 副島雄二2), 内藤隆文1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 961-961, 2022.
Japanese Article P216-24-AM. Evaluation of an investigation and the pharmacist intervention of the adverse event of the use of medical drug patients using a CYP3A4 inhibitor together
落合葉子1), 壁谷めぐみ1), 大村妙子1), 鈴木理珠1), 湯浅周1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 962-962, 2022.
Japanese Article P217-23-PM. Example that intervened in the patients who came to have poor control of PT-INR of the warfarin under the voriconazole internal use
杉本佳寿美1), 喜田昌記1), 中田麻里1), 米澤夏里1), 中村裕昌2), 柏原由佳1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 963-963, 2022.
Japanese Article P218-24-AM. Retrospective investigation of the interaction between continuous intravenous tacrolimus infusion and letermovir in combination with azole antifungal drugs
篠木優里1), 平井利典1), 石橋美紀1), 伊野和子2), 俵功2), 岩本卓也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 964-964, 2022.
Japanese Article P219-23-PM. Report of thrombocytopenia caused by concomitant use of clopidogrel and supplements containing Coleus forskohlii extract
平山武宏1), 関口和2,3), 荒義昭1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 965-965, 2022.
Japanese Article P220-24-AM. Comparison between trough value and AUC in the renal failure prediction of vancomycin
原田紗希1), 羽田野励次1), 菅田哲治1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 966-966, 2022.
Japanese Article P221-23-PM. 1 case that was given oral voriconazole for the Candida glabrata infection in patients with short bowel syndrome
柴田健太1), 高橋未来1), 中田和宏1), 関根彩奈1), 細田悠介1), 木村美由喜1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 967-967, 2022.
Japanese Article P222-24-AM. Construction of population change - pharmacodynamic model to predict a high K blood symptom by the ST medical mixture
平井利典1), 白石ちひろ1), 中井すみれ2), 後美海2), 花田和彦2), 岩本卓也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 968-968, 2022.
Japanese Article P223-23-PM. Development of the simultaneous assay of oral molecular target anticancer medicine using the LC/ESI-MS/MS and the metabolite
菊地正史1,2), 平澤天晴1), 高崎新也2), 公文代將希2), 佐藤裕2), 佐藤紀宏2), 前川正充1,2), 眞野成康1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 969-969, 2022.
Japanese Article P224-24-AM. Establishment of blood concentration measurement system for venetoclax using HPLC-UV
丸藤義翔1), 野村有加1), 安武夫1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 970-970, 2022.
Japanese Article P225-23-PM. One case that developed thrombotic microangiopathy during tacrolimus administration after the kidney transplantation
中野裕貴1), 岩本整1), 今野理1), 木原優1), 赤司勲1), 沖原正章1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 971-971, 2022.
Japanese Article P226-24-AM. Examination of the renal failure risk factor of vancomycin in the AUC-guided TDM
高橋直博1), 小林理栄1), 新井亘1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 972-972, 2022.
Japanese Article P227-23-PM. One case of the pulmonary nocardiosis that administration plan support of the amikacin was useful after the allogeneic hematopoietic stem cell transplantation
水岡大策1,2,3), 越野優希2), 田井達也3), 山口佳津騎1), 田中裕章1), 小坂信二1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 973-973, 2022.
Japanese Article P228-24-AM. 1 case that was able to control blood level by blood tacrolimus levels analysis utilizing the spreadsheet well
齋木雄介1), 山本達郎1), 石田真紗子1), 小玉菜央1), 竹崎正明1), 藤吉正哉1), 島田美樹1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 974-974, 2022.
Japanese Article P229-23-PM. Evaluation about the substitute measurement of blood theophylline levels in patients with caffeinism
福井里菜1), 平松駿一1), 加藤秀雄1), 森川祥彦1), 佐々木典子1), 岡知加2), 岩本卓也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 975-975, 2022.
Japanese Article P230-24-AM. Construction of the population pharmacokinetics model of the tobramycin in the drug resistant bacterium infection patients
松本直也1), 尾田一貴2), 橋口ゆみ2), 山口綾水3), 城野博史2), 斎藤秀之2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 976-976, 2022.
Japanese Article P231-23-PM. Establishment of a method for simultaneous determination of linezolid and tedizolid concentrations in human plasma using LC/MS/MS
佐藤夕紀1), 大聖貴之2), 柏木仁1), 今井俊吾1), 武隈洋2), 菅原満1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 977-977, 2022.
Japanese Article P232-24-AM. Effect of the VCM proper use support with the 24 hours intervention system of the pharmacist
川崎祥平1), 小林義和1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 978-978, 2022.
Japanese Article P233-23-PM. Example that a rise in blood level of mycophenolic acid was seen in by the live donor liver transplant from a Girbert syndrome suspicion donor
齋藤健一1), 小野塚真理1), 大澤雄一郎1), 田沼周平1), 松本嵩史1), 近藤正巳1), 駒込昌彦2), 牧章2), 別宮好文2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 979-979, 2022.
Japanese Article P234-24-AM. Examination of the factor associated with the blood tacrolimus levels change at diet resumption in patients with ulcerative colitis
長友隆雄1), 吉川直樹1), 谷口裕紀1), 横田翼1), 池田龍二1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 980-980, 2022.
Japanese Article P235-23-PM. Association between blood methotrexate concentrations and effectiveness in the methotrexate massive dose therapy for patients with osteosarcoma
長嶺歩1,2), 八島秀明3), 上村あかね4), 白石卓巳4), 高橋雄太1,2), 高橋恵美利1,4), 荒木拓也2,3), 山本康次郎2,3), 大林恭子1,2,4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 981-981, 2022.
Japanese Article P236-24-AM. Investigation about the coadministration of nanoliposomal type irinotecan and levofolinate
野崎圭佑1), 木村美甫1), 長谷川聡司1), 井上聡子1), 高木麻里1), 高田良司2), 藤田敬子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 982-982, 2022.
Japanese Article P237-23-PM. Efforts and practice to medical security in the cancer medical therapy
林美和子1), 間島知佳子1), 小木曽千春1), 柳沢亮太1), 高林成彰1), 小川陽平1), 粂野真由美1), 太田勝1), 伊藤勇人1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 983-983, 2022.
Japanese Article P239-23-PM. It is the blood poison-related comparison of the obese patients in the adjuvant chemotherapy (AC therapy) and patients with non-obesity after the breast cancer technique
高木竜一1), 杉山恵亮1), 築山奈央1), 志賀有雅1), 浅野岳人1), 阿部彩香1), 本山大夢1), 藤井友和1), 杉浦洋二1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 984-984, 2022.
Japanese Article P240-24-AM. Examination about the effectiveness and the safety of the chemotherapy combination nivolumab therapy for the progress recurrent gastric cancer in our hospital
山下剛史郎1), 呉山友教1), 松浦知博1), 鶴田和樹1), 廣瀬孝一1), 船越幸代1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 985-985, 2022.
Japanese Article P241-23-PM. Investigation of the PBPM enforcement situation in the cancer chemotherapy
小暮宗介1), 田中佑京1), 樋口美波1), 戸坂優花1), 高畠啓輔1), 原澤秀樹1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 986-986, 2022.
Japanese Article P242-24-AM. Examination about the effect of the examination of the pharmacist representation input in the HBV-related examination for the HBV reactivation prevention
元木孝1), 栗田征幸1), 渡邊清人1), 高柳昌宏1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 987-987, 2022.
Japanese Article P243-23-PM. Efforts of the introduction of the anticancer medicine regimen order system in the childhood cancer chemotherapy
新田美奈1), 高橋毅行1,2), 山崎智久1,2), 寺薗英之1,2), 西川拓朗3), 岡本康裕3), 武田泰生1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 988-988, 2022.
Japanese Article P244-24-AM. Usefulness of the regimen inspection by the check list type
粉川直明1), 長谷川有希子1), 中野彩萌1), 滝澤苑美1), 大沼明子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 989-989, 2022.
Japanese Article P245-23-PM. Regarding liver function decline and thrombocytopenia caused by trastuzumab and emtansine
阿部多一1), 住谷達也1), 林哲哉1), 清水大輔2), 井口恵美子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 990-990, 2022.
Japanese Article P246-24-AM. The new efforts which used standard conversion for the adoption change of the injection anticancer agent
齊藤安昌1), 浅川杏子1), 久保昌孝1), 島田雅彦1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 991-991, 2022.
Japanese Article P247-23-PM. Examination of the usefulness of the illness medicine cooperation using the tracing report affecting the foreign cancer chemotherapy cooperation full addition
香取祐介1), 稲野寛1), 中込梢1), 佐々木寿子1), 田村和敬1), 佐々木治一郎2), 厚田幸一郎3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 992-992, 2022.
Japanese Article P248-24-AM. Foreign pharmacist activity to lead to cancer patient's share of medical expenses reduction
金澤絵莉1), 村上摩利2), 木村滋3), 三角紳博1), 佐伯哲4), 前田茂人5)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 993-993, 2022.
Japanese Article P249-23-PM. Attempt of the intervention before physician practice to foreign cancer chemotherapy patients
西場弘美1), 千吉良幸子1), 小材直人1), 村田文1), 鈴木達宙1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 994-994, 2022.
Japanese Article P250-24-AM. Construction and usefulness evaluation of the metastases to bone follow system (team BMA) for the purpose of the early intervention for the metastases to bone of patients with cancer
横山加奈1), 森川花絵1), 秦晃二郎1), 近森綾子1), 南晴奈1), 渡部仁美1), 田川慎二1), 末次王卓1), 廣田豪1), 辻敏和1), 金谷朗子1), 江頭伸昭1), 家入一郎1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 995-995, 2022.
Japanese Article P251-23-PM. Efforts of the foreign cancer chemotherapy cooperation full addition calculation by the multi-type of job cooperation
中島誠1), 寺嶋圭子2), 本坊俊和3), 大迫政彦4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 996-996, 2022.
Japanese Article P252-24-AM. Investigation about the information sharing tool "medication notebook for messages" of patients about the oral anticancer medicine and a health insurance pharmacy and the hospital
森光保武1), 岩村高弘1), 藤井秀一1), 山本真理2), 池田雅彦2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 997-997, 2022.
Japanese Article P253-23-PM. One case that was able to be treated with injection anticancer agent administration in being at home by the cooperation with the hospital safely
中村薫1), 川崎博行1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 998-998, 2022.
Japanese Article P254-24-AM. Examination of the intervention effect by the efforts of the self-care promotion of the opioid rescue medicine by the palliative care team
久松大祐1,2), 泊由布子2), 田ノ上美依菜2), 今村繭子2), 樋口文子1,2), 岡本正博2,3), 門田芳幸4), 後藤隆1), 清水裕彰1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 999-999, 2022.
Japanese Article P255-23-PM. Well-known efforts to the multi-clinical department of the colon cancer guidelines revision point using CancerBoard
屋敷大輔1,2), 田中恭人1,2), 岸本真1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1000-1000, 2022.
Japanese Article P256-24-AM. Questionary survey about the needle pad exposure at anticancer medicine preparation in the cancer special hospital
佐野慶行1), 鈴木秀隆1), 川崎敏克1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1001-1001, 2022.
Japanese Article P257-23-PM. About use of closed system anesthesia drug transportation system expansion for exposure measures with the anticancer medicine
茂木佳子1), 河口尚史1), 石川大介1), 堀美香1), 佐藤賢1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1002-1002, 2022.
Japanese Article P258-24-AM. Inspection of the anticancer agent resolution effect with the ozone gas
田崎眞生1), 植村有加里1), 大川恭子1), 桑原晶子1), 田内義彦1), 辻本勉1), 濱宏仁1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1003-1003, 2022.
Japanese Article P259-23-PM. Decontamination effect by pollution status and P-CLEAR of the anticancer medicine preparation, administration environment
福岡智宏1), 山本泰大1), 林宏紀1), 宇都宮純平1), 戸田康裕1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1004-1004, 2022.
Japanese Article P260-24-AM. Examination about a 5-fluorouracil removal effect of the ozone water on tap water and the resolution effect
大塚瑠里1), 外山智章1), 五月女拓也1), 日向野理輝1), 押坂勇志3), 別納弘法2), 仁保誠治2), 篠崎桂子1), 臼井悟1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1005-1005, 2022.
Japanese Article P261-23-PM. Environmental exposure investigation by the anticancer agent in the Kanazawa medical center
有原大貴1), 間宮公教2), 森下拓哉1), 宮澤憲治1), 福島信一郎1), 高木亮1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1006-1006, 2022.
Japanese Article P262-24-AM. Densitometry of ifosfamide and the anticancer medicine included in the gas in the infusion solution bag after the paclitaxel preparation
矢野琢也1), 松本知樹1), 星加寿子1), 松本大輝1), 加藤あゆみ1), 豊田悠希1), 藤田高子2), 福岡竜逸1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1007-1007, 2022.
Japanese Article P264-24-AM. Examination of the long-term abacterial maintenance condition using the simulated vial aiming at use of division of the vial preparation
松浦泰寛1), 眞鍋貴行1,2), 新田悠一朗1), 石川良太1), 仲谷彰規1), 久保靖憲1), 山本譲1), 岩山訓典1,3), 神山直也1,2), 中馬真幸1), 小野尚志1), 田崎嘉一1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1008-1009, 2022.
Japanese Article P265-23-PM. Evaluation of the validity in the device change of the infusor pump to use for continuously administering it of 5-FU
大貫奏1), 金素安1), 田中悠理1), 伊代野佐知子2), 立沢正臣1), 下泰司1,3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1010-1011, 2022.
Japanese Article P266-24-AM. An example of the follow-up that we performed in local progress pancreatic cancer impossible of excision for the patients that Conversion Surgery was enabled
中尾紘子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1012-1012, 2022.
Japanese Article P267-23-PM. About the usefulness of the medicine medicine cooperation tool through the prescription notebook
杉浦孝太郎1), 中村洋司1), 磯部紀子1), 藤田珠理1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1013-1013, 2022.
Japanese Article P268-24-AM. The current situation investigation about the calculation situation and the tracing report of the cooperation full addition
住谷真里子1), 高木俊輝1), 松本哲哉1), 中村智1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1014-1014, 2022.
Japanese Article P269-23-PM. The cooperation enhancement addition calculation situation and tracing report contents analysis
杉山昌秀1), 篠原佳祐1), 宮田智陽1), 吉池麻衣1), 原あや乃1), 堀内賢一1), 三浦篤史2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1015-1015, 2022.
Japanese Article P270-24-AM. The example that a pharmacist intervened in for a medication difficulty by the multiple drug prescription during the cancer chemotherapy enforcement
汐待加織1), 小野寺香里1), 浅田美咲1), 高崎颯隼1), 鷹羽絵里子1), 吉原奈津子1), 佐藤絵美1), 吉田恭子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1016-1016, 2022.
Japanese Article P271-23-PM. Questionnaire results report about patient monitoring duties in the treatment with anticancer medicine which the pharmacist by the academic first subcommittee performs in in 2020
森岡友美1), 郷真貴子2), 中島寿久3), 藤堂真紀4), 林稔展5), 松尾宏一6)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1017-1017, 2022.
Japanese Article P272-24-AM. The current situation and problem of the efforts for regional alliances in our hospital in the foreign chemotherapy
石崎文子1), 相原敏彦1), 本田晴菜1), 増尾昌則1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1018-1018, 2022.
Japanese Article P273-23-PM. One case that we coped with the dermatopathy of patients with stomach cancer during the S-1 therapy enforcement early, but suffered from
河端明子1), 藤田あゆみ2), 杉浦伸哉2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1019-1019, 2022.
Japanese Article P274-24-AM. A case of increased venetoclax blood concentration due to crushing and taking venetoclax tablets
安西麻衣子1), 疋田絵梨1), 安武夫1,3), 小林真之2), 小杉信晴2), 城田幹生1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1020-1020, 2022.
Japanese Article P275-23-PM. Examination of the medication follow-up usefulness for the use of anticancer agent patients at the health insurance pharmacy
湯澤史弥1), 伊野陽子1,4), 山下修司2,4), 玉木啓文1,4), 野口義紘3,4), 長内理大1,4), 寺町ひとみ3,4), 井口和弘1,4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1021-1021, 2022.
Japanese Article P276-24-AM. Usefulness of the follow-up of the drugstore pharmacist referring to the medical institution medical record for patients with foreign cancer
野村春香1), 西村充司1), 舩木志保2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1022-1022, 2022.
Japanese Article P277-23-PM. Report of the case that was able to contribute to foreign cancer chemotherapy by the medication follow-up by the drugstore pharmacist
吉田理人1), 舩木志保2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1023-1023, 2022.
Japanese Article P278-24-AM. Example that was able to intervene by the cooperation with hospital pharmacist and the health insurance pharmacy pharmacist in the early stage of the side effect
小原貴子1), 元茂拓法1), 岩井あゆみ2), 池上早也香2), 大井佑輝2), 三上祥博1), 橋下浩紀1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1024-1024, 2022.
Japanese Article P279-23-PM. About usefulness of the cancer counseling by the pharmacist
樋口浩輔1), 斎藤祐輔1), 西村愛弓1), 木村謙吾1), 加藤浩1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1025-1025, 2022.
Japanese Article P280-24-AM. One case that we connected Baxter in fuser (5-FU sustained administration) to a route bypass for the TPN, and speed decreased
南有里1), 中村俊貴2), 齋藤雅俊1), 平山武司1,3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1026-1026, 2022.
Japanese Article P281-23-PM. Relation of the drugstore pharmacist using the telephone follow-up that continued for patients with cancer
野嶋芳紀1), 石田潤一郎1), 齋藤聡夫1), 松尾宗一郎1), 邑瀬誠1), 深津英人2), 松井洸2), 阿部真也2), 立石大介2), 山口浩2), 吉町昌子2), 野村和彦2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1027-1027, 2022.
Japanese Article P282-24-AM. Study on effective medication counseling method to reduce the anxiety of the side effect in the lung cancer chemotherapy
大澤友裕1), 長谷川貴昭2), 梅田道1), 牧野哲平1), 青山智1), 安田昌宏1), 吉田勉3), 澤祥幸4), 水井貴詞1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1028-1028, 2022.
Japanese Article P283-23-PM. Evaluation of the blood sugar level fluctuation after the use results of olanzapine in patients who received cisplatin combination chemoradiotherapy and the use
佐々木健介1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1029-1029, 2022.
Japanese Article P284-24-AM. Fact-finding of retching vomiting of patients who received steroid spare ring in the Carboplatin administration and evaluation of the effectiveness
小河原晴香1), 越川一誠1), 大谷隼斗1), 今川未紀1), 佐久間けい1), 川上達也1), 菅井瞳1), 柳野紗智子1), 坂本真紀1), 松本高広1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1030-1030, 2022.
Japanese Article P286-24-AM. The fact-finding about retching, the vomiting expression situation in the use of Olaparib patients and the prophylactic antiemesis therapy and search of retching, the vomiting risk factor
小林芽依1), 石原泰子1), 西村健二1), 石田亮2), 亀井健人1), 赤木晋介1), 徳田衡紀1), 高柳和伸1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1031-1031, 2022.
Japanese Article P287-23-PM. Examination about the expression situation of retching vomiting in the trifluridine Tipiracil hydrochloride + bevacizumab combination chemotherapy and the risk factor
松岡芹佳1), 藤井宏典1), 大畑紘一1), 飯原大稔1), 廣瀬智恵美1), 左高史織1), 渡辺大地1), 小林亮1,2), 木山茂3), 牧山明資3), 松橋延壽3), 高橋孝夫3), 吉田和弘3), 鈴木昭夫1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1032-1032, 2022.
Japanese Article P288-24-AM. The effectiveness of the antiemesis therapy by the difference in risk emetic in the gynecologic Paclitaxel + Carboplatin therapy and safe comparison
萩家朱美1), 鎌田宏和1), 清水克次1), 竹田健志1), 辰見明俊2), 高木麻里1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1033-1033, 2022.
Japanese Article P289-23-PM. Look at the actual situation of the digestive organ symptom in the streptozocin administration and the rear about the antiemesis therapy; mark investigation
新藤実香1), 佐野智望1), 西渕由貴子1), 石川光信1), 赤木徹1), 橋本浩伸1), 奥坂拓志2), 古川哲也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1034-1035, 2022.
Japanese Article P290-24-AM. We look at the rear about the effectiveness by the prophylactic antiemesis therapy of olanzapine in the BEP, EP therapy and examine a mark
村井和哉1), 馬見新佳那子1), 楠原正太2), 中島裕理3), 船坂知華子2), 仲尾岳大3), 近藤千紘2), 内藤陽一2), 川崎敏克1), 向原徹2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1036-1036, 2022.
Japanese Article P291-23-PM. The effect of the antiemesis supportive care PD method and the GDA method on TC therapy for gynecologic cancer and comparison of the adverse event
大林恭子1,2), 長嶺歩1), 内山知乃3), 八島秀明3), 大島宗平3), 高橋恵美利1,2), 高橋雄太1), 荒木拓也3,4), 山本康次郎3,4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1037-1037, 2022.
Japanese Article P292-24-AM. One case that it was by steroid combination for the drug-related interstitial nephritis that occurred during the Ipi-Nivo therapy for G-CSF-producing renal cell carcinoma if treatment continuation was possible
中條悠1), 神原諒1), 早川太朗1), 細見俊秀2), 七里泰正2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1038-1038, 2022.
Japanese Article P293-23-PM. Study on risk factor of the immune-mediated adverse event with the immune checkpoint inhibitor
山口敦史1,2), 齋藤佳敬1), 鳴海克哉2), 古堅彩子2), 武隈洋1), 品川尚文3), 秋田弘俊4), 菅原満1,2), 小林正紀2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1039-1039, 2022.
Japanese Article P294-24-AM. Usefulness of the electronic patient-reported outcome monitoring during treatment with immune checkpoint inhibitor
桂英之1), 戸井ひとみ1), 太田浩士1), 高田直子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1040-1040, 2022.
Japanese Article P295-23-PM. Care investigation for a symptom and the symptom of difficulty in swallowing, the taste disturbance of patients with cancer
織戸るり子1), 竜田都加2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1041-1041, 2022.
Japanese Article P296-24-AM. A case of serous retinal detachment during encorafenib + binimetinib + cetuximab therapy
芦埜和幸1), 大澤千鶴子1), 黒田晋平1), 菱沼侑子1), 木村公美1), 横山智2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1042-1042, 2022.
Japanese Article P297-23-PM. The enforcement situation of the examination for UGT1A1 genetic polymorphism before the use of irinotecan preparation in our hospital
林靖久1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1043-1043, 2022.
Japanese Article P298-24-AM. The hiccups expression situation at the dexamethasone single dose in patients with multiple myeloma
兼松哲史1), 山下智穂1), 中村英明1), 吉田均2), 伊藤貴彦2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1044-1044, 2022.
Japanese Article P299-23-PM. About association with surface of a body temperature and the vascular pain at the oxaliplatin administration
志村裕介1), 菅幸生2), 三坂恒1), 澤崎泉3), 岩本礼子4), 海野泰好4), 西川亜沙子4), 伊藤幸津枝4), 村上成美4), 杉本紀子4), 園谷美奈子4), 嶋田努1), 松下良2), 崔吉道1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1045-1045, 2022.
Japanese Article P300-24-AM. The onset of vascular pain situation at dexamethasone injection mixture to oxaliplatin and Fosaprepitant combination
江草徳幸1), 比良大輔2), 佐藤一求2), 栗原晋太郎2), 福家幸子3), 村上利恵3), 徳本和哉4), 別所千枝1), 安原昌子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1046-1046, 2022.
Japanese Article P301-23-PM. Usefulness evaluation of the blood sugar determination based on the protocol in patients with pancreatic cancer during cancer medical treatment
武藤有里子1), 丸山真一1), 永瀬怜司1), 太田恵1), 香取史菜1), 菅野浩1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1047-1047, 2022.
Japanese Article P302-24-AM. Examination of the comparison of the adverse event with nal-IRI/5-FU/LV therapy and the existing treatment to be able to establish treatment after the second treatment of the unresectable pancreatic cancer and the measures
松島彩音1), 佐々木健介1), 亀尾剛士1), 三宅真史1), 隅田英幸1), 山下真史1), 藤井哲英1), 小林美代子1), 二宮洋子2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1048-1048, 2022.
Japanese Article P303-23-PM. Comparison of the expression of Infusion Related Reaction risk factor in FL and DLBCL
廣部祥子1,2,3), 犬飼萌乃1), 藤本梨花1), 深田耕司1), 宮本真由1), 前田真一郎1,2), 前田真貴子1,2,3), 藤尾慈1,2,3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1049-1049, 2022.
Japanese Article P304-24-AM. About the adverse event expression of Palbociclib situation
篠崎千尋1), 桑村恒夫1), 三上忠司1), 野田聖奈子1), 原田智子1), 中川義浩1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1050-1050, 2022.
Japanese Article P305-23-PM. It is the current situation investigation about the onset of Serious Adverse Event in the adjuvant chemotherapy after the pancreatic cancer S-1 technique
野口裕介1), 大坪達弥1), 小林大祐1), 加藤良隆1), 豕瀬諒2), 村木優一2), 友金幹視1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1051-1051, 2022.
Japanese Article P306-24-AM. We look at the rear of the risk factor to affect the onset of diarrhea of the Abemaciclib and examine a mark
野田佳加1), 志村裕介1), 嶋田努1), 崔吉道1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1052-1052, 2022.
Japanese Article P307-23-PM. We look at the rear of the onset of thromboembolism risk factor in patients with progress, recurrence colon cancer which is impossible of curative resection and study a mark
高田遼1), 藤原未稀1), 牧賢利1), 高橋洋子1), 田村浩二1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1053-1053, 2022.
Japanese Article P308-24-AM. Examination of the usefulness of the prophylactic oral antibiotic for the febrile neutropenia at DCF therapy enforcement
山口知紀1), 豊田真史1), 深野光司1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1054-1054, 2022.
Japanese Article P309-23-PM. An evaluation and improvement of actions to be taken for the vascular pain with oxaliplatin
瀧本真紀1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1055-1055, 2022.
Japanese Article P310-24-AM. Anamorelin prescription status survey
河原陽介1), 堀合拓貴1), 加藤良治1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1056-1056, 2022.
Japanese Article P311-23-PM. Exploring the incidence and risk factors of skin disorders caused by the prostate cancer treatment drug apalutamide in actual clinical practice
山田佳織1), 入江慶1,2), 平畠正樹1), 池末裕明1), 橋田亨1,2), 川喜田睦司3), 室井延之1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1057-1057, 2022.
Japanese Article P312-24-AM. The association that developed in vincristine treated patients between peripheral neuropathy and diabetes
内田敬1), 林克剛1), 猪岡京子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1058-1058, 2022.
Japanese Article P313-23-PM. IR reduction effect with the precedent administration of hypersensitivity measures medicine in the PER+HER+ taxane regimen
阿部彩香1), 杉山恵亮1), 本山大夢1), 高木竜一1), 浅野岳人1), 志賀有雅1), 築山奈央1), 藤井友和1), 杉浦洋二1), 雨宮剛2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1059-1059, 2022.
Japanese Article P315-23-PM. Use fact-finding of the CDK4/6 inhibitor for patients with inoperability or recurrent breast cancer
小関利弥1), 合澤啓二1), 岩田一史1), 陣上祥子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1060-1060, 2022.
Japanese Article P316-24-AM. The example that early intervention to the supportive care of the drugstore pharmacist in the foreign chemotherapy and the follow-up with the telephone contributed to treatment continuation
永井基瑛1), 新藤志津子1), 永野悠馬2), 前田守2), 緒形富雄2), 市ノ渡真史2), 長谷川佳孝2), 月岡良太2), 大石美也2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1061-1061, 2022.
Japanese Article P318-24-AM. Look at the multicenter rear about the dose of the levothyroxine for the hypothyroidism of the immune checkpoint inhibitor; mark investigation
小林美奈子1), 佐藤渉2), 鈴木訓史1), 梅内実穂1), 東敬太1), 内藤義博1), 木皿重樹3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1062-1062, 2022.
Japanese Article P319-23-PM. Efforts to the HBV reactivation prevention that a pharmacist works on
國安和仁1), 中居肇1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1063-1063, 2022.
Japanese Article P320-24-AM. Analysis of the risk factor about the low Ca blood symptom under the prophylactic administration by the denosumab for patients with lung cancer
平井成和1), 大崎莉沙2), 有山智博2), 石井敏浩2), 増田雅行1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1064-1064, 2022.
Japanese Article P322-24-AM. Intervention of the pharmacist by PBPM in HBV reactivation measures
笹岡沙也加1), 清野義一1), 寺島孝徳1), 宮澤衣鶴1), 清水健吾1), 岡澤香津子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1065-1065, 2022.
Japanese Article P323-23-PM. About the effect that a neutropenia with the gemcitabine oil xanthan gum (GnP) therapy gives for the prognosis of patients with unresectable pancreatic cancer
長岡侑里1), 今俊介1), 松崎哲郎1), 溝口博之1), 山田清文1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1066-1066, 2022.
Japanese Article P324-24-AM. Example ... that a steroid rotation was effective for case - hiccups that the quality of life of patients in the cancer chemotherapy improved by a tracing report
永田卓也1,2), 渡邊亜矢子1,2), 大戸祐治1,2), 佐伯美沙1,2), 嶋田顕3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1067-1067, 2022.
Japanese Article P325-23-PM. Examination of the usefulness of the skill up training for the disease severity evaluation of the hand-and-foot syndrome
神谷早織1,2,3,4,5), 山本圭祐1), 平川聡史2), 大石大祐1), 佐原由莉1), 澤昇平1), 柏原道志1), 柴崎幾代3), 浅井はるか4), 鈴木英絵4), 森菜採子4), 吉田雅行4), 三木良浩5), 矢部勝茂1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1068-1068, 2022.
Japanese Article P327-23-PM. Search of the risk factor of the eruption in the GC therapy
吉澤祐香里1), 澤昇平1), 石野清亮1), 古橋侑樹1), 佐原由莉1), 山本圭祐1), 矢部勝茂1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1069-1069, 2022.
Japanese Article P328-24-AM. Investigation of the examination for irAE, situation after the checkpoint inhibitor administration in our hospital of immunity
田中昭洋1), 大西翔太1), 高取秀人1), 村富裕貴1), 後藤卓也1), 萱野勇一郎1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1070-1070, 2022.
Japanese Article P329-23-PM. Fact-finding of the cholinergic syndrome of the irinotecan preparation in patients with pancreatic cancer
眞野翔太1), 宮崎公輔1), 安江諒平1), 伊藤健史1), 田中佳子1), 井上壽江1), 平下智之1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1071-1071, 2022.
Japanese Article P330-24-AM. One case that developed duodenitis in irAE with the Pembrolizumab administration
近藤万友美1,2), 吉岡睦展1), 澁谷奈緒1), 高子優子1), 若松雄太1), 細見真世1), 森田聡子1), 西山祐美1), 正置耕一1), 高瀬直人2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1072-1072, 2022.
Japanese Article P331-23-PM. A case in which it was possible to continue treatment at the usual dose with antibiotics and pharmacist intervention for scalp skin disorder that occurred while taking tirabrutinib
溝渕秀敏1), 野毛一郎1), 白石誠一郎1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1073-1073, 2022.
Japanese Article P333-23-PM. 1 case that resulted in tumor lysis syndrome during the chemotherapy enforcement for rectal cancer
眞弓健介1), 出町健1), 坂東英明2), 川崎敏克1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1074-1074, 2022.
Japanese Article P334-24-AM. Investigation about infusion reaction in the daratumumab subcutaneous injection
吉川直樹1), 萩原綾菜1), 相田和希1), 飯島直美1), 森田光枝1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1075-1075, 2022.
Japanese Article P335-23-PM. Examination of the sleeplessness improvement effect of the steroid hormone DHEA which paid its attention to a clock gene for the sleeplessness to occur by anticancer agent administration
白水翔也1), 牛尾聡一郎1), 江角悟1), 北村佳久2), 座間味義人1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1076-1076, 2022.
Japanese Article P336-24-AM. Effect (the fifth report) that an administration timing of the peg filgrastim gives for febrile neutropenia
大神正宏1), 小島友恵1), 渡邊雅明2), 小島卓也3), 泉玲子4), 平井利幸5), 小山田聡6), 本間真人2), 石井武男3), 岡野知子4), 秋山裕史5), 原信田努6), 鈴木美加1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1077-1077, 2022.
Japanese Article P338-24-AM. A case of non-small cell lung cancer where anticancer drug treatment could be continued with the administration of anamorelin hydrochloride
出口真人1), 小玉幸与1), 冨田敦和1), 今西忠宏1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1078-1078, 2022.
Japanese Article P339-23-PM. Regarding the usage history of enfortumab vedotin at our hospital and the incidence of side effects, etc.
田中亜弥1), 衛藤智章1), 高崎紘臣2), 後藤隆1), 清水裕彰1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1079-1079, 2022.
Japanese Article P340-25-AM. About pain-killer prescription order in cancerous pain treatment and rescue medicine, aperient, the prescription situation of the antiemetic a comparison (the first report) before and after the - guidelines revision
丸山昌広1), 定盛理純1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1080-1080, 2022.
Japanese Article P341-24-PM. Investigation about the effect on elimination of pain situation and everyday life of patients with hospitalization cancer
藤田靖之1), 井上知哉1), 大久保翔1), 駒木真理子1), 宿輪紗世1), 原口智彦1), 馬場麗名1), 荒木正義1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1081-1081, 2022.
Japanese Article P342-25-AM. The effectiveness of the naldemedine tosyl acid salt for the opioid-induced constipation
山田正実1), 地丸裕美1), 鳥井小莉1), 高橋一栄1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1082-1082, 2022.
Japanese Article P343-24-PM. About an on admission bringing drug in our hospital and the operation
伊東美歩1), 岡本和也1), 海老原貴之1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1083-1083, 2022.
Japanese Article P344-25-AM. Examination about the effectiveness according to the dose of the mirogabalin for the cancerous pain
地丸裕美1), 山田正実1), 鳥井小莉1), 高橋一栄1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1084-1084, 2022.
Japanese Article P345-24-PM. Medication support by the system construction of the drug self-care for the medical care in the inpatient
畑下真希1,2), 花村藤佳1,2), 朝日仁美1,2), 吉垣亜里沙3), 手渡和子2,3), 牧山稔1), 筒井秀和1), 大塚知信5), 豊田康義2,4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1085-1085, 2022.
Japanese Article P347-24-PM. Clinical examination about the changes from fentanyl patch to a morphine note
工藤佐智子1), 渡邊法男1,2), 吉田知佳子3), 岡村真理子3), 佐藤真由美3), 中島大喜4), 浅井和浩1), 山田卓也5)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1086-1086, 2022.
Japanese Article P348-25-AM. The use situation investigation of the oral hydromorphone slow-release preparation
中原萌子1), 高武嘉道1), 藤本愛理1), 花田聖典1), 川俣洋生1), 橋本雅司1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1087-1087, 2022.
Japanese Article P349-24-PM. Example that a change was performed in from parenteral injection only to an oral formulation for the patients who reported intractable pain under the use of high-dose opioid note by methadone tablets combination
高橋典哉1,2,3,4,5,6), 千葉亮祐2), 佐賀雄大3), 鈴木温4), 吉田ひろ子5), 奥尚6)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1088-1088, 2022.
Japanese Article P350-25-AM. Two cases that changes from methadone to hydromorphone sustained subcutaneous administration were effective
藤本英哲1), 笠原庸子1), 今津邦智1), 荒谷恭子1), 前田裕行1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1089-1089, 2022.
Japanese Article P351-24-PM. Effect factor of analgesic effect and the side effect of oral methadone in patients with cancer pain
国分秀也1), 瀧川千鶴子2), 千原里美3), 原聡志4), 上園保仁5)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1090-1090, 2022.
Japanese Article P352-25-AM. Examination about the opioid combined effect of the tapentadol in the intractable cancer pain
林誠1,2), 松野英美2), 船橋依理子2), 西堀理香2), 岡本典子2), 中井正彦1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1091-1091, 2022.
Japanese Article P353-24-PM. About association with the pre-back predictive index and steroid in the palliative care team activity
山田直輝1), 里岡達哉2), 青山瑛里子1), 井上悠1), 山本浩二郎1), 大里恭章1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1092-1092, 2022.
Japanese Article P354-25-AM. Examination about the change conversion quantity to hydromorphone parenteral injection
安藤寛子1), 野口美幸1), 渡邉理基1), 熊野光翼1), 大信紀明1), 葉山達也2), 堀越建一1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1093-1093, 2022.
Japanese Article P355-24-PM. Verification of changes in feeding status and body weight in hospitalized patients treated with anamorelin hydrochloride
六車裕一1), 藤田真弓1), 宮原阿友美1), 小寺由香1), 宮麻紀子1), 池田久雄1), 足立充司1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1094-1094, 2022.
Japanese Article P356-25-AM. One case that did patients consultation correspondence by a telephone follow-up at opioid introduction by the foreign going to hospital
宮田香織1), 藤田あゆみ2), 杉浦伸哉2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1095-1095, 2022.
Japanese Article P357-24-PM. One case that was able to support drug coinfusion prescription by using it jointly of the dispensary germfree the health insurance pharmacy that does not have clean bench
伊津田知樹1), 赤尾美乃里1), 藤田あゆみ2), 杉浦伸哉2), 杉浦克典2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1096-1096, 2022.
Japanese Article P358-25-AM. One case that was treated with the palliative care that did not have a break until after a discharge from hospitalization by the cooperation of hospital pharmacist and the drugstore pharmacist
土井武司1), 藤田あゆみ2), 三久裕子1), 杉浦伸哉2), 杉浦克典2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1097-1097, 2022.
Japanese Article P359-24-PM. Examination of the patient population where drug introduction for the medical care by the fentanyl patch was suitable for
山脇誉央1), 東真理子1), 淺野肇1), 川口明範1), 藤原季美子1), 竹上学1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1098-1098, 2022.
Japanese Article P360-25-AM. Current status of anamorelin administration in non-small cell lung cancer
東春奈1), 後藤愛実1), 高橋智恵子1), 西原雅美1), 藤阪保仁2), 根尾昌志1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1099-1099, 2022.
Japanese Article P361-24-PM. The use situation investigation for the opioid-induced constipation in our hospital
宮川千珠1), 坂口結斗1), 鈴木ひかり1), 糸山佳奈子1), 知念ほのか1), 喜多幸子1), 森智子1), 人見百合子1), 高江洲夢子1), 井上千尋1), 宇根良祐1), 喜友名舞1), 當間菜央1), 喜多洋嗣1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1100-1100, 2022.
Japanese Article P362-25-AM. Visualization of the problem using an evaluation and the text mining by the drug instruction template introduction
小玉幸与1), 冨田敦和1), 内山耕作1), 鈴川誠1), 今西忠宏1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1101-1101, 2022.
Japanese Article P363-24-PM. Case study about opioid switching from the fentanyl patch in patients of the sedative insufficiency to hydromorphone parenteral injection
脇下大樹1), 金剛圭佑1), 刈谷美里1), 松田ゆかり1), 横町朋子1), 大林加代子2), 橋本泰明1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1102-1102, 2022.
Japanese Article P364-25-AM. The effect that administration of oxycodone gives to a nutrition index on mucous membrane disorder with head and neck cancer treatment
菊田奨之1), 中澤佑介1), 元日田阿子1), 宮沢祐太1), 須田奈美1), 志村英二2), 川久保孝1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1103-1103, 2022.
Japanese Article P365-24-PM. The effectiveness of pregabalin in children and safety
三浦寄子1), 歌野智之1), 余谷暢之2), 山谷明正1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1104-1104, 2022.
Japanese Article P366-25-AM. About the expression situation and the episode of care of the immune-mediated adverse event in the use of immune checkpoint inhibitor
西川豊1), 梶田貴司1), 田中通1), 石田葉月1), 安田早織1), 山口和美1), 黒松誠1), 樽野麻依1), 金松誠1), 奥野智之1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1105-1105, 2022.
Japanese Article P367-24-PM. One patient who gave nivolumab + ipilimumab combination therapy in a malignant peritoneal mesothelioma
豊田真史1), 岡野芳彦1), 深野光司1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1106-1106, 2022.
Japanese Article P368-25-AM. Examination of the usefulness of the tracing report in the foreign cancer chemotherapy
中嶋江美1), 山瀬大雄1), 松本早織1), 原田慶子1), 尾本和彦1), 山田邦義1), 辻井佳代1), 小林政彦1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1107-1107, 2022.
Japanese Article P369-24-PM. Rearward observational study about the effect that a risk factor of the acneform rash with the antiEGFR antibody medicine gives to a survival rate
高橋宏彰1,2), 小池陽聡1), 佐々木悠汰1), 八重樫由紀子2), 齊藤葉子2), 二瓶哲2), 平舩寛彦3), 氏家悠貴2,4), 朝賀純一1,2), 工藤賢三1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1108-1108, 2022.
Japanese Article P370-25-AM. Construction of the plasma concentration assay of the breast cancer therapeutic drug Palbociclib
小玉菜央1), 山本達郎1), 森木邦明1), 門永太一2), 若原誠2), 細谷恵子2), 藤吉正哉1), 島田美樹1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1109-1109, 2022.
Japanese Article P371-24-PM. The effect that Osimertinib introduction time gives for overall survival on patients with EGFR mutation in the gene-positive non-small cell lung cancer: Single institution cohort study
塩飽英二1), 土手賢史1), 小林由佳1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1110-1110, 2022.
Japanese Article P372-25-AM. It is PTX or RDI of the DTX chemotherapy and the examination about the drug choice after before breast cancer, the operation
高木麻衣1), 中村智絵1), 宮崎雅之1), 山田清文1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1111-1111, 2022.
Japanese Article P373-24-PM. It is examination about Axitinib or the continuance of the primary treatment using the sunitinib for patients with renal cell carcinoma with the distant metastasis
松井頌明1), 尾崎正和1), 幸田恭治1), 北原隆志1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1112-1112, 2022.
Japanese Article P374-25-AM. Use fact-finding of the PARP inhibitor in ovarian cancer
黒木百香1), 小関利弥1), 西上依里1), 岩田一史1), 合澤啓二1), 陣上祥子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1113-1113, 2022.
Japanese Article P375-24-PM. Examination of the effect on effect, side effect of probiotics of the immune checkpoint inhibitor
石井岳夫1), 菅原康佑2), Jose Carlos Sandoval Tayag3), 潮平英郎1), 諸見牧子1), 中村克徳1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1114-1114, 2022.
Japanese Article P376-25-AM. One case of the Atezolizumab bevacizumab therapy for patients with unresectable hepatocellular carcinoma with the interstitial pneumonia history
板村亮1), 櫻下弘志1), 吉岡寛美1), 松尾裕彰1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1115-1115, 2022.
Japanese Article P377-24-PM. The effect of menthol on epirubicin killing effect with human liver cancer HepG2 cells: Possibility of the participation of the multidrug-resistant protein MRP
長井克仁1), 田村真由子1), 大谷奎介2), 吉田尚史2), 渡邊利栄2), 福野修平1), 小西廣己1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1116-1116, 2022.
Japanese Article P378-25-AM. 1 case that urinary retention occurred as acute peripheral neuropathy of oxaliplatin
野口祥紀1), 三宅知宏1), 谷村学1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1117-1117, 2022.
Japanese Article P379-24-PM. Examination of the effect of treatment when we gave it just before administration in the FOLFIRI+Aflibercept therapy based on UPCR
花谷直美1), 近藤潤一1), 杉山菜穂1), 津野丈彦1), 小杉三弥子1), 諏訪雄亮2), 渡邉純2), 佐橋幸子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1118-1118, 2022.
Japanese Article P380-25-AM. An example of patients with acute lymphoid leukemia that blood level of the Methotrexate was prolonged by antifungal agent combination
山下智穂1), 兼松哲史1), 伊藤和幸2), 吉田均3), 伊藤貴彦3), 中村英明1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1119-1119, 2022.
Japanese Article P381-24-PM. A renal function evaluation using cystatin C in the TC therapy enforcement case and investigation about myelosuppression
若松綾華1), 田中彩2), 若松遼介1), 山下友輝1), 柴波明男1), 樋浦一哉2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1120-1120, 2022.
Japanese Article P382-25-AM. Fact-finding about the antihypertensive medications internal use situation after bevacizumab completion of treatment and the blood pressure change
村山三佳1), 北村葵1), 奥村啓樹1), 丹羽洋介1), 宮崎雅之1), 溝口博之1), 山田清文1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1121-1121, 2022.
Japanese Article P383-24-PM. An example of the dermatomyositis concurrence stomach cancer during cancer medical therapy support - immunosuppressive drug administration for the special population
川上恵1), 北田徳昭1), 岡村みや子1), 尾崎淳子1), 池見泰明1), 中川俊作1), 今井哲司1), 米澤淳1), 中川貴之1), 土井恵太郎2), 武藤学2), 寺田智祐1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1122-1122, 2022.
Japanese Article P384-25-AM. Look at the rear of the infectious adverse event with GB therapy and the BR therapy for the untreated follicular lymphoma; mark investigation
川崎貴蔵1), 伊藤佳織2,3), 山本孝枝1), 冨田章裕3), 山田成樹2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1123-1123, 2022.
Japanese Article P385-24-PM. The onset of immune-mediated adverse event situation after checkpoint inhibitor completion of treatment of immunity
原友子1), 町田梨絵子1), 野中敏治1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1124-1124, 2022.
Japanese Article P386-25-AM. Example of pharmacy pre-avoidance regarding appropriate dosage of S-1 according to patient's renal function
貴田郁美1), 山田美里2), 細谷晃3), 伊藤秀剛4), 永野悠馬5), 前田守5), 緒形富雄5), 市ノ渡真史5), 長谷川佳孝5), 月岡良太5), 大石美也5)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1125-1125, 2022.
Japanese Article P387-24-PM. The effect that the function display of the family pharmacist gives to the treatment continuation of the Osimertinib remedy patients
千野直英1), 永野悠馬2), 前田守2), 緒形富雄2), 市ノ渡真史2), 長谷川佳孝2), 月岡良太2), 大石美也2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1126-1126, 2022.
Japanese Article P388-25-AM. Exploratory study on test value before treatment to predict chronic administration of the antiPD-1 antibody medicine
前谷一仁1), 新谷拓也1), 池村健治1), 渡邊梓1), 山本智也1), 奥田真弘1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1127-1127, 2022.
Japanese Article P389-24-PM. The effect that the function display of the family pharmacist gives to the treatment continuation of the capecitabine remedy patients
松崎淳1,2), 永野悠馬2), 前田守2), 緒形富雄2), 市ノ渡真史2), 長谷川佳孝2), 月岡良太2), 大石美也2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1128-1128, 2022.
Japanese Article P390-25-AM. The effect that proton pump inhibitor, vonoprazan give for bevacizumab treatment continuation
八木健太1), 丸尾陽成2), 石田俊介3), 鍛治園誠2), 相澤風花3), 新村貴博1), 石澤有紀4), 濱野裕章2), 合田光寛3,5), 座間味義人2,5), 石澤啓介1,3,5)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1129-1129, 2022.
Japanese Article P391-24-PM. Analysis about the dysfunction thyroid with the immune checkpoint inhibitor
鳥山陽子1), 大原義正1), 谷口潤2), 山形真一1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1130-1130, 2022.
Japanese Article P392-25-AM. Thyroid cancer, study on adherence of the Lenvatinib for hepatocytes cancer
寺前美乃里1), 舘合慶一2), 川上和宜2), 横川貴志2), 小林一男2), 柴田直樹2), 鈴木亘2), 清水久範2), 福田直樹3), 高橋俊二3), 尾阪将人4), 笹平直樹4), 堀里子1), 山口正和2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1131-1131, 2022.
Japanese Article P393-24-PM. Investigation about the side effect extracted in the pharmacist interview in the foreign chemotherapy room
桂川健司1), 高取裕司1), 高岡龍蔵1), 遠山幸男1), 久田達也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1132-1132, 2022.
Japanese Article P394-25-AM. One case of the cancer of endometrium which myelosuppression of extravasation therapeutic drug dexrazoxane influenced it, and developed febrile neutropenia after the peg filgrastim administration
森本真宗1), 大矢浩之1), 魚谷隆弘2), 長井智則2), 近藤正巳1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1133-1133, 2022.
Japanese Article P395-24-PM. The effect that the function display of the family pharmacist gives to the treatment continuation of the S-1 remedy patients
唐崎奈央子1), 永野悠馬2), 前田守2), 緒形富雄2), 市ノ渡真史2), 長谷川佳孝2), 月岡良太2), 大石美也2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1134-1134, 2022.
Japanese Article P396-25-AM. Episode of care after the regimen change with the temporary missing part of the albumin suspension type paclitaxel
吉藤和也1), 後藤志典1), 山崎博子1), 赤崎淳子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1135-1135, 2022.
Japanese Article P397-24-PM. Analysis - that we paid our attention to a type of - combination PPI about the effect that PPI combination gave for CDDP origin-related renal failure reduction
寺田明里1), 植田有希1), 高橋愛未1), 口分田章典1), 山東真寿美1), 坂上嘉浩1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1136-1136, 2022.
Japanese Article P398-25-AM. About the effect on effect of treatment of the docetaxel after the Enzalutamide administration and side effect
山下慎司1), 光家勉1), 藤森信也1), 西川光1), 篠村恵理子1), 石戸谷哲2), 上田豊実1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1137-1137, 2022.
Japanese Article P399-24-PM. Relative examination of nourishment metrics and the side effect expression in the R-CHOP therapy
菊池健1), 澤田桃香2), 武田元樹1), 相馬貴史1), 鶴山辰1), 佐藤秀紀2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1138-1138, 2022.
Japanese Article P400-25-AM. Survey on the usage status of niraparib and occurrence of adverse events at our hospital
樋口文子1), 衛藤智章1), 清水裕彰1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1139-1139, 2022.
Japanese Article P401-24-PM. A case in which tepotinib was administered to gastric cancer that was confirmed to be positive for MET gene mutation by cancer gene panel test
西岡菜々子1), 松沼悟1), 輿石徹1), 磯貝博之1), 中村洋典1), 青木琢也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1140-1140, 2022.
Japanese Article P402-25-AM. About the inquiry situation of the pharmacist in the foreign chemotherapy and future efforts
大西翔太1), 田中昭洋1), 高取秀人1), 松本芳樹1), 村富裕貴1), 梅林良英1), 坂口奈津子1), 後藤卓也1), 萱野勇一郎1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1141-1141, 2022.
Japanese Article P403-24-PM. Fact-finding about the end of the nucleic acid analog preparation remedy after the chemotherapy enforcement in patients with HBV infection malignant tumor
應和矢寛1), 有馬崇充1), 田中聖二1), 中島寿久1), 齋藤義正1), 石川光信1), 赤木徹1), 橋本浩伸1), 古川哲也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1142-1142, 2022.
Japanese Article P404-25-AM. 1 case that developed heart failure after the Lenvatinib remedy for thymic carcinoma: Lenvatinib and consideration from blood level of IL-6
関夏望1), 朝倉充俊1), 見野靖晃2), 中津川瑛美2), 小泉知展3), 内藤隆文1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1143-1143, 2022.
Japanese Article P405-24-PM. Construction and evaluation of the examination of the hepatitis B-related examination check system aiming at improvement in rate of use
二瓶貴幸1), 松浦正樹1), 堀川美帆1), 前嶋隆弘1), 大柳元1), 赤坂和俊1), 菊地正史1), 前川正充1), 井上隆輔2), 勝見真琴3), 井上淳4), 大内康太5), 高橋雅信5), 石岡千加史5), 眞野成康1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1144-1144, 2022.
Japanese Article P406-25-AM. The effect that the nab- paclitaxel supply anxiety problem in patients with pancreatic cancer gave for treatment preferences
白神霞1), 丸花奈央1), 篠崎浩司1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1145-1145, 2022.
Japanese Article P407-24-PM. Change of tumor marker and the liver residual function with the Atezolizumab bevacizumab combination therapy for the unresectable hepatocellular carcinoma
西和哉1), 川田彰彦1), 佐々木崇1), 佐賀利英1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1146-1146, 2022.
Japanese Article P408-25-AM. Association of Bcr-Abl inhibitor duration of treatment and the alcohol intake in patients with chronic myelogenous leukemia
山川裕介1), 八木健太2), 吉岡俊彦1,3), 佐藤真希3), 丸尾陽成4), 宮田晃志3), 相澤風花1), 國木悠理香3), 新村貴博2), 坂口暁2), 石澤有紀5), 合田光寛1,3), 座間味義人4), 石澤啓介1,2,3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1147-1147, 2022.
Japanese Article P409-24-PM. Relations of a dose and the intensity of treatment of the gemcitabine cisplatin therapy in patients who received adjuvant chemotherapy before total cystectomy
小栗良介1), 関谷泰明1), 井上壽江1), 平下智之1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1148-1148, 2022.
Japanese Article P410-25-AM. Search of the risk factor of the dermatopathy of DTX in patients with breast cancer
森本奈緒美1), 星田唯史1), 眞下惠次1), 藤原大一朗1), 木村佳世1), 武田祐子1), 和田祥明1), 野田明宏1), 多喜和夫1), 田辺和史1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1149-1149, 2022.
Japanese Article P411-24-PM. Mean association of the relative dose intensity and neutrophilic/lymphocytes ratio, platelet/lymphocytes ratio in the patients who received adjuvant chemotherapy (XELOX therapy) after the colon cancer technique
林宏紀1), 山本泰大1), 福岡智宏1), 宇都宮純平1), 戸田康裕1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1150-1150, 2022.
Japanese Article P412-25-AM. The effectiveness of the Osimertinib for the elderly people EGFR mutation in the gene-positive non-small cell lung cancer and safe examination
岩崎文香1), 有山智博1), 平井成和2), 増田雅行2), 真坂亙1), 石井敏浩3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1151-1151, 2022.
Japanese Article P413-24-PM. Two patients who conducted dose adjustment of the TC therapy to patients with severe obesity
大城真理奈1,2), 山口芽衣1,2), 中谷香織1,2), 縄田修一1,2), 三村貴志3), 嶋村弘史1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1152-1152, 2022.
Japanese Article P414-25-AM. The case that responded to platinum combination therapy for the extensive-stage small-cell lung cancer of elderly patients again
冨井隆弘1), 松沼悟1), 輿石徹1), 江里口大介2), 吉元公一1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1153-1153, 2022.
Japanese Article P415-24-PM. The side effect expression situation of the checkpoint inhibitor combination therapy in the lung cancer of immunity
田口伸1), 渡邊智穂1), 泉谷紘平1), 佐藤優弥1), 和地徹1), 柳田真樹子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1154-1154, 2022.
Japanese Article P416-25-AM. Rearward investigation about the length of stay of patients who received craniocervical part cancer chemoradiotherapy
中尾なつみ1), 北口梨紗1), 甲元大樹1), 河村茉衣2), 竹内彩子2), 森英樹1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1155-1155, 2022.
Japanese Article P417-24-PM. It is the investigation to the health insurance pharmacy for the improvement of system of the medicine medicine cooperation in the foreign cancer chemotherapy
丸田基史1), 福山雄卯介1), 井上善博2), 三角紳博1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1156-1156, 2022.
Japanese Article P418-25-AM. Recurrence, one case of the intractable multiple myeloma that EPd therapy succeeded by the tenth treatment
西村直朗1), 上津沙織1), 柿原圭佑1), 吉国健司1), 小倉秀美1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1157-1157, 2022.
Japanese Article P419-24-PM. About the use situation of the antimicrobial for the COVID-19 patients in the Tokyo health medical care public corporation 6 Hospital
松澤弘志1), 佐々木康弘2), 福山博務3), 田中義幸4), 陳内博之5), 根岸真利子6), 方岡小百合7), 塩地園代3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1158-1158, 2022.
Japanese Article P420-25-AM. One case that PT-INR increased by combination of rem decibuilding and warfarin
山内健1), 吉川明良1), 佐古有紀1), 伊藤徳明2), 沖本真史2), 渡辺美和1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1159-1159, 2022.
Japanese Article P421-24-PM. The onset of liver damage investigation in patients receiving rem decibuilding and examination of the risk factor
高橋まどか1), 阿部多嘉浩1), 宮崎公爾1), 板谷眞理恵1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1160-1160, 2022.
Japanese Article P422-25-AM. Surveillance and neutralizing antibody monitoring of the adverse event after the new corona vaccination
池田博昭1), 青山さくら1), 井上奈々1), 金子真夕1), 金本奈々1), 大江健人1), 夛田羅勝義2), 藤岡譲2), 池田純子3), 中妻章1), 芳地一1), 森久美子1), 飯原なおみ1), 河野清尊4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1161-1161, 2022.
Japanese Article P423-24-PM. Safety investigation of sotrovimab administration to patients infected with the new coronavirus in late pregnancy at our hospital
上柳汐果1), 池上洋平1), 小原直紘1), 小田亮介1), 丸山直岳1), 土井敏行1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1162-1162, 2022.
Japanese Article P424-25-AM. Effect of the immunosuppressive drug in SARS-CoV-2 antibody titers and the treatment of the COVID-19 patients
新崎孝夫1), 河野えみ子1), 三箇山宏樹1), 關嘉人1), 中森靖2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1163-1163, 2022.
Japanese Article P425-24-PM. Analysis of the second response after the first and the second inoculation of the new corona vaccine of the staff
佐藤智功1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1164-1164, 2022.
Japanese Article P426-25-AM. Use history of sotrovimab (Xevudy) at Chidoribashi Hospital and Tatara Rehabilitation Hospital
岐部このみ1), 松村千晶2), 石橋美希1), 中村大祐1), 菖蒲沙織1), 八板謙一郎3), 有馬泰治4), 駒井孝企4), 山本一視4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1165-1165, 2022.
Japanese Article P427-24-PM. Survey on the use of sotrovimab in COVID-19 patients
中谷亮介1), 岡田雅弥1), 下川福子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1166-1166, 2022.
Japanese Article P428-25-AM. Use fact-finding of the COVID-19 therapeutic drug in our hospital
玉城哲子1), 仲俣桃華1), 城間盛彦1), 木奈崎昭男1), 島袋朝太郎1), 安座間照子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1167-1167, 2022.
Japanese Article P429-24-PM. The second responses of the new corona vaccine third inoculation walk 1, the second and the difference (followup)
中村和彦1), 中村嘉孝1), 塚本友紀江2), 横井さおり3), 小竹克博4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1168-1168, 2022.
Japanese Article P430-25-AM. Sotrovimab use results survey in Covid-19 patients
三宅純子1), 生島繁樹1), 石巻靖弘1), 堀智貴1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1169-1169, 2022.
Japanese Article P431-24-PM. Fact-finding of the renal function test value abnormality with the rem decibuilding administration to patients with severe impaired renal function
山村翔1), 荒木良介1), 山田英紀1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1170-1170, 2022.
Japanese Article P432-25-AM. Usage status of casirivimab/imdevimab [Ronapreve(R)] and sotrovimab [Xevudy] in the treatment of COVID-19 at Nishi Municipal Hospital
石田洋史1), 奥野昌宏2), 中浴伸二1), 田中詳二1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1171-1171, 2022.
Japanese Article P433-24-PM. New coronavirus vaccine: Analysis of side effects caused by Comirnaty intramuscular injection
鈴木一成1), 村田文1), 新木美枝1), 鈴木達宙1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1172-1172, 2022.
Japanese Article P434-25-AM. The examination that a second response is easy to emerge after the third inoculation as for the person whom a second response developed in after the mRNA vaccine 1, the second inoculation
林幹也1), 後藤志典1), 伊藤美登里2,3), 平田貴代美3), 赤崎淳子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1173-1173, 2022.
Japanese Article P435-24-PM. Report of health observation results for patients taking oral molnupiravir
鈴木佑果1), 井本陽子1), 上野花純1), 三木郁帆1), 渡邊裕之1), 宅和真由美1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1174-1174, 2022.
Japanese Article P436-25-AM. About the questionnaire result about efforts and the second response to new coronavirus vaccine third inoculation
篠山淳美1), 三木芳晃1,2), 白戸美希1), 松本芳樹1), 梅林良英1), 川口尚子2), 萱野勇一郎1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1175-1175, 2022.
Japanese Article P437-24-PM. Second response investigation with the new coronavirus vaccine additional inoculation in the Tohoku University Hospital
佐藤朗1,2), 佐藤裕1), 佐藤智見1), 鷹尾月舟1), 菅原英里奈1), 鈴木博也1,2), 公文代將希1), 佐藤紀宏1), 前川正充1), 徳田浩一2), 眞野成康1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1176-1176, 2022.
Japanese Article P438-25-AM. The expression situation and risk factor analysis of the hyperkalemia with the administration of nafamostat mesilate for COVID-19
小玉健太郎1), 今井徹1), 淺井康夫2), 神津悠2), 林健太郎2), 清水哲夫2), 權寧博2), 大塚進1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1177-1177, 2022.
Japanese Article P439-24-PM. Incidence of hypersensitivity and infusion reactions due to sotrovimab at our hospital and effects on laboratory test values
樽屋志保1), 藏本裕信1), 権藤直人1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1178-1178, 2022.
Japanese Article P440-25-AM. The effect that a second response gives for duties after the inoculation of the new coronavirus vaccine for the medical institution staff
児玉暁人1), 水庫彩1), 今井兼貴1), 勝浦正人1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1179-1179, 2022.
Japanese Article P441-24-PM. Development situation and Sotrovimab iv. of the COVID-19 cluster in our hospital Of this about use experience
林智樹1), 牧野以佐子1), 田中佳代1), 望月惠理子1), 大胡幹子1), 野崎容右1), 伊藤淳雄1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1180-1180, 2022.
Japanese Article P442-25-AM. Attitude survey about the new corona vaccine for the medical institution staff
水庫彩1), 児玉暁人1), 今井兼貴1), 勝浦正人1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1181-1181, 2022.
Japanese Article P443-24-PM. Drug control for the measures of the COVID-19-positive pregnant woman at admission and new drug proper use in the medical therapy
藤井稚奈1), 前川真己1,2), 中園裕利華1,2), 佐々木貴之1,2), 加藤恵一1), 大里和広3), 白木克哉2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1182-1182, 2022.
Japanese Article P444-25-AM. Report of a case of rapid increase in BUN after administration of Molnupiravir
肥後美月1), 渡慶次賀博2), 喜多洋嗣1), 仲村亮太1), 田仲祐子1), 村雲智久1), 近藤理美1), 水野康平1), 吉村美菜1), 野下綾子1), 菅近晴美1), 佐伯星依奈1), 船臺三央1), 又吉嘉寿人1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1183-1183, 2022.
Japanese Article P445-24-PM. About effect and the associated factor which everyday life stress of the hospital pharmacist accompanied with the new coronavirus infection pandemic prolongation gives to normal business routine
白石貴寿1), 坂本拓也1), 川村ひとみ1), 小川実華1), 井口舞香1), 高木栄希1), 図師彩音1), 山田智栄子1), 青柳晴彦1), 荒井宏人1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1184-1184, 2022.
Japanese Article P446-25-AM. Duties investigation of the drug section accompanied with the new corona infection expansion in the national capital municipal hospital chief pharmacist council participation institution
喜古康博1,7), 廣井順子2,7), 石坂敏彦3,7), 森本茂文4,7), 本田一春5,7), 山田英紀6,7)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1185-1185, 2022.
Japanese Article P447-24-PM. About the efforts of the community medical care function promotion mechanism (JCHO) pharmacist in Osaka temporary medical facilities of the new coronavirus infection of the disaster grade
東克彌1), 福田裕子2), 森脇崇3), 仲田美智代4), 鈴木朋克5), 秋吉尚雄6), 北澤文章4), 辻川正彦3,8), 片山歳也7,9)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1186-1186, 2022.
Japanese Article P449-24-PM. With COVID-19 serious case center establishment, it is efforts to duties efficiency and prevention of incident by the clinical path introduction
田中こずえ1), 山村智代1), 船引梓2), 谷澤由香2), 武富太郎3), 中川秀光4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1187-1187, 2022.
Japanese Article P450-25-AM. Of new corona vaccination duties by the multi-type of job collaboration, actually
堀口悠太1), 西村真央1), 山本祐聖1), 木村実央1), 裏山悠哉1), 竹原涼子1), 濱崎淳哉1), 向井淳治1,3), 澤田隆吾2), 奥田広志1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1188-1188, 2022.
Japanese Article P451-24-PM. Intervention ... by one ward pharmacist who is not as main duties by response of the ward pharmacist ... infection control at outbreaks development due to the new coronavirus infection
山元孝俊1), 光永義治1), 柴田裕介1), 足立匠1), 岡田雄介1), 河村剛至1,2), 渡部多真紀1,2), 安野伸浩1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1189-1189, 2022.
Japanese Article P452-25-AM. About the oral medicine management method in a new coronavirus infection and the analogous case of a disease patients
吉田朱里1,4), 竹内菜穂1,4), 平沼朋子1), 古川睦2), 上野一枝2,4), 尾花祥世1,4), 福田英克1), 山本光成3,4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1190-1190, 2022.
Japanese Article P453-24-PM. Correspondence to a sedative supply difficulty by the multi-type of job cooperation in the middle scale hospital operating room
磯野礼果1,2,3), 細野真吾1), 亀井幹子2), 白井壽子2), 澁田達史3), 山崎崇1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1191-1191, 2022.
Japanese Article P454-25-AM. Investigation of contraindicated drug cases in patients using nirmatrelvir/ritonavir and countermeasures
沼田裕也1), 沢田佳祐1), 西山晃1), 中谷丈之1), 河野修治1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1192-1192, 2022.
Japanese Article P455-24-PM. Relation of the pharmacist for the new coronavirus infection (COVID-19) therapeutic drug in our hospital
河野透子1), 牛島裕貴1), 福中咲愛1), 今村陽子1), 坂本欣直1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1193-1193, 2022.
Japanese Article P456-25-AM. Cooperation of the efforts dispatch pharmacist of the JCHO pharmacist about the pharmacist wide area dispatch to Tokyo temporary medical facilities of the new coronavirus infection and the pharmaceutical specialist job
樋口泰子1), 加藤淳一2), 奥主仁3), 水野宏昭4), 荻野知紀5), 齋藤雄大6), 藤掛沙織7), 我妻央陽3), 佐野真由実7), 菅原真那2), 久保瞳8), 野田美保9), 森田淳介2), 伊藤典子2,10), 片山歳也9,11)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1194-1194, 2022.
Japanese Article P457-24-PM. Examination about the usefulness of the holiday ward drug duties in the COVID-19 ward
相賀真由1), 陳内博之1), 津吹澄1), 沖田直美1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1195-1195, 2022.
Japanese Article P460-25-AM. Pulmonary suppuration due to the Panton-Valentine leukocidin-positive dimethoxyphenyl penicillin which we have the onset, and age 6 was able to save on a day-sensitive staphylococcus aureus
本田勝亮1), 柏原道志1), 長岡翔1), 堤克成1), 菊池新2), 杉浦弘2), 大木茂2), 金子寛3), 中南秀将3), 矢部勝茂1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1196-1196, 2022.
Japanese Article P461-24-PM. Use of antimicrobial turn of eventss by the oral third generation cephem-based adoption reduction
塩田智子1), 谷長美菜子1), 村瀬大翔1), 段林正明1), 高橋一栄1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1197-1197, 2022.
Japanese Article P462-25-AM. Examination of the cefepime dosing period for the affection patients with the blood malignant tumor with unidentified fever
西綾香1,2), 吉川明良1), 増田博久1), 常友盛勝1), 綾部ゆか1), 新谷貴洋2), 渡辺美和1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1198-1199, 2022.
Japanese Article P463-24-PM. About the change of the AST activity in the Kyushu medical center and the effect
橋本雅司1), 高武嘉道1), 山口泰弘1), 坂口晋哉2), 鶴山萌子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1200-1200, 2022.
Japanese Article P464-25-AM. The analysis of the factor about the FLCZ tolerance and examination of the initial drug of choice
青柳千愛1), 山科卓也1), 山崎貴史1), 下村真代1), 兵藤沙耶2), 平木洋一3), 肥山和俊4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1201-1201, 2022.
Japanese Article P465-24-PM. Efforts for the oral third generation cephalosporin antimicrobial consumption reduction by the intervention of the antimicrobial proper use support team
古川大樹1), 伊藤嘉英1), 大橋武司1), 林房枝2), 梶田麻美2), 菱田志乃3), 中尾彰宏4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1202-1202, 2022.
Japanese Article P466-25-AM. Intervention effect ... in efforts - UTI for the consumption reduction of LVFX
福本康之1), 工藤悠翔1), 長山晃1), 森下和美1), 川上典子1), 近藤昌子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1203-1203, 2022.
Japanese Article P467-24-PM. Examination of the acute renal failure onset risk in vancomycin hydrochloride and tazobactam/piperacillin combination therapy of the renal function normalcy patients
高畑智瑛1), 本山大夢1), 澤田和久1), 奥平正美1), 杉浦洋二1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1204-1204, 2022.
Japanese Article P468-25-AM. Survey on the implementation of de-escalation of tazobactam and piperacillin at Handa City Handa Hospital
石川舞依子1), 榊原洋一1), 伊藤実優1), 板倉由縁1), 横田学1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1205-1205, 2022.
Japanese Article P469-24-PM. One case of the hyperviscosity-related Klebsiella pneumoniae bacteremia treated with combination of meropenem 6g/day and levofloxacin
安東大智1), 下山雄一朗1), 後藤俊元1), 宮澤由記子2), 合田智則3), 宗広樹1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1206-1206, 2022.
Japanese Article P470-25-AM. Examination about the infection prophylaxis effect by the comparison of the single dose group and three times group given mandibular extraction of impacted wisdom teeth in front of the art
齋藤千愛1), 吉田謙介1), 児玉泰光2), 冨原圭2), 外山聡1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1207-1207, 2022.
Japanese Article P471-24-PM. About the efforts by other types of job for the suspension introduction for the amikacin liposome inhalation
水口侑子1), 和田宜久1), 澤井祐樹1), 上田理絵1), 岩田浩幸1), 的場美香1), 木村貴1), 木澤成美1), 金銅葉子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1208-1208, 2022.
Japanese Article P472-25-AM. Intervention of the pharmacist based on PK-PD theory in the use of antimicrobial at the blood culture positive
田村麻衣1), 本舘諭1), 畑中祐磨1), 奈良昇悦2), 越前谷卓磨2), 中居肇1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1209-1209, 2022.
Japanese Article P473-24-PM. About the usefulness of the evaluation using the template to the use of tazobactam/piperacillin patients in our hospital
牧田亮1), 古谷一平1), 田中佳子1), 井上壽江1), 平下智之1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1210-1210, 2022.
Japanese Article P474-25-AM. The introduction of "the renal function antiinfection medicine doses list" which we made newly and the evaluation
谷長美菜子1), 塩田智子1), 村瀬大翔1), 段林正明1), 山田正実1), 高橋一栄1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1211-1211, 2022.
Japanese Article P475-24-PM. Examination of the factor that metronidazole was not as effective for Clostridioides difficile infection
臼井和明1), 吉田悦朗1), 大石丸美1), 安藤暢彦1), 和泉寿紀1), 近藤真由1), 長島章1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1212-1212, 2022.
Japanese Article P476-25-AM. Clinical evaluation - of maintenance, the introduction of adequacy - clinical path of aspiration pneumonia treatment by the antimicrobial proper use support team
松岡知子1), 大橋健吾1,4), 篠田康孝1,4), 森卓之1), 横山達郎2,5), 加賀城美智子3,5), 高橋崇真4,5), 吉村知哲1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1213-1213, 2022.
Japanese Article P477-24-PM. Investigation on the onset of cytomegalovirus infection after completion of letermovir administration
加茂真宏1), 角真太郎1), 久保利樹1), 祖川倫太郎1), 島ノ江千里1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1214-1214, 2022.
Japanese Article P478-25-AM. Efforts ... for the proper use of the AS activity - betamethasone valerate gentamicin ointment that a pharmacist can do it
八汐祥恵1), 石田智之1), 森美保菜1), 末永尚輝1), 鶴永大貴1), 中村有莉恵1), 堀内智裕1), 赤星真広1), 森岡友美1), 池増鮎美1), 佐多照正1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1215-1215, 2022.
Japanese Article P479-24-PM. One case with suspected encephalopathic onset metronidazole-induced on the administration start next day
小池彩子1), 花房伸幸1), 川上隆弘1), 田村安希1), 中島誠2), 小橋春彦3), 森英樹1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1216-1216, 2022.
Japanese Article P480-25-AM. A dose of the antimicrobial in children with suspected community-acquired pneumonia by BLNAR and examination of the dosing period
西尾公志1), 大石博史1), 片山陽介1), 田中誠1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1217-1217, 2022.
Japanese Article P482-25-AM. Examination of the intervention effect on blood culture-positive patients by the antimicrobial proper use support team
中島彰信1), 出羽祐基1), 近野祐里1), 中村直美1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1218-1218, 2022.
Japanese Article P483-24-PM. Efforts in our hospital for the third generation oral cephalosporin antimicrobial proper use
尾花祥世1,5), 吉田朱里1,5), 尾崎絢果1,5), 地守絢子2,5), 桑名良和2,5), 上野一枝3,5), 福田英克1), 山本光成4,5)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1219-1219, 2022.
Japanese Article P484-25-AM. The effect that efforts to rate of application adequacy gives for patients outcome on amino acid-containing general electrolyte infusion prescription patients
田井達也1), 山口佳津騎2), 新村航2), 松原亜季2), 渡邊政博3), 間嶋由美子1), 横田恭子1), 田中裕章2), 小坂信二2), 門脇則光1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1220-1220, 2022.
Japanese Article P485-24-PM. Examination about the usefulness of the chemical intestinal tract measures in the colon cancer elective surgery
佐々木康弘1), 橘淳1), 宮本智恵子2), 畑地健一郎3), 手塚徹4), 桂川秀雄3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1221-1221, 2022.
Japanese Article P486-25-AM. The effect of the bacterial species in the outcome of the enterococcus bloodstream infection and examination about the risk of death factor
末廣陽子1,2), 塚本仁1,2), 東高士1,2), 古俵孝明1), 飛田征男3), 岩崎博道2), 後藤伸之1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1222-1222, 2022.
Japanese Article P487-24-PM. Examination about the risk factor of the Clostridioides (Clostridium) difficile infection onset
渡邊歩1), 池上幸子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1223-1223, 2022.
Japanese Article P488-25-AM. Investigation of the infective endocarditis case in our hospital
榊原洋一1), 石川舞依子1), 伊藤実優1), 稲葉史恵1), 横田学1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1224-1224, 2022.
Japanese Article P489-24-PM. Questionary survey about the antimicrobial study session enforcement in the pharmacy
末延道太1), 藤野優1), 原尻学志1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1225-1225, 2022.
Japanese Article P490-25-AM. Analysis and evaluation of the efforts of the antimicrobial proper use support team in our hospital
金原加苗1), 藤田昌美1), 藤原加奈子1), 古谷佳美1), 松本文佳1), 矢木真一1), 細田尚美1), 市川大介1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1226-1226, 2022.
Japanese Article P491-24-PM. Examination of the prophylactic antimicrobial for the infection after the transrectal prostatic aspiration biopsy
青山真之1), 岩本里美2), 内藤淳3), 森下真圭4), 金田大生5), 鈴木幹三4,6), 成瀬国男1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1227-1227, 2022.
Japanese Article P493-24-PM. Effect of the antimicrobial proper use support with the infection specialist for blood culture-positive patients
石田茂伸1,2), 山田加代子2), 藤原大亮1,2), 眞野裕1), 多胡友絵1), 星育子1), 小泉祐一1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1228-1228, 2022.
Japanese Article P494-25-AM. Problem extraction for search of the use of foreign antimicrobial index using the J-SIPHE antimicrobial count application and the future foreign AMR activity
鈴木朋克1,2), 小島さおり3), 片山歳也2), 田子加代子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1229-1229, 2022.
Japanese Article P495-24-PM. Investigation for catheter-associated bloodstream infections due to B. cereus
田村安希1), 花房伸幸1), 川上隆弘1), 小池彩子1), 香川麻衣2), 奥格3), 森英樹1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1230-1230, 2022.
Japanese Article P496-25-AM. Efforts to dose adequacy of the meropenem in the Gunma center Hospital
國分真理1), 田子尚史1), 鈴木達宙1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1231-1231, 2022.
Japanese Article P498-25-AM. Look at the rear of the fever work up compliance before the wide area antimicrobial administration in the Okayama University Hospital; mark investigation
東恩納司1,2), 森下陽介1,2), 西原茂樹1,2), 座間味義人1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1232-1232, 2022.
Japanese Article P499-24-PM. Comparison of the blood culture-positive patients round case before and after the outbreak of new coronavirus occurrence
大竹友里恵1), 天野哲史1), 鈴木厚志1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1233-1233, 2022.
Japanese Article P500-25-PM. A comparison of the antiHIV therapy using the treatment satisfaction evaluation from patients: Patient reported outcome multicenter study
日笠真一1), 石原正志2), 築地茉莉子3), 國本雄介4), 登佳寿子5), 木村丈司6), 山本有紀7), 治田匡平8), 柏原陽平9), 藤井健司10), 木村健1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1234-1234, 2022.
Japanese Article P501-24-PM. The use of prescription notebook situation investigation of patients with HIV infection
藤井健司1), 田中まりの1), 石井聡一郎1), 大東敏和1), 春日真由2), 小川和彦2), 重留佳代子2), 畝井浩子2), 山崎尚也3), 藤井輝久3), 松尾裕彰1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1235-1235, 2022.
Japanese Article P502-25-AM. Comparison ... with proper use information - beef lead Pare plus of peripheral venous nutrition therapy infusion energy Freed
倉本敬二1), 大原宏司2), 杉山奈津子1), 伊東岳1), 加藤芳徳1), 前澤佳代子1), 百瀬泰行1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1236-1236, 2022.
Japanese Article P503-24-PM. One - that we showed improvement of the nutritional status by a device choice by role - multi-type of job cooperation of the pharmacist in our hospital NST and enforcement of the TPN
平野龍一1), 井須恭平1), 菅基次1), 曽我和子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1237-1237, 2022.
Japanese Article P504-25-AM. One patient who conducted nourishment management for short bowel syndrome by NST leadership
三宅美有紀1,2), 稲葉静香1), 森友美2), 庄野剛史2), 下川福子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1238-1238, 2022.
Japanese Article P505-24-PM. About the use situation of psychiatry therapeutic drug and the constipation therapeutic drug and association
福山雄卯介1), 宮崎敦2), 三角紳博1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1239-1239, 2022.
Japanese Article P506-25-AM. A fall, the fall in the east of the Sumida River Hospital inpatient and relative investigation of the prescribed medicine
石田留美1), 保戸塚里美1), 疋田絵梨1), 安武夫1,2), 城田幹生1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1240-1240, 2022.
Japanese Article P507-24-PM. The effect that the telephone support of the drugstore pharmacist gives to the treatment continuance rate of SNRI, the SSRI remedy patients
坂井信之1,2,3), 中村友美2), 西面恵太3), 飯塚敏美3), 浦本太一郎1), 西郷勝行1), 渡邉文之2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1241-1241, 2022.
Japanese Article P508-25-AM. The suggestion of the list of delirium risk drugs and examination of the delirium onset factor
冨田優子1), 宮尾眞一2), 武藤達也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1242-1242, 2022.
Japanese Article P509-24-PM. Relative investigation with the medical therapy in patients with schizophrenia using the multivariate analysis and the drug-related constipation
村田晶1,2), 岩田優俊1), 湯川裕光1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1243-1243, 2022.
Japanese Article P510-25-AM. Examination of the patients background factor having an influence on the advisability of the change to TRI (Twelve-weekly Release Injection)
赤瀬川豊1), 甲斐孝弘2), 井上雅文3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1244-1244, 2022.
Japanese Article P511-24-PM. One patient who reintroduced Aripiprazole durability parenteral injection into patients with comorbidities of bipolar disorder and the addiction, and maintained adherence
島田治子1), 西脇健三郎2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1245-1245, 2022.
Japanese Article P512-25-AM. Comparison of the nightmare frequency with the orexin receptor blocker
山崎由夏1), 神原弘和1), 野村暢彦1), 池田久雄1), 足立充司1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1246-1246, 2022.
Japanese Article P513-24-PM. Psychiatry liaison team in the Toyokawa Municipal Hospital: We evaluate the activity of the continuous team
山崎孝佳1,2), 國澤真希子1,2), 渡邉淳子1), 伊藤良和1), 楠井由紀1), 佐々木直子1), 松井亨介1), 古井和雄1), 山本孝枝2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1247-1247, 2022.
Japanese Article P514-25-AM. Survey of the remedy medicine situation in our hospital dementia care team intervention patients
田口諒1), 元木孝1), 土井竜樹1), 渡邊清人1), 高柳昌宏1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1248-1248, 2022.
Japanese Article P516-25-AM. Carbocisteine internal use during pregnancy and examination of the risk of developing congenital anomalies of the child born
磨田真理子1), 左勝則2), 小林瑞希1), 永野浩之1), 山根律子4), 八鍬奈穂3), 後藤美賀子3), 村島温子3), 眞壁秀樹1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1249-1249, 2022.
Japanese Article P517-24-PM. One case of the pharmaceutical intervention for the AT3 deficiency merger pregnancy
中島春佳1), 片岡達夫1), 三木陽介1), 佐伯康之1), 松尾裕彰1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1250-1250, 2022.
Japanese Article P518-25-AM. 2 cases using the coronavirus therapeutic drug new late in the pregnancy
手島慶子1), 藤川理紗1), 瀬川侑里香1), 木村真策1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1251-1251, 2022.
Japanese Article P519-24-PM. Examination about pharmacist intervention and the after giving birth psychiatry hospitalization to schizophrenia expectant mothers
小泉寿子1), 田久保陽司2), 西悠吾1), 永瀬怜司1), 辻野尚久2), 菅野浩1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1252-1252, 2022.
Japanese Article P520-25-AM. It is ... about an effect of the multicenter LIVE participation type practice using attempt - picture for the enhancement of "the pregnancy, the nursing and the medicine" in the business training
三好文子1), 小林亜貴子1), 稲見彩香1), 岩田みなみ1), 栗原明日香1), 出雲貴文1), 小茂田昌代1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1253-1253, 2022.
Japanese Article P521-24-PM. The medication situation investigation of a pregnant woman, the nursing mother in our hospital
田口舞子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1254-1254, 2022.
Japanese Article P522-25-AM. Examination of 2 cases that led to the pregnancy after the MTX discontinuation of women with the rheumatoid arthritis
赤阪未来1), 平井利典1), 金田倫子2), 西岡美喜子2), 池田智明2), 岩本卓也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1255-1255, 2022.
Japanese Article P523-24-PM. Examination of the SGLT2 inhibitor effect on patients with hyperuricaemia merger diabetes using the tendency score matching
中嶋丈晴1), 石本昌裕1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1256-1256, 2022.
Japanese Article P524-25-AM. Questionary survey about the instruction contents for the injection timing at super quick effect type insulin preparation introduction
上杉章紀1), 河原陽介2), 突田壮平3), 加藤良治2), 田邉文明1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1257-1257, 2022.
Japanese Article P525-24-PM. Investigation about the tendency to onset of adverse event in the incretin analogous drug using the Japanese adverse drug reaction database
青山京介1), 野口義紘1), 久保賢晃1), 吉澤俊輔1), 舘知也1), 寺町ひとみ1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1258-1258, 2022.
Japanese Article P526-25-AM. Example that led to healing by medicine for external application therapy for 2 degrees burn with the boiling water
西村博之1), 吉田陽1), 塩山由紀1), 守田彩文1), 高田雅文1), 栗並昇2), 鈴木知子2), 梶原敬三2), 稗島州雄2), 杉山正悟2), 陣内克紀2), 陣内冨男2), 陣内秀昭2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1259-1259, 2022.
Japanese Article P527-24-PM. Examination - about the factor having an influence on questionary survey - medication compliance about the medication situation in the antidiabetic drug internal use patients
岩村雪菜1), 畑中崇志2), 大田垣奈津美3), 森泰子1), 谷上知絵里1), 田村浩二1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1260-1260, 2022.
Japanese Article P528-25-AM. Evaluation of the efficacy and safety of the new GLP-1 receptor agonist injection semaglutide (Ozempic) in patients with type 2 diabetes mellitus
楊奈月1), 早川伸樹1,2), 津川透1,3), 福井愛子1), 亀井浩行1), 桑原宏貴3), 公文尚子2), 松尾悠志2), 鈴木敦詞2), 山田成樹3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1261-1261, 2022.
Japanese Article P529-24-PM. eGFR investigation and problem of the current situation and the metformin remedy patients of the antidiabetic drug prescription of our hospital
鎌田敬志1), 松田千佳1), 田中大輔1), 清野由利1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1262-1262, 2022.
Japanese Article P530-25-AM. The adverse drug reaction database (JADER) vonoprazan induction nephropathic safe signal detection that we used
石田将之1), 土屋雅美2), 飯原大稔1,8), 内藤順子3), 河添仁4), 渡辺大地1), 野中佑二郎5), 佐野美佳6,8), 境浩康7,8), 熊田恵介8), 大倉宏之3), 清水雅仁7,8), 鈴木昭夫1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1263-1263, 2022.
Japanese Article P531-24-PM. Efforts of CKD team activity and the CKD education hospitalization
桝屋根佳子1), 倍味亜矢子1), 佐武喜美子1), 足立哲也1), 藤原木綿子2), 右梅貴信3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1264-1264, 2022.
Japanese Article P532-25-AM. The screening of patients in CKD in the health insurance pharmacy: We guess from prescribed medicine
島祐子1), 有山知代1), 那須祥子1), 山森直子1), 萩原睦子1), 川端昌康1), 清川大知1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1265-1265, 2022.
Japanese Article P533-24-PM. Investigation of iron dynamics and Hb levels in hemodialysis patients switched from high-dose erythropoiesis-stimulating factors to roxadustat
野田聖奈子1), 桑村恒夫1), 中川義浩1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1266-1266, 2022.
Japanese Article P534-25-AM. One case that intervened pharmaceutical for the constipation of the peritoneal dialysis patients that constructed gastric fistula and hypokalemia
森脇健太郎1,2), 鈴村雅之1), 野々山英人1), 窪田知仁2), 水谷日花里2), 田中裕子2), 大矢知立城2), 松田千裕2), 森実優2), 加藤公人2), 川崎好人2), 西川嘉広2), 橋本陽2), 今西義紀2), 小出哲朗2), 伊藤久美子2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1267-1267, 2022.
Japanese Article P535-24-PM. Seasonal variation of eGFR based on the serum creatinine level of the outpatient
甲元大樹1), 花房伸幸1), 中尾なつみ1), 小池彩子1), 大道淳二1), 森英樹1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1268-1268, 2022.
Japanese Article P536-25-AM. Change of the trough level by the TEIC inside the hospital regimen revision
加藤渓1), 野呂智晴1), 山下悠希1), 上坊健太1), 田辺和史1), 小林謙一郎2), 久保健児2), 古宮伸洋2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1269-1269, 2022.
Japanese Article P537-24-PM. Examination of the kidney protection by vildagliptin and the kana glyph rosin combination
阿部多嘉浩1), 大橋春香1), 宮越貴之1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1270-1270, 2022.
Japanese Article P538-25-AM. Prescription adequacy by the renal function test value confirmation in the ethical pharmacy
山口貴大1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1271-1271, 2022.
Japanese Article P539-24-PM. Effect of the antipsychotics in the deglutition dysfunction patients
長田一晃1), 横山匠太1), 森川記道1), 安原昌宏1), 原田靖子1), 有田裕一2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1272-1272, 2022.
Japanese Article P540-25-AM. The prospects of the efforts of the pharmacist in the elderly people care team for the improvement of the polypharmacy
小山晃紀1), 高山慎司1), 山田宇以2), 西沢幸子3), 齋藤尚子3), 田中万里子3), 田口雅子3), 岡村大介4), 小貫早希4), 並木千裕4), 熊谷三智5), 仲野真由美6), 後藤一美1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1273-1273, 2022.
Japanese Article P541-24-PM. Inspection of the delirium risk screening based on results
永江隆二1), 屋敷久恵2), 中川友樹1), 和泉柚衣3), 塩崎真由3), 内山幸子1), 松田守弘4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1274-1274, 2022.
Japanese Article P542-25-AM. Effect of polypharmacy measures utilizing "elderly people pharmaceutical products proper use promotion business" by Ministry of Health, Labour and Welfare
陶山泰治郎1), 香川瞭子1), 今滝泉1), 佐藤拓洋1), 篠永浩1), 原田典和1), 加地努1), 三河麻里2), 松永徹也3), 合田佳史3), 植松由美子4), 藤川達也5)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1275-1275, 2022.
Japanese Article P543-24-PM. Examination of the effect that polypharmacy conference gives to a physician, a nurse
土田真菜1), 古見嘉之1), 鯨井あずさ1), 関根祐介1), 佐藤友彦2), 清水聰一郎2), 竹内裕紀1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1276-1276, 2022.
Japanese Article P545-24-PM. Research about problems of the medication in the special elderly nursing home
勝村紀香1), 幡生あすか2), 亀井章3,4), 大石雅子3), 上田幹子2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1277-1277, 2022.
Japanese Article P546-25-AM. Single institution crossing study of the frailty-related factor in elderly people who received a clinical survey 65 years or older
高橋雄太1), 新木美枝2,3), 大山善昭4), 長嶺歩1), 高橋恵美利1,2), 今井邦彦5), 林邦彦6), 中村哲也4), 倉林正彦7), 大林恭子1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1278-1278, 2022.
Japanese Article P547-24-PM. Meta analysis about pressure sore degree of improvement and the oral serum zinc using the PUSH score
中山裕一1,2), 近藤晃代1,3), 福田愛1,4), 藤村睦子1,3), 首藤哲也1,5), 濱添陽平1,5), 野村美佐子1,6), 五十嵐敦之1,7)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1279-1279, 2022.
Japanese Article P548-25-AM. About the efforts of the pharmacist in the pressure sore measures team
新城唯1), 横田幸子1), 矢野遥子1), 藤岡英子2), 高橋智子3), 東直美4), 馬屋原孝恒5), 杉山成史6), 森英樹1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1280-1280, 2022.
Japanese Article P549-24-PM. Evaluation of the effectiveness of the naldemedine in the bowel control of the artificial respiration management COVID-19 patients
疋田絵梨1), 城田幹生1), 安武夫2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1281-1281, 2022.
Japanese Article P550-25-AM. Survey on the efficacy and safety of romosozumab in combination with active vitamin D preparations
森崎崇文1), 星野輝彦1), 下田賢一郎1), 杉山留美子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1282-1282, 2022.
Japanese Article P551-24-PM. One case that intervened pharmaceutical for use of DDAVP oral medication to the central diabetes insipidus due to the injury
横澤大輔1,2,3,4), 金子恵未2), 木村相樹3), 水谷雅臣4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1283-1283, 2022.
Japanese Article P552-25-AM. Setup of the palliative care team in the safety net hospital
下村真代1), 赤峰伴子2), 古海和博1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1284-1284, 2022.
Japanese Article P553-24-PM. Factor search to be involved after the operation in Remy masochist lymphangioleiomyomatosis treated patients at awakening time
桑名諒美1), 石野清亮1), 高岡雄一1), 柏原聖人1), 矢部勝茂1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1285-1285, 2022.
Japanese Article P554-25-AM. About the contribution to the medical therapy by the medication follow-up to be carried out and medical economy of the drugstore pharmacist
塚田泰隆1), 中山恵子1), 三部陽司2), 小沼美佐2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1286-1286, 2022.
Japanese Article P555-24-PM. Search of the factor having an influence on the number of the egg collection in the GnRH antagonist method
清水美希1,2), 加藤芳徳1,3), 磯奈津実3), 小山芽衣3), 尾形育恵3), 島袋里沙子3), 齋藤勲2,3), 末永昭彦5,6), 中村裕義1,3,4), 山田治美1,3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1287-1287, 2022.
Japanese Article P556-25-AM. Use experience of the zoledronic acid (once a year preparation) in our hospital
野口直子1), 延藤勇1), 豊浜隆1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1288-1288, 2022.
Japanese Article P557-24-PM. About the development of the foam-formed medication supplement and effect on drug dissolution
瀧川雄太1), 倉家健太朗1), 深谷京子1), 金谷太作1), 中西謙次郎1), 小林正志1), 齊藤順平2), 小村誠2), 阿部浩之3), 山谷明正2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1289-1289, 2022.
Japanese Article P559-24-PM. Change of the Levodopa injection preparation consumption after conversion table making common knowledge from a Parkinson's disease internal use therapeutic drug in Nagoya Memorial Hospital to Levodopa injection preparation
近藤奈央子1), 湯浅周1), 壁谷めぐみ1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1290-1290, 2022.
Japanese Article P560-25-AM. Safe evaluation of dapagliflozin propylene glycol tablets to patients with chronic cardiac insufficiency in the decreased renal function patients
西尾洋平1), 古谷一平1), 関谷泰明1), 井上壽江1), 平下智之1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1291-1291, 2022.
Japanese Article P561-24-PM. Stocktaking of the drug adjustment at delirium measures that a dementia care team performs
瀬古高裕1), 辻内喜久雄2), 山名知子3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1292-1292, 2022.
Japanese Article P562-25-AM. Of the polypharmacy activity in the Saiseikai Hiroshima Hospital, actually
佐々木雄啓1), 浜本友絵1), 高橋栄子1), 山田真帆1), 梶山大地1), 山橋昌代1), 岡村和彦1), 松本公治2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1293-1293, 2022.
Japanese Article P563-24-PM. Relation of the pharmacy for patients with congenital afibrinogenemia
石橋真実1), 新城唯1), 矢野遥子1), 大道淳二1), 森英樹1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1294-1294, 2022.
Japanese Article P564-25-AM. Evaluation of the copper-dependent enzyme activity in the brain tissue of the Menkes disease model animal
平野茉優1), 竹下日南乃1), 鈴木詩菜1), 丸目彩華1), 児玉浩子2), 高橋秀依3), 深水啓朗4), 山岸喜彰1), 工藤敏之1), 伊藤清美1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1295-1295, 2022.
Japanese Article P565-24-PM. Study on substitute end-point (surrogate endpoint) in the cancer clinical study
真貝理子1), 原明日香1), 村井由奈1), 前田英紀1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1296-1296, 2022.
Japanese Article P566-25-AM. Efficiency of trial secretariat duties by the train introduction to magnetize of the trial-related document
秋吉明子1), 早川郁子1), 陣上祥子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1297-1297, 2022.
Japanese Article P567-24-PM. The current situation and problem in the clinical experimental medicine administrative work transfer to the pharmacy
吉川あゆみ1), 伊藤直哉1), 山田彩加1,2), 塚野千尋1), 伊東孝子1,2), 本郷文教1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1298-1298, 2022.
Japanese Article P568-25-AM. The current situation and wish of the pharmacist of the hospital in the home visit practice being able to do it
三浦美香1), 川埼智子1), 齊藤文香1), 新穂裕子1), 吉澤雅恵1), 山田浩介1), 西須永実理1), 前原正規2), 長澤宏之1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1299-1299, 2022.
Japanese Article P569-24-PM. Community medical care cooperation systems construction first report for the cooperation-based dementia early detection of community-acquired drugstore pharmacist - Primary care physician
甲斐麻美子1), 勢島英2), 冨永宏冶1), 森田一俊1), 林稔展1), 小野和彦1), 山口良介3), 田頭仁美4), 高田真紀子5), 勢島充4), 江川孝1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1300-1300, 2022.
Japanese Article P570-25-AM. Inquiry analysis second report about the TPN from the ethical pharmacy
掛水瑞芳1), 五十嵐遼1), 竹林佑花1), 松田直子1), 吉岡小都子1), 星泉1), 佐々木美由紀1), 福田まゆみ1), 岩原良晴1), 河野裕則1), 沢田憲彦1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1301-1301, 2022.
Japanese Article P571-24-PM. Intervention of the nutrition education in the community pharmacy for patients with ulcerative colitis
高見陽一郎1), 岩倉沙耶1), 金本拓始1), 神垣真理子1), 松尾陽子1), 松元享平1), 安倉央1), 高橋正志1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1302-1302, 2022.
Japanese Article P572-25-AM. Consideration about a function, the nature of the pharmacist sought by the at-home palliative care support drugstore (tentative name)
高柳論也1), 高橋幸江1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1303-1303, 2022.
Japanese Article P573-24-PM. Attitude survey of the operation situation and physician, pharmacist of the tracing report in Higashi-ku, Sapporo-shi
徳留章1,2), 佐藤彩伽1,2), 鈴木直哉2,3), 藤村拓也2,4), 重成大介2,5), 菊池健2,6), 谷口亮央2,3), 樋浦一哉7), 山下美妃7), 木明貴幸1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1304-1304, 2022.
Japanese Article P574-25-AM. Example that suffered from the bowel control in the home care patient
高木綺1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1305-1305, 2022.
Japanese Article P575-24-PM. An example of the breast cancer terminally ill patients during the home care that olanzapine was effective for nausea, vomiting, inappetence with the cachexia
大野(川井)朋子1,2), 中村仁美3), 清水一樹1), 大田和枝4), 百賢二2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1306-1306, 2022.
Japanese Article P576-25-AM. Good use of check sheet for the outpatient whom a health insurance pharmacy works on
銭田真里1), 二口恵子1), 佐藤麻美子1), 安田留美1), 杉田尚寛2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1307-1307, 2022.
Japanese Article P577-24-PM. Inspection about the usefulness of the new coronavirus study session for support groups as the indirect support to the issue of infection of the alien
池浦恵1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1308-1308, 2022.
Japanese Article P578-25-AM. We want to look at home. Can you come back in this? - - important the preparations until a discharge
荒川昌史1), 遠藤径世1), 堀越亜希子2), 安藤恵3), 竹野信吾4), 小林友稀4), 境美智順5), 藤村昭太1), 小坂仁2), 今井靖1,6)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1309-1309, 2022.
Japanese Article P579-24-PM. One case that it ached, and a diary was useful in introduction of the opioid therapy for patients with old cancer during home care
宮田成康1), 藤田あゆみ2), 菅原大典1), 小林徹也1), 杉浦伸哉2), 杉浦克典2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1310-1310, 2022.
Japanese Article P580-25-AM. Fact-finding about PCA pumps, and the like in the at-home palliative care for health insurance pharmacies
飛鷹範明1,3), 宇都宮晴菜2), 河野安3), 縄田幸裕3), 宇田雅実3), 古川清3), 田中守1,3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1311-1311, 2022.
Japanese Article P581-24-PM. The example that tried medicine medicine cooperation about the case that a low Na blood symptom and cognitive impairment occurred by valproic acid prescribed for elderly people epilepsy from the at-home specialization type drugstore
藤原將平1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1312-1312, 2022.
Japanese Article P582-25-AM. Example ... which was able to provide optimal medical therapy by the cooperation with the type of job other than in role - area of the hospital pharmacist in the treatment at home
坂口美智子1), 西村幾美1), 永井聡子2), 宮脇光二3), 服部雄司1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1313-1313, 2022.
Japanese Article P583-24-PM. Problem in the correspondence to the foreign language speaker patients at the health insurance pharmacy
高橋恵美利1), 廣木美玲1), 長谷川史朗2), 大林恭子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1314-1314, 2022.
Japanese Article P584-25-AM. Making and pharmacist questionary survey of the minute assessment-based digestive organ internal medicine TR (tracing report) model
菊地健太1), 松永裕理1), 川村道子1), 元木有加里1), 小栗るみ子1), 川端春乃2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1315-1315, 2022.
Japanese Article P585-24-PM. Illness medicine for patients with COPD cooperation aiming at screening and early diagnosis in the ethical pharmacy
山下祥史1), 小川愛2), 田口浩史1), 犬塚博貴2), 森田みゆき2), 楠富伊織2), 椛田昇治2), 福井大樹1), 森岡美行1), 淺井季晴1), 廣瀬隆2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1316-1316, 2022.
Japanese Article P586-25-AM. Efforts and evaluation by the collaboration with the drugstore pharmacist for the purpose of the medicine medicine cooperation reinforcement in the foreign chemotherapy
北出紘規1), 菅幸生2), 宮永和美1), 西野正義1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1317-1317, 2022.
Japanese Article P587-24-PM. The making of structure to make use of a cancer domain tracing report in improvement in further pharmacist power
中村久美1), 鬼窪利英1), 淺野未代子2), 窪田靖3), 木村紗也加4), 宮澤遥5)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1318-1318, 2022.
Japanese Article P588-25-AM. The use situation of the family drugstore in patients in the antiHIV therapy and the prescription notebook
成田綾香1), 高山次代2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1319-1319, 2022.
Japanese Article P589-24-PM. Investigation of contents and the reflection rate of the tracing report from the health insurance pharmacy
村川公央1), 猪田宏美1), 座間味義人1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1320-1320, 2022.
Japanese Article P590-25-AM. Inventory survey about the intervention to the current situation and prescription adequacy of the polypharmacy in the pharmacy service under health insurance drugstore
図師彩音1), 小松浩大1), 井口舞香1), 奥田和貴1), 渡邊卓巳1), 伊達悠香1), 山田智栄子1), 白石貴寿1), 荒井宏人1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1321-1321, 2022.
Japanese Article P591-24-PM. The current situation and the problem of the tracing report in Rousaibyoin, China: Kure, Hiroshima district investigation
富永祥子1), 西園寺真二1), 松田翔平1), 高橋優美1), 森内貴子1), 藤井朋子1), 山崎美保1), 面田恵1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1322-1322, 2022.
Japanese Article P592-25-AM. Construction of the medicine medicine cooperation using "a heart failure follow-up sheet"
大橋泰裕1), 中澤実紀1), 和田厚幸2), 松浦佳代1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1323-1324, 2022.
Japanese Article P593-24-PM. Operation of the doubt inquiry simplification protocol in outside Parliament and the in-hospital prescription
玉置秀成1), 草巻直人1), 丸山奈緒子1), 瀬尾崇識1), 紙谷瑞希1), 三瀬宏海1), 西本美由紀1), 冨岡謙二1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1325-1325, 2022.
Japanese Article P594-25-AM. One case that contributed to treatment of invasive pulmonary aspergillosis by medicine medicine cooperation in the outpatient department
田村知子1), 吉岡睦展2), 高子優子2), 若松雄太2), 石津智司2), 小澤拓2), 饒平名長武2), 岡本忠司3), 小溝優子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1326-1326, 2022.
Japanese Article P595-24-PM. Fact-finding of the necessary information of the information contact book between institutions before hospitalization in the regular hospital such as person with a disability institutions, and the like
木村美紗子1), 星野輝彦1,2), 杉山留美子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1327-1327, 2022.
Japanese Article P596-25-AM. Questionary survey about the drug information sharing system between hospital - health insurance pharmacies at hospitalization and release
前川綾子1), 西村健二1), 石田亮2), 亀井健人1), 赤木晋介1), 徳田衡紀1), 高柳和伸1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1328-1328, 2022.
Japanese Article P597-24-PM. Efforts for the pharmacist training specialized in local pharmacy care in the Kitano Hospital
近藤篤1,2), 西村碧2), 尾上雅英1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1329-1329, 2022.
Japanese Article P598-25-AM. Fact-finding about the medication reporting book
鶴野結花理1), 須永雅恵1), 仁井田怜子1), 堀内美樹博1), 塩地園代1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1330-1330, 2022.
Japanese Article P600-25-AM. Relation of a medication reporting book and the hospital pharmacist
高橋知里1), 麻生美佐子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1331-1331, 2022.
Japanese Article P601-24-PM. Inventory survey about the current situation of the pharmaceutical management in the cancer chemotherapy for the pharmacy service under health insurance drugstore
伊達悠香1), 奥田和貴1), 小澤明日香1), 小松浩大1), 駒沢穂乃佳1), 高木栄希1), 鈴木美和1), 白石貴寿1), 荒井宏人1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1332-1332, 2022.
Japanese Article P602-25-AM. Investigation about the recognition to drug control summary in an insurance pharmacist and the hospital pharmacist
石橋楽至1), 赤羽孝之1), 高野尊行1), 内藤裕之1), 中丸朗1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1333-1333, 2022.
Japanese Article P603-24-PM. Use investigation of "the inhalational instruction enforcement report, reporting book" of the city unification pattern
土田裕貴1,2,3), 吉岡睦展1), 高子優子1), 村上紘世2), 小溝優子2), 田村知子2), 森本愛2), 畑世剛2), 灘波良信3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1334-1334, 2022.
Japanese Article P604-25-AM. Start of the health insurance pharmacy for patients with cancer and the cooperation meeting in the Osaka Red Cross hospital
山瀬大雄1), 藤原洋一2,3), 松本早織1), 中嶋江美1), 原田慶子1), 尾本和彦1), 吉野秀紀1), 谷大輔1), 安田成男1), 門馬佳代子1), 山田邦義1), 辻井佳代1), 岡田錦2,4), 高田光治2,5), 堀越博一6,7), 小林政彦1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1335-1335, 2022.
Japanese Article P605-24-PM. Inflection of the discharge drug information cooperation summary in the medicine medicine cooperation and the evaluation
津吹澄1), 八木智美2), 陳内博之1), 大塚健太3), 沖田直美1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1336-1336, 2022.
Japanese Article P606-25-AM. The example that prevented the disadvantage of patients by information from hospital pharmacist
浅野陽子1), 日高良昌1), 岡敦子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1337-1337, 2022.
Japanese Article P607-24-PM. The making of the exclusive tracing report for the foreign cancer chemotherapy and examination of the usefulness
丹羽今日子1), 加藤寛子1), 櫻井秀司1), 鈴木景子1,3), 船渡三結1), 西田承平1), 廣瀬智恵美1), 藤井宏典1), 石原正志1), 小林亮1,2), 飯原大稔1), 安田浩二1), 鈴木昭夫1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1338-1338, 2022.
Japanese Article P608-25-AM. As compared with effect investigation - regular hospital that the ward drug duties in the local inclusion care ward give to medication adherence ...
石原瑛太郎1), 大嶋成奈優1), 石井照樹1), 沖廣絵里子1), 高橋公子1), 篠永浩1), 原田典和1), 加地努1), 石山晃子2), 中津守人3), 矢野禎浩4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1339-1339, 2022.
Japanese Article P609-24-PM. The construction of the contact system to the physician for the tracing report and evaluation of the usefulness
櫻井秀司1), 加藤寛子1), 丹羽今日子1), 鈴木景子1,3), 船渡三結1), 西田承平1), 廣瀬智恵美1), 藤井宏典1), 石原正志1), 小林亮1,2), 飯原大稔1), 安田浩二1), 鈴木昭夫1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1340-1340, 2022.
Japanese Article P610-25-AM. It is applied the withdrawal request book one package of the cancellation drug before surgery, examination for the health insurance pharmacy
阿部圭輔1), 妹尾啓司1), 西本早紀1), 河村勇介1), 岡原夏実1), 白木政博1), 渡邊篤1), 松本俊治1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1341-1341, 2022.
Japanese Article P611-24-PM. Investigation about the reception of the tracing report through the cooperation full addition and the in-hospital utilization situation
千葉典子1), 安田真貴子1), 高田美香2), 山下慈2), 小野優紀1), 柴田美代子1), 棟方正樹3), 山本章二1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1342-1342, 2022.
Japanese Article P612-25-AM. Efforts for the introduction of the doubt inquiry simplification protocol for the outside Parliament prescription in children, the perinatal medical special hospital
岩西雄大1), 大津由美子1), 望月千枝1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1343-1343, 2022.
Japanese Article P613-24-PM. The current situation investigation of efforts and the tracing report for medicine medicine cooperation reinforcement to affect cancer chemotherapy
小森智也1), 坂本靖宜1), 川邉桂1), 小池博文1), 佐橋幸子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1344-1344, 2022.
Japanese Article P614-25-AM. Through problem - majority disabled acceptance training of the supply system of the prescription order medicine at disaster -
森川祥彦1), 田坂健1), 赤阪未来1), 寺村文恵2), 家城洋平2), 向原里佳1), 岸和田昌之2), 岩本卓也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1345-1345, 2022.
Japanese Article P615-24-PM. Inventory survey for the purpose of the stocktaking of the consciousness about the disaster medical care relief activities in the pharmacy service under health insurance drugstore and regional alliances
駒沢穂乃佳1), 井上優子1), 渡邊卓巳1), 小澤明日香1), 小川実華1), 図師彩音1), 高橋里沙1), 青柳晴彦1), 白石貴寿1), 荒井宏人1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1346-1346, 2022.
Japanese Article P616-25-AM. Uptake to pharmacist upbringing to be engaged in disaster medical care
上田賢太郎1), 下石和樹1), 合澤啓二1), 岩田一史1), 古庄弘和1), 富島喜朗1), 小山勢納1), 陣上祥子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1347-1347, 2022.
Japanese Article P617-24-PM. About night holiday BCP development of the pharmacy and the utilization
杉村沙樹1), 椴山麻紗子1), 中村美月1), 宮井悠里1), 宮本翔子1), 前川真己1), 藤井稚奈1), 青木勇樹1), 寺尾さくら1), 佐々木貴之1), 杉本央司1), 山川智一1), 佐々木香織1), 加藤恵一1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1348-1348, 2022.
Japanese Article P618-25-AM. Relation of the pharmacist to the disaster medical care in the Osaka disaster medical care cooperation hospital
福田裕子1), 大井隆広1), 柿花美沙紀1), 森田貴子3), 高橋務2), 北澤文章1), 辻川正彦1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1349-1349, 2022.
Japanese Article P619-24-PM. Examination of the economic effect that the intervention of the pharmacist by the foreign establishment before operation gives in a hospital
千葉陽月1), 中鏡暁子1), 笹野央1), 井上真由美1), 佐藤邦義1), 荒川隆太郎1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1350-1350, 2022.
Japanese Article P620-25-AM. Evaluation of the effect about the administration of cover suspicion medicine evasion with the uniform management system of a side effect, the allergic information for outpatients
荒木良介1), 村上春奈1), 加藤加奈恵1), 浜本知之2), 田中恒明3), 山田英紀1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1351-1351, 2022.
Japanese Article P621-24-PM. Efforts to the proper use promotion of the unrest in the ward, sleeplessness indicator
渡邊一史1), 西川まり絵1), 奥沙耶佳1), 栗原陽介1), 大橋養賢1), 増田純一1), 寺門浩之1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1352-1352, 2022.
Japanese Article P622-25-AM. The study implementation situation as HBV (HBV) reactivation measures in our hospital
大森悠翔1), 平手大輔1), 今多亮介1), 三間晋也1), 若井香鈴1), 桑島遥1), 小山内大雅1), 本郷文教1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1353-1353, 2022.
Japanese Article P623-24-PM. Introduction of in-hospital formulary for sleeping pills and its effectiveness
萩原大樹1), 伊藤弥紀1), 東恵理1), 永江寛子2), 敷島友喜1), 兼重晋2), 神村英利2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1354-1354, 2022.
Japanese Article P624-25-AM. About a change of the number of near miss by the near miss paper chase
片原憂斗1), 加藤礼奈1), 横井妙子1), 島崎良知1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1355-1355, 2022.
Japanese Article P625-24-PM. The efforts which makes use of a report of incident event level 0 (zero) in improvement
三浦忠将1), 浅野岳人1), 高木竜一1), 阿部彩香1), 白井麻奈1), 杉浦礼菜1), 中村和行1), 奥平正美1), 杉浦洋二1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1356-1356, 2022.
Japanese Article P626-25-AM. It is ... for medical safe activity - fall rate improvement by the sleeping drug formula reintroduction in the friendship medical center
高安芽衣子1), 平識善彦1), 安丸史織1), 小杉卓大1), 大城匡史1), 國分千代1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1357-1357, 2022.
Japanese Article P627-24-PM. Fall fall risk factorial experiments (validity inspection in the validation group) using the on admission evaluation score
石田亮1), 赤木晋介2), 西出康晴3), 塩津昭子3), 徳増裕宣1), 橋本徹3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1358-1358, 2022.
Japanese Article P628-25-AM. The effect that familiarity gives to name similarity and the appearance similarity on pharmaceutical products
村高紫野1), 向井淳治1), 裏山悠哉1), 堀口悠太1), 西村真央1), 木村実央1), 山本裕聖1), 奥田広志1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1359-1359, 2022.
Japanese Article P629-24-PM. It is the examination about the effect by the withdrawal system introduction for oral medicine 1st
田村研太郎1), 橋本光生1), 近藤智幸1), 簑島弓未子1), 増渕幸二1), 鈴木正樹1), 多地貴則1), 斉藤芳敬1), 設楽愛美1), 榎本尚哉1), 荻野健吾1), 武田知佳1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1360-1360, 2022.
Japanese Article P630-25-AM. The system maintenance and the medical economical effect that was obtained on improvement in doubt inquiry rate
松本貴行1), 立石裕樹1), 池田都1), 永田理佳1), 矢野洋平1), 山下大貴1), 宮津大輔1), 田中博和1), 井上幸子1), 渡邊裕之1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1361-1361, 2022.
Japanese Article P631-24-PM. Preventive measures against administration day mistake of the peg filgrastim subcutaneous injection in our hospital
西村真央1), 向井淳治1), 小竹優希1), 坂本竜平1), 竹原涼子1), 上田真隆1), 山田佳菜子1), 奥田広志1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1362-1362, 2022.
Japanese Article P632-25-AM. Investigation of suspension pH when we suspended multiple drugs by simple suspension at the same time
大野峻1), 田辺優斗1), 平塚優稀佳1), 武田元樹1), 菊池健1), 鶴山辰1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1363-1363, 2022.
Japanese Article P633-24-PM. The effect that the improvement of drug duties by the pharmacist increase of the staff gives to a medical safe clinical index
松尾裕彰1), 柴田ゆうか1), 佐藤智人1), 泉谷悟2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1364-1364, 2022.
Japanese Article P634-25-AM. Efforts to incident recurrent prevention with the overdose of the heparin Na preparation
青砥孝道1), 陣野大輔1), 小久保博子2), 大塚幹夫2), 黒田純子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1365-1365, 2022.
Japanese Article P635-24-PM. One patient whom an allergic symptom developed in with optical resolution pharmaceutical products and the racemic body pharmaceutical products including the same ingredient: Consideration from questionary survey and package insert mention information
市川慶1), 内田裕之1), 満田正樹1), 河井良智1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1366-1366, 2022.
Japanese Article P636-25-AM. Examination about the quantity of upper limit setting of the pediatric dose for the purpose of the overdose prevention
山本崇1), 加藤果林1,2), 松村由美1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1367-1367, 2022.
Japanese Article P637-24-PM. Change (competitive review with 2019) of the doubt inquiry contents in the outside Parliament prescription
高取俊和1), 前田貴人1), 千田純子1), 東山千央1), 岡本知久1), 沖田健太郎1), 竹田克明1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1368-1368, 2022.
Japanese Article P638-25-AM. Investigation about the duties of the pharmacist in the patients support center
竹村充代1), 本名房美1), 高田史1), 勝浦正人1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1369-1369, 2022.
Japanese Article P639-24-PM. Efforts for the injectable potassium preparation proper use from the central veins route in the regular hospital and the evaluation
中山典幸1,2), 八島秀明1), 金田亜季子1), 阿部正樹1), 荒木拓也1), 小松康宏2), 山本康次郎1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1370-1370, 2022.
Japanese Article P640-25-AM. The personality test Myers-Briggs Type Indicator workshop for the pharmacy student and the outcome
河添仁1,2), 大里洋一3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1371-1371, 2022.
Japanese Article P641-24-PM. Knowledge degree of achievement of the palliative care domain before and after the hospital business training for the pharmacy school student in Miyagi, investigation of the understanding degree
大内竜介1,2), 薄井健介1,2), 渡邊卓嗣1,2), 岡田浩司1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1372-1372, 2022.
Japanese Article P642-25-AM. The effect that the practice about the line design of the injection drug administration gives for the understanding of the pharmacy school business trainee
内海明香里1), 石川雅之1,2), 大久保正人1), 内田雅士1,2), 鈴木貴明1,2), 石井伊都子1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1373-1373, 2022.
Japanese Article P643-24-PM. Attitude survey of the business trainee about the perinatal medical care
曽我部直美1), 植松和子2), 岩佐千尋3), 小泉寿子4), 間宮伸幸5), 楠見彰宏5), 田中嘉一3), 菅野浩4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1374-1374, 2022.
Japanese Article P644-25-AM. Efforts and evaluation for the maintenance of the quality of will and the training of the business trainee in the corona evil
岩切智美1), 関屋裕史1), 大野梨絵1), 畑中真理1), 奥村学2), 保田和哉1), 吉川直樹1), 田崎智也1), 竹島秀美1), 岩田円夏1), 池田龍二1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1375-1375, 2022.
Japanese Article P645-24-PM. Examination of the education effect by the on-line multi-type of job cooperation education in the business training
林太祐1), 安武夫3), 今井亮4), 伊勢雄也1), 横堀將司2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1376-1376, 2022.
Japanese Article P646-25-AM. Approach to the duties improvement in upbringing duties of the new face pharmacist
花房伸幸1), 甲元大樹1), 平良奈々1), 山本水緒1), 小池彩子1), 大道淳二1), 森英樹1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1377-1377, 2022.
Japanese Article P647-24-PM. The preliminary study of the pneumonia level using the pocket echo for pharmacy students and the attitude survey
庄田卓矢1), 徳永仁1), 吉岡日沙子1), 皆良田吉晶1), 園田純一郎1), 興梠靖幸2), 緒方賢次2), 高村徳人2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1378-1378, 2022.
Japanese Article P648-25-AM. Production of the video teaching materials about the physical assessment training utilizing patients simulator and the synthetic sound
皆良田吉晶1), 徳永仁1), 庄田卓矢1), 吉岡日沙子1), 園田純一郎1), 興梠靖幸2), 緒方賢次2), 高村徳人2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1379-1379, 2022.
Japanese Article P649-24-PM. Student attitude survey about the injection maneuver in the learning before business true lessons
廣澤伊織1), 山本健1), 森元能仁1), 神林弾1), 渡部一宏1), 廣原正宜1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1380-1380, 2022.
Japanese Article P651-24-PM. Efforts for the employment of hospital pharmacist power reinforcement for securing of continuous human resources
田村亮1), 平野達也2), 鎌田里紗1), 藤井尚子1), 木下恵1), 奥吉博之2), 山岡健太1), 杉上裕3), 橋田亨1), 室井延之1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1381-1381, 2022.
Japanese Article P652-25-AM. Efforts of the pharmacy business training in our hospital in the corona evil
村田翔1), 神田純1), 芳山健太郎1), 増尾正則1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1382-1382, 2022.
Japanese Article P654-25-AM. Examination of the hospital training program for drugstore pharmacists
猪田宏美1), 久保和子1), 川西秀明1), 村川公央1), 座間味義人1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1383-1383, 2022.
Japanese Article P655-24-PM. Enforcement example of the pharmacist training specialized in local pharmacy care in the Kurashiki center Hospital
徳田衡紀1), 仁熊宏樹1), 石原泰子1), 菅直恵1), 西田麻以1), 赤木晋介1), 高柳和伸1), 河田英之2), 鶴海宏之3), 難波安紀美4), 西宮祐輔5)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1384-1384, 2022.
Japanese Article P656-25-AM. Efforts and problem of the local pharmacy care training of the small and medium size hospital
津曲恭一1), 松田絵理菜2), 上原智博1), 鈴木寛人1), 東盛裕里1), 長谷部歩1), 平田亮介1), 千田祥子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1385-1385, 2022.
Japanese Article P657-24-PM. Generalization of the Tokyo University of Science academic D tailor training program optimizing prescription
小茂田昌代1,2,3), 宮埼美子3,4), 山本美智子5), 宮崎智2), 高橋秀依2), 西川元也2,3), 斎藤顕宜2,3), 和田毅2), 嶋田修治2), 青山隆夫2,3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1386-1386, 2022.
Japanese Article P658-25-AM. Questionary survey about the workshop holding situation in the corona evil and the future held pattern
大野奈子1), 久保萌美1), 喜多力1), 真井雄規1), 越野早紀1), 金澤沙衣1), 能登数馬2), 田中悠季1), 三本松泰孝1), 佐藤弘康1), 田村広志1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1387-1387, 2022.
Japanese Article P659-24-PM. Examination about the significance of the hospital training by the drugstore pharmacist
渡邉尚也1), 猪田宏美2), 長谷川佳孝3), 月岡良太3), 村川公央2), 座間味義人2), 大石美也3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1388-1388, 2022.
Japanese Article P660-25-AM. Construction and evaluation of the postgraduate training curriculum aiming at pharmacist upbringing to practice team approach in medical care
宮崎俊明1), 筒井由佳1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1389-1389, 2022.
Japanese Article P661-24-PM. Effect on cooperation by the intern acceptance of the pharmacist specialized in local pharmacy care
高子優子1), 吉岡睦展1), 土田裕貴1), 細見真世1), 澁谷奈穂1), 若松雄太1), 石津智司1), 近藤万友美1), 森田聡子1), 西山祐美1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1390-1390, 2022.
Japanese Article P662-25-AM. Investigation of the expectation to the managerial class that we obtained from the non expert skill training for eyes for accession 4-6 years
新井亘1), 土屋裕伴1), 増田裕一2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1391-1391, 2022.
Japanese Article P663-24-PM. Consideration ... from efforts - questionnaire results of the health insurance pharmacy pharmacist acceptance in our hospital
高取秀人1), 田中昭洋1), 村富裕貴1), 大西翔太1), 後藤卓也1), 萱野勇一郎1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1392-1392, 2022.
Japanese Article P664-25-AM. Aim at the attractive acceptance system for introduction process of the pharmacist resident system and result - student; and ...
小池博文1), 川邉桂1), 畠山成寛1), 山本幸二郎1), 佐橋幸子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1393-1393, 2022.
Japanese Article P665-24-PM. PPT activity in our hospital for 4 years
手塚博文1), 川上健司1), 久保田靖子1), 畠山令1), 小林ゆみ1), 高橋佳暉1), 紅野友美子1), 長田真一1), 山本輝代1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1394-1394, 2022.
Japanese Article P666-25-AM. Investigation, analysis about the sale cancellation factor of the ethical drug
伊藤麻結1), 若林和貴1), 矢野瑞紀1), 馬場安里1), 高砂美和子1), 幸田恭治1), 北原隆志1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1395-1395, 2022.
Japanese Article P667-24-PM. Relation of the pharmacist by the osteoporotic liaison service in the secondary fracture prevention after the fragile bone fracture
藤井芳範1), 鬼窪利英1), 小平博之2), 櫻井利康3), 藤澤太一4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1396-1396, 2022.
Japanese Article P668-25-AM. We analyze a factor of the instructions unobservance about the stopping medicine during preoperation
長崎裕也1), 赤嶺聡彦1), 冨澤淳1), 新井万理子1), 厚田幸一郎1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1397-1397, 2022.
Japanese Article P669-24-PM. Making of the medication adherence guidelines (NICE CG76) Japanese edition
藤宮龍祥1), 川口崇1), 上田彩2), 前田幹広3), 川上和宜4), 増田純一5), 井上岳6), 添石遼平7), 大原里佳8), 益山光一8)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1398-1398, 2022.
Japanese Article P670-25-AM. Medication support tool development and inspection of the usefulness
三枝美和1,2), 澤井珠紀1), 岩下亜希子1), 村田真弓1), 坪井彩香1), 岩崎剛士1), 井原摂子1), 青島広明1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1399-1399, 2022.
Japanese Article P671-24-PM. Result by the balun strike scorecard utilization of 2021 in the Yokohama General Hospital pharmacy
鯉淵寛之1), 稲垣和幸1), 内田仁樹1), 井上純樹1), 倉田武徳1), 廣瀬直樹1), 佐村優1), 谷川浩司1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1400-1400, 2022.
Japanese Article P672-25-AM. Consideration - using the current situation findings of examination - Japanese Society of Hospital Pharmacists 2021 hospital pharmacy gate about the current situation and the problem in the drug section duties of the small and medium size hospital
佐村優1), 瀧祐介1), 横山敏紀1), 上野山周雄1), 遠藤武弘1), 大神修一1), 宮川哲也1), 吉田明弘1), 荒川隆之1), 濱浦睦雄1), 筒井由佳1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1401-1401, 2022.
English Article IP-01. Attenuation of cardiac pathological alterations in sulfotransferase 1a1-deficient mice with chronic kidney failure through decreased indoxyl sulfate accumulation
Aina Nishigaki1), Yuki Narita1,2), Yuichiro Arima3), Kenichi Tsujita4), Hirofumi Jono1,2), Hideyuki Saito1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1402-1403, 2022.
English Article IP-02. Photoisomerization of Sulindac and Ozagrel Hydrochloride by Vitamin B2 Catalyst Under Visible Light Irradiation
Mayuko Suga1), Kosho Makino1), Hidetsugu Tabata2), Tetsuta Oshitari2), Hideaki Natsugari3), Hideyo Takahashi1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1404-1405, 2022.
English Article IP-03. Simultaneous quantification of remimazolam and its carboxylic acid metabolite in human plasma using high-performance liquid chromatography-tandem mass spectrometry
Kenta Nakaya1), Satoshi Ueshima1), Mayu Kawamura1), Daiki Hira1,2), Yu Matsuura3), Tomonobu Okano1), Kaneyuki Kawamae3), Mikio Kakumoto1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1406-1407, 2022.
English Article IP-04. The precision of area under the concentration-time curve of vancomycin by Bayesian approach using creatinine-based equations of estimated kidney function in bedridden elderly Japanese patients
Akihiro Sonoda1), Yoshitaka Iwashita1), Yukina Takada1), Ryu Hamazono1), Masahiro Kambori1), Nako Nagashima1), Sho Shibata1), Chisa Morinaga1), Mayo Kodama1), Kazuhisa Ishida1), Hiroshi Imamura2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1408-1409, 2022.
English Article IP-05. Development and Evaluation of Renal Function Monitoring for Vancomycin use
Hee Jung Kim1), Eunjin Lee1), Eunkyeong Choi1), Nam kyung Je2), Sung Jin Bae1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1410-1411, 2022.
English Article IP-07. Circulating miR-320a-3p and miR-483-5p level associated with pharmacokinetic-pharmacodynamic profiles of rivaroxaban
Hanxu Zhang1,2), Zhuo Zhang1), Zhiyan Liu1), Guangyan Mu1), Qiufen Xie1), Shuang Zhou1,2), Zhe Wang1), Yu Cao3), Yunlong Tan4), Xiaohua Wei5), Dongdong Yuan6), Qian Xiang1), Yimin Cui1,2,7)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1412-1413, 2022.
English Article IP-08. Effect of Serum Erythropoietin Concentration on Chemotherapy Induced Peripheral Neuropathy Caused by Weekly Paclitaxel Therapy
Chiyomi Okamoto1), Yuichiro Kurone1), Aiko Okuda2), Yoichiro Eimura2), Saori Nakagawa3), Naoto Hirata1), Shin Ohta1), Sadahiko Shimoeda1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1414-1415, 2022.
English Article IP-09. Analysis of Pharmacist Intervention Status for Contraindications of Concomitant Drugs through Drug Utilization Review
Sang Hee Lee1), Yu Jeong Lee1), Myoung joo Kim1), Da ei Jung1), Nam kyung Je2), Sung Jin Bae1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1416-1417, 2022.
English Article IP-10. Evaluation of the Effectiveness of Atropine Administration for Prevention of Acute Cholinergic Syndrome Associated with Irinotecan
You-Ock Choi1), Eun-Ah Jo1), So-Hee Lee1), Ae-Ryoung Park1), Jeong-Yi Yoon1), Jin-Suk Kang1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1418-1419, 2022.
English Article IP-12. The Association Between the Use of Antibiotics and the Risk of Rash in Children with Infectious Mononucleosis : A Multicenter, Retrospective Cohort Study
Jiaxing Zhang1), Juan Xie1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1420-1420, 2022.
English Article IP-13. Association of Orexin Receptor Antagonists with Falls during Hospitalization
Rintaro Sogawa1), Akiko Emoto1), Yuki Miyamoto1), Misako Yukawa1), Chisato Shimanoe1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1421-1421, 2022.
English Article IP-14. The risk of acute kidney injury following prescription of proton pump inhibitor and macrolide antibiotic use
Keiko Ikuta1), Shunsaku Nakagawa1), Chinami Yamawaki1), Kotaro Itohara1), Daiki Hira1), Satoshi Imai1), Atsushi Yonezawa1), Takayuki Nakagawa1), Minoru Sakuragi2,3), Noriaki Sato2,3), Eiichiro Uchino2,3), Motoko Yanagita2), Tomohiro Terada1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1422-1423, 2022.
English Article IP-15. Analysis of adverse events with nintedanib using the Japanese Adverse Event Spontaneous Reporting Database
Masaki Fujiwara1,2), Mayako Uchida3), Yoshihiro Uesawa4), Tadashi Shimizu2), Hiroaki Ikesue1), Nobuyuki Muroi1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1424-1425, 2022.
English Article IP-16. Evaluation of Cardiac Adverse Events Associated with Carfilzomib Using a Japanese Real-World Database
Shuhei Nakao1), Mayako Uchida2), Aya Satoki1), Kenya Okamoto1), Yoshihiro Uesawa3), Ken-ichi Kiyomiya1), Tadashi Shimizu1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1426-1426, 2022.
English Article IP-17. Intestinal microbiome associated with immune-related adverse events for patients treated with anti-PD-L1 inhibitors, a real-word study
Wenhui Liu1,2), Fang Ma3), Bao Sun1,2), Yiping Liu1,2), Zhiying Luo1,2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1427-1428, 2022.
English Article IP-18. Pharmaceutical and Medical Device Act and Traceability of Pharmaceuticals for patient safety in Japan
Takao Orii1,2), Koichi Uemura3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1429-1429, 2022.
English Article IP-19. Comprehensive analysis of ixazomib-induced adverse events using the Japanese pharmacovigilance database
Kenta Yamaoka1,2), Masaki Fujiwara1,2), Mayako Uchida3), Yoshihiro Uesawa4), Tadashi Shimizu2), Nobuyuki Muroi1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1430-1431, 2022.
Japanese Article MS1. It is ... mainly on a point of invention ... age changes that you should be careful about of nourishment management and the Chinese medicine combination aiming at healthy life expectancy extension
水野英彰
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1438-1438, 2022.
Japanese Article MS2-1. Way - of the drug choice that information sharing with there being the initial treatment for acute heart failure how, and there being it took important - condition of a patient into consideration
佐藤直樹
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1438-1438, 2022.
Japanese Article MS2-2. New age of the SIADH
森建文
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1438-1438, 2022.
Japanese Article MS3. Cancer chemotherapy and hyperuricaemia
山内高弘
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1439-1439, 2022.
Japanese Article MS4. Supporting player in the sepsis-related DIC practice
安藝敬生
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1439-1439, 2022.
Japanese Article MS5-1. Benefit risk of the JAK inhibitor in the rheumatoid arthritis
岡田正人
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1440-1440, 2022.
Japanese Article MS5-2. Efforts ... of role - our hospital of the pharmacist by the team approach in medical care for patients with rheumatic disease
松原司, 舟橋惠子
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1440-1440, 2022.
Japanese Article MS6. It is ... for ... TS-1 proper use with the appropriate renal function index at dose adjustment for the decreased renal function patients
今村知世
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1441-1441, 2022.
Japanese Article MS7. History of rectal cancer treatment and the latest therapy
野澤宏彰
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1441-1441, 2022.
Japanese Article MS8. Lung cancer perioperative treatment strategy in the new era of immunotherapy - Shin tecentriq lung cancer postoperative adjuvant therapy -
渡部聡
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1442-1442, 2022.
Japanese Article MS9. ... which we think about in the case of ... cancer medical therapy to want to become a pharmacist of the interpersonal anti-thing having no restrictions
小井土啓一
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1442-1442, 2022.
Japanese Article MS10. Issue of destruction ... of medical expenses and the preparation Residual medicine becoming evolution and pit - remarkable rise of the anticancer medicine
宇佐美英績
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1443-1443, 2022.
Japanese Article MS11-1. Appearance in ... cancer treatment cares to join society together with ... patients
野澤桂子
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1443-1443, 2022.
Japanese Article MS11-2. Symptom management ... to work on by dermatopathy ... patients caused by cancer medical therapy-centered team approach in medical care
山崎直也
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1443-1443, 2022.
Japanese Article MS12. It is ... from basic ... acute phase of the fluid therapy to think about from protein to elderly people
杉浦伸一
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1444-1444, 2022.
Japanese Article MS13-1. In utilizing TDM for infection practice support; is ... through the use of important thing - LM1010
塩田有史
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1444-1444, 2022.
Japanese Article MS13-2. Re: It is ... from introduction to operation in TDM life - community care mixture type Hospital to begin with zero
畑本慶太
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1444-1444, 2022.
Japanese Article MS14. About the anti-GD2 antibody Unituxin, a new treatment for neuroblastoma
原純一
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1445-1445, 2022.
Japanese Article MS15-1. The cancer cachexia treatment that is full of misunderstanding
尾阪将人
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1445-1445, 2022.
Japanese Article MS15-2. Pharmacist intervention to begin with "we have no appetite"
中村匡志
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1445-1445, 2022.
Japanese Article MS16. Safe medical therapy and pain control of elderly people
小島太郎
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1446-1446, 2022.
Japanese Article MS17. Medical treatment in the IBD practice
八木周
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1446-1446, 2022.
Japanese Article MS18. Importance ... of the irAE management ... patients follow in the immune checkpoint inhibitor
駄賀晴子
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1447-1447, 2022.
Japanese Article MS19. Including super practical approach - delirium risk measures for the sleeplessness of the inpatient -
井上真一郎
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1447-1447, 2022.
Japanese Article Importance of the HBV reactivation risk management
日本医療薬学会
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1448-1448, 2022.
Japanese Article MS21. A 2022 medical service fees revision and the trend of the pharmaceutical policy: Significance and introduction example of the Biosimilar promotion
川上純一
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1449-1449, 2022.
Japanese Article MS22. personalized medicine for PLWH
石原正志
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1449-1449, 2022.
Japanese Article MS23. Algorithmic utilization - corresponding to the role - oral & transluminal administration of the pharmacist for the eating deglutition functional decline
倉田なおみ
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1450-1450, 2022.
Japanese Article MS24. Trend ... of treatment - these days of the malignant lymphoma
塚本憲史
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1450-1450, 2022.
Japanese Article MS25. It is ... based on new development ... new antiemetic drug and PBPM of the antiemesis therapy in the cancer medical therapy
橋本直弥
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1451-1451, 2022.
Japanese Article MS26. The medical care that is SDGs which big data and science open up
石澤啓介
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1451-1451, 2022.
Japanese Article MS27. It is ... for a case in analysis in ... GERD about a cost effectiveness evaluation of the medicine
五十嵐中
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1452-1452, 2022.
Japanese Article MS28-1. We data-process it with knowledge management, the joint ownership about pharmaceutical products done right now
神崎浩孝
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1452-1452, 2022.
Japanese Article MS28-2. It is ... mainly on introduction - data management of the tip drug information management mechanism, search mechanism
佐古卓人
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 1452-1452, 2022.
▲